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 Rotaviruses, causative agents of gastroenteritis in young animals and humans, are 
large icosahedral viruses with a complex architectur . The double-stranded RNA (dsRNA) 
genome composed of 11 segments, that codes for 6 structural and 6 non-structural proteins, is 
enclosed within three concentric capsid layers. 
 NSP5, a non structural protein, is encoded by segment 11. It is produced early in 
infection and localizes in ‘viroplasms’, cytoplasmic inclusion bodies in which viral RNA 
replication and packaging take place. NSP5 is essential for the replicative cycle of the virus 
since, in its absence, viroplasms are not formed and viral RNA replication and transcription 
do not occur. 
 NSP5 is known to undergo two different types of posttranslational modifications, a 
cytoplasmic O-glycosylation and phosphorylation, which lead to the formation of proteins 
differing in electrophoretic mobility. Although the hyperphosphorylation process of NSP5 
seems to be very complex, its role in the replicative cycle of rotavirus is unknown.  
 We demonstrated  that NSP5 operates as an auto-regulator of its own phosphorylation 
as a consequence of two distinct activities of the protein: substrate and activator. In the first 
part of the thesis we have shown, that phosphorylation of Ser-67 within the SDSAS motif 
(amino acids 63-67) was required to trigger hyperphos orylation by promoting the activation 
function. The evidence coming from iv vitro experiments, including kinase assay with 
recombinant casein kinase 1α from zebrafish, proved that this enzyme is responsible for a key 
phosphorylation step that initiates the whole hyperphosphorylation cascade of NSP5. 
 In the second part of the dissertation, using MALDI TOF/TOF spectroscopy, we added 
new data to the information about the posttranslational modifications of NSP5. We confirmed 
that the region of the protein encompassing Ser-67 is phosphorylated in vivo. Additionally we 
managed to map which parts of NSP5 sequence carries N-acetyloglucosamine and which 
regions bear phosphorylated serines or threonines.  
 There is no evidence about structure of NSP5 so far. In the last chapter we focused on 
investigating the structural organization of this crucial viral protein. To achieve this, in 
addition to the full length protein, one point mutation and two different truncation mutants 
were constructed, expressed, purified and refolded. The secondary structure of the different 
proteins was analyzed by circular dichroism spectros opy and general information about 
protein conformation was provided. Our findings, together with an analysis of NSP5 sequence 
indicate that NSP5 can be an intrinsically unfolded/ isordered protein. 
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LIST OF ABBREVIATIONS  
 
3’CS  3’consensus sequence    
5’CS  5’consensus sequence 
aa  amino acids 
Ala  alanine 
Asp  aspartic acid 
ATP  adenosine triphosphate 
bp  base pair 
BSA  bovine serum albumin 
CD  circular dichroism 
CID  collision-induced dissociation 
CK1  casein kinase 1 
CK2  casein kinase 2 
C-terminal carboxy-terminal 
DLP  double layered particles 
DMEM  Dulbecco’s modified Eagle’s medium 
dsRNA  double stranded RNA 
DTT  dithiothreitol 
EDTA  diaminoethanetetraacetic acid 
EGFP  eukaryotic green fluorescent protein 
eIF4GI  eukaryotic initiation factor 4GI 
ER  endoplasmic reticulum 
ESI   electrospray ionization 
FPLC  fast protein liquid chromatography 
GST   glutathione-S-transferase 
GTP  guanosine triphosphate 
HIT  histidine triad 
HPLC  high performance liquid chromotography 
HRP  horse radish peroxidase 
IEC   ion exchange chromatography 
IMAC  immobilized metal affinity chromatography 
IPTG  Isopropyl β-D-1-thiogalactopyranoside 
kDa  kilo Dalton 
Km  Michaelis constant 
MALDI  matrix-assisted laser desorption/ionization 
min  minute 
m.o.i.  multiplicity of infection 
MS   mass spectrometry 
N-terminal amino-terminal 
NSP  viral nonstructural protein 
ORF  open reading frame 
PABP  polyA binding protein 
PAGE  polyacrylamide gel electrophoresis 
PBS  phosphate buffer saline 
PFU  plaque forming units 
p.i.  post infection 
PKC  protein kinase C 
RPHPLC reverse phase HPLC 
SDS  sodium dodecyl sulfate 
Ser  serine 
SLP  single layered particle 
ssRNA  single stranded RNA 
TLP  three layered particle 
TOF   time-of-flight 
UTR  untranslated region 
VLP  virus like particle 
VLS  viroplasm like structure 
VP  viral structural protein 
wt   wild type
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Until the 1970s, the etiological agents of diarrhea were not specified. Bacterial, viral, 
or parasitic agents could be detected in only 10% to 30% of children with diarrhea. In 1973, 
Bishop et al. noticed a 70 nm virus particle while using electron microscopy to detect 
infection in the duodenal epithelium of children hospitalized for treatment of acute diarrhea 
[11]. It soon became clear that the 70 nm particle, subsequently called rotavirus for its wheel-
like appearance (Fig.1) (Latin, rota=wheel), was a causing agent of acute infantile 
gastroenteritis. Within 5 years after that discovery, rotavirus was recognized as the most 
common cause of diarrhea in infants and young children worldwide, responsible for 







Fig.1.    Rotavirus particles visualized by immune 
electron microscopy in stool filtrate from child 
with acute gastroenteritis. 70-nm particles 
possess distinctive double-shelled outer capsid. 
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1.1. Rotavirus classification 
 
  
The dsRNA viruses are classified into six major families that are distinguished by they 
genome organization, strategies for protein coding, virion structures, host range and other 
differences. While the simplest members of the Totiviridae family posses single dsRNA 
segment, more complex viruses like members of the Reoviridae family contain 10-12 
segments of dsRNA.  Rotaviruses (RV) are classified as a genus within this family. Common 
morphological, and biochemical features of Rotaviruses are listed in table 1. 
 
 
Tab.1. General characteristics of Rotaviruses [1]. 
 
 
Rotavirus strains are classified by three antigenic specificities- group, subgroup, and 
serotype/genotype. There are seven RV groups (A-G), determined by serological specificity to 
the structural protein of the inner capsid, VP6, predominant group antigen. The human 
pathogens belong to groups A, B, and C, the most important of which are those in group A. 
 
Structure 
65- to 75-nm icosahedral particles 
Triple-layered protein capsid 
Nonenveloped (resistant to lipid solvents) 
Capsid contain all enzymes for mRNA production 
 
Genome 
11 segments of dsRNA 
Purified RNA segments are  not infectious 
Each RNA segment codes for at least one protein 




Cultivation facilitated by proteases 
Cytoplasmic replication 
Inclusion body formation 
Unique morphogenesis involves transient enveloped particles 
Virus released by cell lysis or by nonclassic vesicular transport in polarized epithelial cells 
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Group B viruses have been associated with outbreaks of severe adult diarrhea in China, those 
in group C cause rare and sporadic outbreaks of disease in children in many countries [14] 
[14]. RVs in groups D-G infect only animals.  
Subgroup is also determined by epitopes of VP6, and is divided into two categories, 
marked as I and II. Further classification of RVs involves a binary system based on two 
proteins, VP7 and VP4. The outermost capsid glycoprotein, VP7, determines the G 
(G=glycoprotein) type of a RV strain. G type refers to either VP7 serotype or genotype as 
determined by antibody neutralization or nucleic acid sequence, respectively. To date, all 
identified G serotypes and genotypes are concordant. Thus, the G type of RV is expressed as a 
single digit, for example, G2. There are 15 G types found in humans but most abundant are 
those from G1 to G4.  
The RV spike protein, VP4, determines the P type (protease-sensitive) of a strain. P 
types also consist of serotype and genotype, though eac  is denoted separately in current 
nomenclature. P serotype is listed first followed by P genotype in brackets, e.g. P1[8]. Eleven 
P serotypes have been identified while twenty one P genotypes are known. Among them 
seven are found in humans [15]. 
RV field isolates are monitored worldwide and have provided useful information 
about RV genetic variation. Prevalent strains can differ between regions in the same country, 
as well as from year to year in the same region. Additionally, no correlation exists between 
disease severity and serotype [15]. Over the past 30 years, the majority of RV disease in 
North America, Europe, and Australia has been caused by P[8]G1 strains [14].  
Summarizing, classification of rotaviruses is based on scheme: group, designed by 
roman capital letters (A-G), subgroup, represented by Roman numerals and serotype (G or P), 
designed by Arabic number. However emergence of an increasing number of unusual strains 
that cannot be classified in either subgroup or are classified to both subgroups [16] have been 
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1.2. Structure of rotavirus 
 
1.2.1. Rotavirus architecture 
 
Tree- dimensional structures of  different members of Reoviridae family, as 
bluetongue virus (BTV) of Orbivirus genus and several strains of Reovirus genus were 
obtained using electron cryomicroscopy (Cryo-EM) and computer image reconstruction 
techniques [17]. The overall organization is similar among these viruses. 
Rotavirus is the best characterized virus of Reoviridae. The first Cryo-EM 
reconstruction (made up to a resolution of 40Å) of rotavirus was demonstrated by Prasad et al. 
in 1988. These studies were performed on the simian strain SA11. Two years later 
reconstruction (at higher resolution) of another rotavirus strain, rhesus RVV, was showed [4]. 
The analysis of these two rotavirus strains revealed very similar structural features [1]. 
The virion of rotavirus is, as all virions of dsRNA viruses except bacteriophages from 
Cystoviridae family [18], non-enveloped. It is relatively large, has a diameter of around 
1000Å and a left handed T=13 icosahedral symmetry, characterized by 132 aqueous channels 
and 60 surface spikes [19]. Capsid is composed of three concentric protein layers. The 
complete rotavirus virions are called TLPs (triple-layered particles), particles that lacks the 
outer layer are named DLPs (double-layered particles) and, in contrast to TLPs, are non-
infectious. Particles that lack two the outer shells are called SLPs (single-layered particles) or 
cores.  The outer layer is made of two proteins- spike- rotein VP4 and VP7. The intermediate 
one is built of VP6 trimers and surrounds the inner shell, core, composed of the structural 
protein VP2. The layer of VP2 protects two structural viral proteins involved in virus 
replication and transcription (VP1 and VP3) and elev n dsRNA segments, the rotavirus 
genome, that encode six structural and six nonstructural proteins (Fig. 2). 
 
 
1.2.2. The outer capsid layer 
 
The outer capsid layer plays the crucial role in first phase of virus infection as is 
implicated in host cell attachment, membrane penetration and cell entry [20]. In rotavirus, the 
outermost shell is made up of VP4 and VP7 proteins. Cryo-EM studies indicate that the 780 
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molecules of VP7, arranged as 260 trimers and located t the local and strict three-fold axes of 
a T = 13 (left-handed) icosahedral lattice, are uniformly distributed and form a smooth 
surface. From the surface protrude 60 spikes, bilobed at the distal end and 100- 120Å long. 
The spikes are composed of dimeric VP4 protein, so in the whole virion there are 120 copies 
of VP4 [19] [21]. Subsequent cryo-EM studies discovered that VP4 has a large globular 
domain that is buried inside the inner layer, making the total length of the spike about 200Å 




Fig 2. Architectural features of rotavirus. (A) PAGE gel showing 11 dsRNA segments comprising the 
rotavirus genome. The gene segments are numbered onthe left and the proteins they encode are indicated 
on the right. (B) Cryo-EM reconstruction of the rotavirus triple-layered particle. The spike proteins VP4 
is colored in orange and the outermost VP7 layer in yellow. (C) A cutaway view of the rotavirus TLP 
showing the inner VP6 (blue) and VP2 (green) layers and the transcriptional enzymes (shown in red) 
anchored to the VP2 layer at the five-fold axes. (D) Schematic depiction of genome organization in 
rotavirus. The genome segments are represented as inverted conical spirals surrounding the transcription 
enzymes (shown as red balls) inside the VP2 layer in green.(E and F) Model  from Cryo-EM 
reconstruction of transcribing DLPs. The endogenous transcription results in the simultaneous release of 
the transcribed mRNA from channels located at the five-fold vertex of the icosahedral DLP [20]. 
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The characteristic feature of rotavirus is the presence on the surface of not only VP4 
spikes but also 132 aqueous channels (Fig.2F, 3 and 4) that link the outer surface with the 
inner core [17]. The channels, about 140 Å deep, are localized at all the five- and six-
coordinated positions of the T = 13 lattice. There a three types of channels that can be 
distinguished according to their position and size (12 type I, 60 type II and 60 type III) [1]. 
Type II and III are about 55Å wide while type I have a narrower and more circular opening 
around 40Å in diameter and they are defined only by VP6.  








The base of the type I channels is closed in the center by the VP2 pavement [24] [25]. Type I 
channels are involved in importing metabolites required for RNA transcription and exporting 
the nascent mRNA (Fig 2E, F) [24]. 
 
Fig. 3. Surface view of the 37Å rhesus rotavirus 
reconstruction viewed along two fold symmetry 
axes display T = 13 icosahedral lattice symmetry. 
The characteristic features of the outer surface are 
the 60 prominent spikes extending over 100 Å from 
the virion surface and a relatively smooth, 
spherical outer capsid perforated by 132 holes of 
three types: 12 type I holes at the icosahedral 
vertices; 60 type II holes at the peripentonal 
positions; and 60 type III holes encircling the 
icosahedral threefold axes of symmetry [4]. 
Fig. 4.  Aqueous channels. 
Central (equatorial) sections of the 37Å, 
reconstructions viewed along a twofold direction are 
displayed with reverse contrast (bright regions 
correspond to high mass density). The three types of
holes identified in Fig.4 are labeled. Icosahedral 
symmetry axes that lie within the equatorial plane 
are also shown [4]. 
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1.2.3. The intermediate layer 
 
Intermediate layer of rotavirus virion is formed by260 trimers of structural protein 
VP6, the most abundant protein of the virion. The distribution of the protein mass in the 
second layer of the virion is not uniform and has a bristly appearance in contrast to the smooth 
VP7-VP4 surface. The trimers are assembled, like the outer shell, on T=13 lattice, and interact 
with outer shell proteins in a way that the channels in these shells are in register [19] [4]. All 
the surfaces of VP6 that are implicated in interactions with VP4, VP7 and VP2 contain the 
most conserved residues. Extensive lateral interactions between trimers and outer shell 
involve charged residues, whereas contacts with VP2 are mainly hydrophobic [26]. 
 
 
1.2.4. The inner layer, subcore and genome structure 
 
The most inner shell of rotavirus is composed of 120 molecules of VP2 protein (60 
dimers), possess T=1 symmetry and is quite smooth on the exterior [27] [1].The layer is 
interrupted by small pores that connect the core interior with environment. Whereas type I and 
type II channels are terminated at this layer, the typ  III channels continue beyond this shell 
[1]. This surface provides a structural platform for assembly of VP6 trimers, preventing 
aggregation of the core (VP1 and VP3 are highly hydrophobic proteins). This is the only 
rotavirus structural protein that has ability to self-assemble into a native-like icosahedral 
structure on the physiological conditions when exprssed in insect cells. This suggests, that 
VP2 can be the scaffold for three layered particle formation [28] [29]. The two other proteins 
that are part of the core, VP1, the RNA-dependent RNA polymerase [30], and VP3, the 
guanylyl and methyl transferase (mRNA capping) [31] [32], are ten times less abundant than 
VP2 [33], and provide enzymatic functions required for producing the capped mRNA 
transcripts and genome replication. Biochemical and structural studies have shown that VP1 
and VP3 are located in close proximity to each other and that form a heterodimer [34] [25]. 
VP2 is known to bind RNA through its N-terminal residues, what was observed in cryo-EM 
structure of DLS. The N-terminal region of VP2 protrudes inward at the fivefold axis to form 
a pentagonal shape and is also implicated in anchoring VP1/VP3 complex. This position is 
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consistent with releasing of nascent mRNA though the type I channel [35]. It is still not 
completely clear, but the N-terminus residues of one VP2 subunit appears to be occupied in 
transcription enzyme holding, while the N-terminal residues of the other subunit may be 
involved in interaction with the underlying genomic RNA [20].  
The precise structural organization of rotavirus genome is not completely clear. It was 
however demonstrated that the genome forms concentri  layers, separated by a distance of 28-
30Å [36], where each segment of RNA is spooled around transcription enzymes complex, 
located at the icosahedral vertices. Possible model suggested by Goeyt et. al. for the 
















This model allows 12 independent transcription complexes, each attached to an individual 
dsRNA segment. It is concordant with the fact that till now no dsRNA virus with more than 








Fig. 5. Model of structural organization of rotavirus 
genome. Each dsRNA segment is coiled in a cone shape 
at the fivefold vertex [5]. 
 
  Introduction 
 16  
1.3. Organization of rotavirus genome segments 
 
The total length of rotavirus genome is about 18 550 kbp. It consists 11 segment of 
dsRNA with a size range of 0.6 to 3.3 kbp [38]. Deproteinated rotavirus dsRNA segments are 
not infectious, confirming the need for presence of RNA-dependent RNA polymerase to 
transcribe the individual RNA segments into active mRNA. Purified dsRNA segments can be 
resolved by polyacrylamide gel electrophoresis and, according to the order of migration 
(length) of segments, are numbered from 1(the slowest) to eleven (the fastest) (Fig. 2A).   
The sequence of different genome segments, also derive  f om distinct rotavirus strains, show 
common characteristics (Fig. 6.) [1]: 
- sequences are A+U rich (58 to 67%) 
-  segments are base-paired end to end 
- the positive RNA strands contain cap structures at the 5’ end, while lacking  3’ 
terminal poly (A ) tails (distinctly to the most ofcellular mRNAs) [39] 
- each (+) RNA segment starts at 5’-prime end with guanidine, followed by a set of 
conserved nucleotides that are part of  5’-noncoding sequences (called untranslated 5’ 
region, 5’UTR), then followed by usually unique open reading frame (ORF) for  the 
protein product, that ends with the stop codon, and then finished by set of noncoding 
conserved 3’ sequences (3’UTR) with two terminal cytosines at the very end 
- all the sequenced genes possess at least one long ORF initiated by a strong initiation 
codon based on Kozak’s rules, although some of the gen s contain additional in-phase 
ORF (segments 7, 9 and 10) or out of  phase alternative ORF (segment 11)  
- all genes are monocistronic, except gene 11, that codes for two different proteins. 
The roles of the UTRs are not completely elucidated but they are probably targets for 
rotavirus RNA-binding proteins that participate in RNA synthesis, regulation of gene 
expression and packaging. In addition to primary sequences, secondary structures present in 
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As all the 11 mRNAs are replicated by the same VP1 polymerase, they must share 
common cis-acting signals and these signals are likely to be formed by secondary structures 
rather than by primary sequences. Some of the cis-acting signals for rotavirus RNA 
replication and translation have been identified but packaging rules still have to be clarified. 
Each mRNA has to contain a unique signal because 11 mRNAs must be distinguished from 
one another. Possible explanation can depend on secdary structure of positive RNA strands 
because secondary panhandle-like, and especially, different in each (+)RNA, stem-loop 











Fig. 6. Major features of rotavirus gene structure. Schematic shows the overall structure of 
rotavirus genes from the published sequences of genes 1 to 11. All eleven rotavirus genes lack a 
polyadenylation signal, they are A+U rich, and they contain conserved consensus sequences 
(UTRs) at their 5’ and 3’ ends [1]. 
AUG 
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The structural protein VP1 is codified by the gene 1 of rotavirus.  It is a basic protein and 
for the bovine rotavirus (RF strain) has an apparent molecular mass of 125 kDa [43]. It is 
present in the cores only in a few copies and together with VP3 forms a heterodimer. VP1 has 
two recognized functions: 
- acts as a  transcriptase - using as a template minus strand of dsRNA synthesizes 
primary viral transcripts which are extruded into the cell’s cytoplasm through the I- 
class channels  
- functions as a replicase synthesizing minus strand on the template of (+)RNA strand. 
These functions were found on the basis of several observations. It reveals non specific 
affinity to RNA [44] and it is the only protein of rotavirus that shows sequence-specific 
recognition of viral RNA (binds to 3’end of gene 8 mRNA) [45]. Moreover, it shares the four 
common motifs conserved among sequences of all RNA- dependent RNA polymerases of 
other RNA viruses [43]. VP1 binds nucleotides and was demonstrated that crosslinking of 
photoreactable nucleotide azido-adenosine triphosphate (azido-ATP) to VP1 inhibits 
transcription [30].  
Additionally its temperature sensitive mutant of don t synthesize ssRNA at the non 
permissive temperature [46]. Reconstitution experimnts with baculovirus-expressed protein 
have shown that VP1 requires VP2 for replicase activity and presence of VP2 stimulates VP1 
replicase activity several fold. VP1 is able to bind viral mRNA in the absence of any other 
viral proteins but its replicase activity requires previous VP2 interaction with RNA [45] [47]. 
 Moreover it was demonstrated several times that VP1 is able to interact with NSP2 
[48, 49] and can be chemically crosslinked in living cells with NSP5 [49]. However, the 
experiments performed recently in our laboratory showed, that the interaction of  NSP5 with 
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1.4.2. VP2 
 
VP2 is the most abundant protein of the rotavirus core (around 90%). It is encoded by 
gene 2 and yields the 882aa protein with a molecular mass of 102.5 kDa. Between amino acid 
536 and 686 are localized two leucine zippers that m y play a role in VP2 oligomeryzation 
into the core where it is present in the form of 60 dimers [1] .VP2 interacts with VP6, 
genomic dsRNA and with VP1/VP3 replication-transcription complex. Contact with the VP6 
layer is created on the base of hydrophobic interacions [26]. VP2 is the only structural 
protein that has the ability to self-assembly into a native like icosahedral structure, when 
expressed in insect cells. This observation strongly indicates that it may play as structural 
scaffold for the proper assembly of other viral proteins. Co-expression in baculovirus of VP2 
together with VP6 leads to formation of  VP2/6 double layered complex called Virus Like 
Particles (VLPs) [29].Same results were obtained expressing these two proteins in vaccinia 
system [51] [52].  
It is known that VP2 interact with VP1 and VP3 by its N-terminal region. That was 
deduced from biochemical studies on recombinant VLPs, containing VP2 with amino-
terminal deletions, co-expressed with VP6, VP1 and VP3. Lack of 25 residues on the N-
terminus completely prevents incorporating of VP1/VP3 replication/transcription complex 
[53] [20].  
Further evidence suggests that the amino terminus of VP2 plays a major role in 
organizing the major components of the endogenous transcription apparatus, the genomic 
dsRNA and the VP1-VP3 enzyme complexes, within the cor  of the virion. It was found that 
the N-terminal 132aa domain of VP2 is implicated in RNA binding. Through that region VP2 
is able to bind single and double stranded RNA [54]. Subsequent experiments have shown 
that removal of as few as the first 25 amino acids from the amino terminus of VP2 completely 
abolishes RNA binding activity, suggesting that theint grity of the complete amino-terminal 
domain is critical for the conformation of the RNA binding site. The predicted amino acid 
sequence of this domain contains several motifs which could potentially form the site of 
interaction between VP2 and RNA [55] [56]. In support of these observations, the structure of 
the native double-layered particle (DLP) determined by electron cryomicroscopy shows 
significant interactions between the inner surface of VP2 and the genomic dsRNA near the 
icosahedral fivefold axes and minor interactions along the icosahedral twofold axes [25]. 
These interactions result in nearly 25% of the genomic dsRNA adopting a highly ordered 
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conformation. Clearly the VP2 capsid layer is highly instrumental in organizing the genomic 






VP3 is a 98kDa (835aa) basic protein coded by genom segment 3. It is the minor 
component of the core that together with VP1 forms a homodimer- transcription/replication 
complex. Encapsidation of VP1 and VP3 in the inner core depends on interaction with the N-
terminal of VP2 [53]. VP3 expressed in rotavirus covalently bound GTP what suggest that 
VP3 alone is a guanyltransferase [32]. Subsequent studie  showed that VP3 interacts with 
GTP [57] and forms covalent VP3-GMP adducts [58] that confirmed the previous finding. It 
was also noticed that VP3 has ability to bind ssRNA but does not bind dsRNA. The ssRNA-
binding is sequence independent, but higher interaction affinity was found for uncapped than 
for capped RNA [47] [44]. The guanylyltransferase activity of VP3 is nonspecific as it can 
cap plus- and minus-strand viral RNAs, non viral RNAs, and RNAs initiating with G and A 
residues, but not dsRNA [32]. It was also demonstrated by VP3 binding to S-adenosyl-l-
methionine (SAM), a substrate necessary for cap methylation of RNA, that open rotavirus 
cores possess active methylotransferase activity. 
All the data indicate that VP3 is a multifunctional capping enzyme as it shares 
characteristics with capping enzymes of other members of the Reoviridae, including the VP4 






VP4 is a structural non glycosilated protein, encoded by genome segment 4.  It is 
known to be the main component of rotavirus cell entry apparatus therefore plays essential 
role in the virus life cycle. Indeed antibodies against VP4 neutralize the virus and block cell 
entry [59]. 
 It is a very distinctive element of rotavirus architecture as it forms characteristic 60 
spikes on the surface of the virion. Recent studies iscovered that VP4 is a very flexible 
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protein and during virus cell entry process performs series of molecular rearrangements that 
change its conformation. Initially, prior to trypsin cleavage, VP4 has a flexible conformation. 
Trypsin digestion rigidifies VP4 molecules and prime rotavirus to infect the cell. In this state 
VP4 is organized in a dimer that forms a rigid spike, third VP4 molecule remain flexible (Fig. 
9A). This is a crucial moment in rotavirus infection as without proteolytic activation virus can 
not enter the cell.  During digestion, VP4 (88 kDa) is cleaved into VP8* (28 kDa, aa 1–247) 
and VP5* (60 kDa, aa 248–776), the cleavage products remain associated in the virion [60]. 
The VP8* fragment contains a globular domain, the VP8* core, which forms the ‘head’ of the 
spike. Portions of both VP8* and VP5* make up the ‘body’ that is linked by an asymmetric 








VP8* masks the hydrophobic apex of VP5* on primed spikes [9]. It contains a 
hemagglutination motif and sialic acid (SA) binding site in the strains that use this receptor to 
enter the cell. These strains are able to agglutinate red blood cells by binding SA on the 
surface of erythrocytes [60]. Involvement of SA during rotavirus infections is not an essential 
step for all rotavirus strains. In many rotavirus strains, including human rotaviruses, cell entry 
is SA independent [61]. In these viruses, the majority f neutralizing monoclonal antibodies 
that recognize VP4 select mutations in VP5* [62], suggesting that cell entry is mediated 
mainly by the VP5*. The VP8* core is an important target of neutralizing antibodies against 
rotavirus and major determinant of P serotype for bth SA-dependent and SA-independent 
strains [63]. VP8* can also play  intracellular role in virus replication as it has been shown to 
activate cell signaling pathway upon binding the tumor necrosis factor receptor-associated 
factors (TRAFs) [64]. 
Fig. 7.  VP4 domains scheme .Head (H), 
body (B), stalk (S) and foot (F) regions of the 
VP4 spikes are indicated. The drawing is 
based on an electron cryomicroscopy image 
reconstruction from [4]. Copied from [9]. 
 
 
  Introduction 
 22  
  VP8* has a β-sandwich fold of the galactines- a family of sugar binging proteins. The 
crystal structure reveals that the core is organized n a single domain composed from two β-
sheets, formed by five-stranded and six-stranded β-strands. β-strands are flanked by two α-
helixes, a shorter one, laying in the inter-sheet loop and C-terminal, bridging parallel β-
structure and extended β-ribbon. The central part of a structure is composed by the cleft 
situated between two β- sheets. The tight fold of β-sandwich with short loops between strands 
and dense hydrophobic cores between the major structural elements suggest a rigid structure 
that is unable to undergo major rearrangements during cell entry. The compactness favors 
protease resistance [65]. Although crystal structure of the equivalent VP8* domains from the 
sialic acid-independent rotavirus strains differ functionally, share the same galectin-like fold. 
Differences in the groove region that corresponds to the SA binding site make it unlikely that 
SA-independent rotavirus binds an alternative carbohydrate ligand in this location [66]. 
Another, not yet elucidated event triggers VP4 to change the conformation for a 
second time (Fig. 8 B.). Two VP5* subunits fold-back and join a third subunit to form a 
tightly associated trimer. VP8* domain dissociates (interactions with VP5* are due to 
hydrophobic interactions) and expose a hydrophobic apex of VP5* that is a potential 
















Fig. 8. Models of two VP4 conformations. (A) The trypsin primed state. Two rigid subunits form the 
spike visible in electron cryomicroscopy, a third subunit is flexible. VP8* is gray, with an N-terminal 
tether and a globular head creased by the sialoside-binding site. The VP5* antigen domain is green 
bean-shape, with a red membrane interaction region and a yellow GH loop. An additional b-strand C-
terminal to the antigen domain is also yellow. The spike body includes the VP5* antigen domain, part 
of the VP8* tether, and the GH loop. The foot is blue, as is a protruding region that rearranges into 
the coiled-coil. (B) The putative post-membrane penetration state. VP8* has dissociated; the yellow 
parts of each subunit have joined in a b-annulus; the a-helical triple coiled-coil has zipped up; and the 
VP5* antigen domain has folded back [7]. 
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The structure of VP5* fragment, VP5CT, was solved by crystallization. It is the 
strongest evidence confirming trimeric, folded-back state of VP5*. VP5CT is a protease 
cleaved fragment of rhesus rotavirus (RVV) that consists of residues A248 to L525 (or 528); 
the missing C-terminal is a part of the ‘foot’ that is buried in the VP7 layer and interacts with 
VP6. VP5CT is a well-ordered homotrimer that resembl s a folded umbrella (Fig. 9A). The 
‘post’ of the umbrella is a C-terminal, α-helical, triple coiled-coil. Each of the three panels 
comprising the ‘shade’ of the umbrella represents a N-terminal globular domain. The core of 
each globular domain is an eight-stranded anti-parallel β-sandwich. The flexible tip of one of 
the β-hairpins is exposed to the solvent and contain a sequence motif (DGE), probably 
implicated in rotavirus binding to α2α1 integrin (Fig.9A). Another interesting aspect of this 
structure is that the tips of loops projecting from the bottom edge of globular domains possess 
a hydrophobic region that may function in membrane penetration. The sequence of these 
loops shares a sequence similarity with alphavirus loops implicated in membrane disruption 
but the loop and domain structures are different. Thus, the sequence similarity probably 
reflects selection for hydrophobicity and flexibility in both loops, but not common ancestry 
[9]. 
 










Fig. 9. VP5CT and the VP5* antigen domain. (A) Ribbon diagram of the VP5CT trimer, colored to 
match Figure 1. VP5CT does not include the foot region. Int- integrin binding motif; IM- potential 
membrane interaction loop (B) Ribbon diagram of a single VP5CT subunit. The part that forms the 
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Apart from cell entry VP4 may be implicated in other interactions inside of infected 
cell. It was demonstrated that VP4 interacts with VP7 and NSP4 [67]. Newly synthesized VP4 
particles are present in the space between periphery viroplasms and outside of ER [68]. It was 
found at the plasma membrane and it colocalizes with the cytoskeleton of infected cells. 
Recently it was shown that it is strongly associated with lipid raft microdomains and binds to 
two cellular proteins, GTPase Rab5, and  to prenylated Rab acceptor (PRA1) that regulate the 
vesicular traffic and the motility of early endosomes along microtubules. These results 
suggest that Rab5 and PRA1 may be involved in the localization and trafficking of VP4 in 







VP6 is encoded by segment 6 of the genome. It is a highly immunogenic, very 
hydrophobic 45 kDa protein that is conserved among most of rotavirus strains. It is the most 
abundant structural component of the virus. It forms, organized in 260 very stable trimers, the 
intermediate layer of virion structure and the most uter shell in DLP in the way so that the 
aqueous channels in the two T = 13 layers are in register. In the overall organization of the 
rotavirus, VP6 appears to integrate the two principal functions of the virus, cell entry and 
endogenous transcription, through its interactions with the outer layer proteins VP7 and VP4, 
and the inner layer protein VP2. Biochemical studies indicated that none of the component of 
DLP alone is able to transcribe the dsRNA but VP6, despite of lack of enzymatic function, is 
essential for endogenous transcription of the genome [70] [71]. 
The structure of VP6 was revealed by crystallography [26]. Each VP6 monomer has 
two distinct domains, defined as B and H. Domain B is present at the base of the molecule 
and is composed of a bundle of eight α-helices that derive from two different segments of 
polypeptide chain. The first segment comes from N-terminal part of VP6 while remaining 
three helices are formed from C-terminus end of the sequence.  In domain B the only β-sheet 
element consists of β-hairpin that connects two α-helices. That β-hairpin motif of contains a 
highly conserved sequence that protrudes into the channel I and plausibly may play a 
functional role in the translocation of the nascent mRNA transcripts during endogenous 
transcription. The electrostatic repulsion between the negatively charged channel surface and 
the nucleic acid is likely to facilitate the extrusion of the transcript by increasing its fluidity. 
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Domain H making up the top of the molecule, folds into β-sandwich with the jelly-roll 
topology. Hydrophobic interactions in this domain are responsible for trimerization of VP6, as 
mutant lacking that domain can not form the trimer while deletion mutants that lack the 
domain B are capable to trimerize [72]. The characteristic feature of the VP6 trimer structure 
is a Zn2+ ion that essentially contributes to the trimer stabilization. 
VP6 trimers interact specifically with itself and with all three structural proteins in the 
virion. Interactions with VP2 are mainly hydrophobic whereas contacts between VP4 at the 
sides of domain H and VP7 at the top of domain B utilize charged residues. The lateral 
interactions between the trimers that involve charged residues are not sufficient to form the 
closed shell. Therefore it is likely that a proper scaffold for the assembly of VP6 into T=13 
icosahedral organization is provided by VP2 layer. All the interaction surfaces relay on the 
most conserved amino acids of polypeptide chain. The experiments like detailed mutational 
analysis based on pseudo-atomic model of VP6 [71] and cryo-EM structural studies on DLP-
anti (VP6) MAb complexes [34] [73] clearly indicate hat not only the observed proper 
assembly of VP6 trimers on VP2 but also intact dynamics of interaction between these two 






VP7 (37 kDa) is encoded by genome segment 9 in SA11 strain. It is the second, after 
VP6, most abundant structural protein of rotavirus. Together with VP4 it is responsible for 
forming the most outer layer of the virion implicated in cell attachment and entry. 
VP7 is a glycoprotein that contains three N-glycosylation sites, from which only two 
are apparently used. Biochemical studies indicate that modifications contain N-linked adding 
of high mannose oligosaccharides, which are processed by trimming [74] [75] [76]. 
Man8GlcNAc2 and Man6GlcNAc2 oligosaccharide residues are found on intracellular VP7 
while Man6GlcNAc2 is found on mature virus particles [77] [74]. VP7 is cotranslationally 
glycosylated as it is inserted into the membrane of the ER, and insertion is directed by a 
cleavable signal sequence localized at the amino-terminus of the protein [78] [79] [74]. The 
ORF of 326 amino acids begins with an initiation codon with a weak consensus sequence. A 
second, in-frame initiation codon precedes two regions of hydrophobic amino acids (H1 and 
H2), which can act as the signal sequence to direct VP7 to the ER, although the second is 
thought to be the major species used in cells. The site of cleavage of signal peptide is 
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glutamine 51 [80]. VP7 lacks the characteristic KDEL sequence important in conferring ER 
[81] retention but contains a conserved region with hydrophobic amino acids (consensus 
peptide LPXTG) which acts as the signal sequence in directing VP7 to ER [82]. 
Although these residues are critical for retention, the method by which VP7 remains in the ER 
is unresolved. After its insertion into membranes, VP7 is resistant to digestion with 
proteolytic enzymes, suggesting it is not a membrane-spanning protein [74] [76]. It remains 
membrane associated after high salt treatment and release of microsomal contents at alkaline 
pH what suggest that it is an integral membrane protein with a luminal orientation 120 [74]. 
VP7 in infected cells forms oligomers with VP4 and NSP4 [67].These interactions 
appear to be important for the assembly of VP7 into outer capsid. Mature VP7 lacks all amino 
acids proximal to Gln 51 but many conserved amino acids are present before the second 
hydrophobic domain. Proper folding of VP7, in which are involved highly conserved cysteins, 
requires ATP [83].It was found that this process requires also cellular factors like ER-
associated chaperone calnexin, interacting also with NSP4 [84].  
The precise role of VP7 during early interactions of the virus with the cell is not clear, 
but it has been postulated that VP7 may modulate the function of VP4 during the attachment 
and entry process [85]. It may interact with cell surface molecules after the interaction is 
initiated by VP4 [86]. It was found that VP4 contai sequences that bind integrins. It has two 
sequences motifs that may be important in this process, CNP that interact with integrin αvβ3 
[87] and GPRP that is bound by integrin αxβ2 [88]. VP7 in its sequence containes pralines 
that binds calcium and the sensitivity of virions to low calcium concentrations is strain-
dependent [89] [90]. Several studies also have suggested calcium-driven conformational 
changes in VP7 [91]. Studies on baculovirus-expressed recombinant VP7 have shown a 
requirement for calcium in the formation of VP7 trimers, which crystallize into hexagonal 
plates mimicking the arrangement of VP7 on the capsid [92]. Thus, while appropriate levels 
of calcium help maintain the structural integrity of the VP7 layer, low calcium concentrations, 
similar to those in the cytoplasm, trigger the disassociation of VP7 trimers leading to 
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Rotavirus NSP1 (55kDa) is the product of the genome segment 5. It is known to be the 
least abundant protein of rotavirus. Although in infected cells it localizes throughout the 
cytoplasm [93] in contrast to most other rotavirus proteins that concentrate in viroplasms, it is 
able to interact with NSP3, NSP5 and NSP6 [94]. Moreover NSP1 was found associated with 
the cytoskeleton when analyzed by subcellular fractionation [93]. 
NSP1 is also the least conserved protein among all rotavirus nonstructural proteins.  
The only conserved part is the N-terminus. In its sequence there are present eight cysteins and 
two histidines that form the part of zinc finger domain. That domain has an affinity to 5’ 
region of all viral mRNAs [93] [95]. 
NSP1 apparently is not required for rotavirus replication. Strains isolated from animals 
and from both immune-deficient and immune-competent children containing rearrangements 
in gene 5 that result in the synthesis of truncated NSP1 have showed to replicate in cell 
culture to titers close to those of their wild-type counterparts [96]. Also knockdown 
experiments using RNA interference have confirmed that he protein is not needed for virus 
replication [97]. Although NSP1 is not crucial for replication, production of other viral 
proteins and formation of viroplasms, it seems to be essential for proper rotavirus cell-to-cell 
spread [98] [99]. 
Analysis of interaction with cellular proteins showed that NSP1 interact with interferon 
regulatory factor 3 (IRF-3) [96] [100]. This protein during normal cell state accumulates as an 
inactive monomer in the cytoplasm. Events associated with virus infection like production of 
double-stranded RNA and expression of viral proteins trigger the innate immune response 
mechanisms that include the phosphorylation of IRF3 by cellular kinases. That modification 
initiates structural changes in IRF3 that results in its dimerization [101]. The dimer, an active 
form of IRF3, is translocated to the nucleus, where it interacts with specific promoter 
elements, stimulating expression of IFN-α and IFN-β. The secreted IFNs promote the 
production and activation of antiviral proteins in neighboring cells blocking the virus cell-to-
cell spread [102]. It was demonstrated that NSP1 mediat s IRF3 degradation through a 
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proteasome-dependent pathway. The role of this interaction in rotavirus infection could be 
diminishing the cellular interferon response [96].  
The fact that NSP1 protein is much more conserved among rotaviruses infecting the 
same host may explain in part why rotavirus strains causing severe gastroenteritis in a 
homologous animal model are usually less infectious and asymptomatic in a heterologous 







NSP2, encoded by segment 8, is a highly basic protein of relative molecular mass 
35kDa. In vivo studies have shown that NSP2 and NSP5 together with VP1, the RNA 
polymerase, are co-localized in the viroplasms of infected cells and are the main constituents 
of the replication intermediates [104] [105]. Indee several facts demonstrate that NSP2 is 
essential for viral replication. Temperature-sensitive mutants of NSP2 fail to replicate the 
genome and produce mostly empty particles, which implicates NSP2 in genome replication 
and packaging [106] [107]. This experiment is concordant with the observation that silencing 
NSP2 synthesis by RNA interference causes complete blocking of viroplasms formation, 
production of viral proteins and rotavirus replicaton [97]. Additionally functional and 
structural similarities were described among NSP2, bluetongue protein NS2 and reovirus 
σNS, suggests that they are functional homologs [108]. 
NSP2 selfassembles into stable doughnut-shaped octamers, formed by the tail-to-tail 
interaction of two tetramers [10]. The overall architecture of such octamers is highly 
conserved even among distantly related groups of rotaviruses [109].  
Many biochemical studies on recombinant NSP2 have specified its roles in genome 
replication and packaging. The octamers have single-stranded sequence-independent ssRNA-
binding activity thanks to which are capable of destabilizing RNA–RNA duplexes by an ATP 
and Mg2+ independent mechanism [110] [111]. In addition, the octamers have a Mg2+-
dependent nucleosidetriphosphate phosphohydrolase (NTPase) activity that cleaves the γ-β 
phosphoanhydride bond of any nucleoside triphosphate (NTP), yielding the products NDP 
and Pi. Following cleavage, the γP is transferred to NSP2, generating a short-lived 
phosphorylated form of the protein [110] [112]. It was demonstrated that hydrolytic activity 
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of NSP2 is essential for genome replication [109]. Moreover NSP2 octamers in the presence 
of NTPs undergo a conformational transition, shifting from a relaxed to a more condensed 
state as is typical of molecular motors [113]. 
All together, these properties have led to the suggestion that the NSP2 octamer may 
facilitate genome packaging and replication by relaxing secondary structures in viral template 
RNAs that impede polymerase function and by assisting in the translocation of viral RNAs 
into pre-virion cores in genome replication and packaging [114]. 
The understanding of these mechanisms has been muchfacilitated by solving the 
structure of NSP2 by X-ray crystallography to a resolution of 2.6A° [10]. NSP2 crystallizes as 
an octamer using crystallographic 4-2-2 symmetry, resulting in one monomer per asymmetric 
unit. The NSP2 monomer has two distinct domains (Fig. 10), an N-terminal domain from 
residue 1 to 141 and a C-terminal domain from 151 to 313. A striking feature of the monomer 
is a presence of electropositive 25 A° deep cleft tha lies between the two domains.  
The N-terminal domain has a novel fold. Although predominantly α -helical, has two 
pairs of anti-parallel β -strands towards the N terminus. In this domain ca be noticed two 
sub-domains that are connected by a 24-residue-long predominantly basic loop (Fig. 10, 
arrow). There are three highly conserved prolines (53–55) at the start of this loop, which may 
be essential for its conformation. This loop lines the prominent grooves that run diagonally 
across the 2-fold axes of the doughnut-shaped octamer (Fig 11), and contributes to their basic 
character.  
The C-terminal domain has an α /β fold. The important feature of this domain is the 
twisted anti-parallel β-sheet flanked by helices, formed by residues from 150 to 245, in a 
β3αβ2α configuration. The anti-parallel β -strands, between residues 186 and 191 (β7), and 
between 226 and 230 (β9), along with the loop, between residues 221 and 226, constitute the 
base of the cleft. The interdomain loop and the helix α5 from the N-terminal domain form a 
major part of one side of the cleft, whereas the other side of the cleft is made of helix α 11 and 
a loop between residues 245 and 260. The remainder of the C-terminal region, from residues 
260 and 311, consists predominantly of α -helices (α 12– α16). That domain has a significant, 
limited only to the tertiary structure level,  homology with the protein kinase C interacting 
protein (PKCI), a member of the Histidine Triad (HIT) family of nucleotide-binding proteins 
[115]  [10]. 
  On that base the location of the NTP-binding site was initially proposed. Now it is 
known that it is localized in 25 Å cleft, between the two domains of the monomer. Although 
lacking a precise signature of HIT motif, mutagenesis studies have indicated that conserved 
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basic residues in the cleft form a HIT-like motif, responsible for the binding and hydrolysis of 
NTPs [112]. More recently, data obtained by co-crystallization f NSP2 with nucleotide 
analogs has shown that His225 is the catalytic residu  of the motif [116].  
Extending diagonally across the NSP2 octamer surface (Fig. 11.) are four highly basic 
grooves, 30 Å wide and 25 Å deep, which function as ssRNA-binding sites. [10] [117]. Each 
groove is lined by two 24-residue electropositive loops, originating between the two 
subdomains of the N terminus of each monomer (Fig. 10, arrow). The location of these loops 
is such that they position the electropositive residues at the entrance of the clefts containing 




















Fig. 10. The ribbon representation the monomeric 
subunit of NSP2. The secondary structural elements in 
the monomer are coloured: α-helices in red, β-strands in 
green and loops in blue. The basic loop in the groove 
between the subdomains in the N-terminal domain is 
shown by an arrow [10]. 
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Fig.11. Structural proximity of the NTP-binding cleft and t he RNA-binding grooves. Surface 
representation of the NSP2 octamer viewed along the 4-fold (a) and 2-fold axes ((b) and (c)). Two 
monomers have been identified in the octamer (green and yellow). The image in (b) represents a 90° 
rotation along the x-axis with respect to the image in (a). Residues 53 to 76 that form part of the 
electropositive loops, which line the RNA-binding grooves, are denoted in blue. (c) The image in (b) was 
rotated 45° clockwise along the y-axis to allow visualization into the cleft. Residues within the cleft that 




Recently it was demonstrated that that the NSP2 octamer has also RTPase activity and 
that the RTPase and NTPase activities of the octamer utilize the same HIT-like motif and 
generate indistinguishable phosphorylated intermediat s. It was also shown that ssRNA is 
preferred as a substrate over NTPs in hydrolysis reactions, likely due to the higher affinity of 
the octamer for ssRNA. It was discovered that NSP2 uses a HIT-like motif to direct both 
RTPase activity and NTPase activity [114]. 
The donut-shaped NSP2 octamer also displays a central hole with a diameter of 35 Å. 
One interesting possibility is that the central hole f the NSP2 octamer could be used as a 
protective environment for newly synthesized dsRNA emerging from VP1 or to serve as a 
passive conduit for its packaging during the assembly of VP2 capsid layer [117]. It looks as 
the octameric structure of NSP2 forms a tempting platform or a scaffold around which the 
replication complex is organized. It is possible that the hydrophobic side of the octamer, 
around the four-fold axis, may bind to the VP1. Furthe more the molecular partner of NSP2, 
NSP5, is an acidic protein and the basic grooves of the NSP2 octamer may be the sites for its 
binding. In fact recent observation utilizing cryo-electron microscopy has indicated that a 
truncated species of NSP5 binds along the same electropositive grooves involved in RNA 
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NSP3, encoded by gene seven is a basic nonstructural 36 kDa protein that localizes in 
cytoplasm of infected cells [118]. The experimental evidence shows that NSP3 is responsible 
for shutting off cellular protein synthesis, while ensuring at the same time the translation of 
viral mRNAs. Rotaviruses rely on the host translation machinery to produce the proteins 
encoded by their genome. Rotaviral transcripts are c pped at their 5’ end by the action of the 
structural protein VP3 during transcription but their 3’ ends are not poly-adenylated like most 
of cellular mRNAs. In the host cells only poly-adenylated and capped messages are known to 
be efficiently translated. This is brought about by recognition of the 5’ cap by eIF4E (cap 
binding protein) and the poly-A tail by PABP (poly-A binding protein) which then interacts 
with a cellular factor eIF4GI. This factor is a multipurpose adaptor protein that is responsible 
for assembling the cellular translational complex composed by the proteins eIE4E, eIF4A 
(helicase), PABP, eIF3 as well as bound and circulaized by the complex mRNA. The 
complex then is delivered to the ribosome where the translation begins. Rotaviruses overcome 
the lack of a poly-A tail by possessing on 3’ ends of theirs mRNAs a consensus sequence 
(UGACC) which is specifically bound by NSP3 [119] [120] [121] [122]. While the N-
terminal domain of NSP3 binds this consensus sequence, the C-terminal half interacts with 
eIF4GI with an affinity greater than cellular PABP to give translation of the rotavirus 
messages a selective boost following infection [120].  
Resolving the structure of NSP3 by X-ray crystallography has helped to understand 
better mechanisms of these actions. NSP3 consists of two readily separable domains divided 
by a dimerization domain [94] [121]. N-terminal domain forms a heart-shaped, asymmetric 
homodimer with a medial basic deep cleft on the surface that creates a basic dead end tunnel 
that binds the 3’ terminal consensus nucleotides of rotavirus mRNA. This tight interaction not 
only promotes translation of the rotavirus mRNA but also prevents degradation of the 
rotavirus message by cellular nucleases and excludes the possibility of cellular sequences 
recognition. Biophysical studies demonstrate a high affinity binding leading to increased 
thermal stability and slow dissociation kinetics, consistent with the NSP3 functions [123, 
124]. On the other hand C-terminal domain is an α-helical symmetric homodimer. It 
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recognizes a fragment of eIF4GI and binds it with an affinity greater than PABP [125] in 
pockets at the dimmer interface. Site-directed mutagenesis and isothermal titration 
calorimetry documented that NSP3 and PABP use analogous eIF4GI recognition strategies, 
despite marked differences in tertiary structure[126, 127].  
Recent studies [128] seem to revise mentioned model qu stioning how NSP3 blocks 
cellular protein synthesis and ensures at the same time the translation of viral mRNAs. In this 
work, the expression of NSP3 in infected cells was knocked down using RNA interference. 
Unexpectedly, under these conditions the synthesis of viral proteins was not decreased, while 
the cellular protein synthesis was restored. Also, the yield of viral progeny increased, which 
correlated with an increased synthesis of viral RNA. Silencing the expression of eIF4GI 
further confirmed that the interaction between eIF4GI and NSP3 is not required for viral 
protein synthesis. These results indicate that NSP3 is neither required for the translation of 
viral mRNAs nor essential for virus replication in cell culture.  
These newly found discoveries can be elucidated in ifferent ways. Even though the 
interactions of NSP3 with eIF4GI and the 3’ end of viral mRNAs have been clearly 
established, there is no direct evidence that NSP3 engages simultaneously in these two 
interactions to promote the circularization of viral mRNAs, and although it is generally 
accepted, there is also no evidence that these interactions favor the translation of viral 
mRNAs. 
Moreover interaction of NSP3 with eIF4GI is not necessary for viral translation. 
Furthermore, an increased level of viral RNA synthesis (both single stranded and double 
stranded) was detected in cells where NSP3 was silenced, suggesting that rather than 
promoting the translation of viral mRNAs, the interaction of NSP3 with the 3’ end of viral 
mRNAs might prevent them from being selected for replication. 
The explanation why eIFG4I silencing decrease total cellular protein production only 
slightly can be explained by the fact that eIF4GII can functionally complement eIF4GI [129]. 
Thus, the small reduction of total protein synthesis when the expression of eIF4GI was 
silenced could result from complementation of eIF4GII under these conditions. The fact that 
in standard rotavirus-infected cells (where NSP3 is expressed at normal levels) a more severe 
shutdown of cellular protein synthesis is observed suggests that NSP3 binds to both eIF4GI 
and eIF4GII. Indeed, the region of eIF4GI that interacts with NSP3 is very similar, if not 
identical, in eIF4GII [127]. Thus, although not formally proven, it might be expected that 
NSP3 could bind both factors, displacing PABP from both eIF4GI and eIF4GII, resulting in 
the severe shutoff of cell protein synthesis. It has not been already ruled out, but rotaviruses 
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might use more than one mechanism to control the translation machinery of the cell. It is 
possible that virus needs such a sophisticated mechanism to shut off the synthesis of a 
particular set of cellular proteins that could interfere with the replication cycle and/or 
propagation of the virus in vivo. The inhibition of protein synthesis could also be required to 








NSP4 encoded by gene segment 10 is a multifunctional protein with roles in viral 
assembly and pathogenesis of infection. The 28 kDa glycoprotein has three hydrophobic 
domains on N-terminus and a C-terminal coiled-coil d main. NSP4 is inserted into the ER 
bilayer by its N-terminus. Its firs hydrophobic domain that is exposed to the ER lumen 
contains two N-linked high-mannose oligosaccharide esidues. The transmembrane domain 
anchor the protein in ER bilayer (aa 22-44) [130]. The basis of ER retention of the protein is 
unknown, as NSP4 contains no characterized retention signals [131]. The coiled-coil domain 
is responsible for oligomerization of the protein that form dimers and tetramers stabilized by 
Ca2+ [132] what is interesting because of the fact that c lcium mobilization by NSP4 is 
considered to be one of the mechanisms by which that protein fulfils its enterotoxic function. 
The cytoplasmic C-terminus (aa 45-175) interacts also with viral and cellular proteins. 
Residues 161-175 bind VP6 on the surface of DLPs [133]. During rotavirus maturation, NSP4 
acts as a receptor for these subviral particles budding into the ER lumen, where the outer coat 
and spike protein assemble [134]. Furthermore residu  112-148 of the C terminus bind VP4 
and VP7 during outer layer assembly [135]. Another studies have shown that last 54 residues 
of NSP4 act as a microtubule binding domain that despit  of lack of homology with other 
microtubule associated proteins, seems to play a role in microtubules binding and preventing 
the traffic between ER and Golgi [136]. Recent studies that used RNA interference indicated 
that silencing of NSP4 in rotavirus-infected cells di rupts assembly, evidenced by a 75% 
reduction in progeny and the alteration in synthesis and redistribution of other rotaviral 
proteins. While there was a strong production decrease of VP2, VP4, VP7, NSP2 and NSP5 
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the synthesis level of NSP3 was twofold increased. Also the redistribution of some proteins in 
the cell was changed [137].  
NSP4 displays enterotoxigenic activities pertinent to rotavirus pathogenesis. Purified 
NSP4 or even peptide 114-135 is sufficient to induce Cl- secretion and diarrhea in neonatal 
mice by a Ca2+ mediated mechanism [138] [139].  
NSP4 induces intracellular Ca2+ mobilization by at least two mechanisms. When added 
exogenously to uninfected Sf9 and HT-29 cells, as well as to isolated mouse intestinal villi 
and crypt epithelia, the enterotoxin induces Ca2+ release via a receptor-mediated 
phospholipase C cascade with phosphatidylinositol 4,5- bisphosphate  cleavage to release 
inositol trisphosphate  [140]. Endogenously expressed NSP4 induces a PLC-independent 
mechanism for mobilizing Ca2+ [141]. NSP4 also promotes plasma membrane Ca2+ 
permeability, resulting in influx of Ca2+ from extracellular sources [140]. Thus, NSP4 
stimulates increased intracellular Ca2+ by multiple mechanisms and is postulated to do so for 
varying purposes. Proposed model [142] in which intracellular NSP4 induces Ca2+ 
permeability of the plasma membrane and Ca2+ ions mobilization early in rotavirus infection 
to promote an ionic environment desirable for virus maturation [143]. It is well documented 
that high calcium concentration is required for structural stability of the outer capsid [142] 
[144]. During subsequent cycles of replication, NSP4 is proposed to be secreted from infected 
cells to exert enterotoxic effects on neighboring uinfected cells via PLC-dependent Ca2+ ions 
mobilization with accompanying Cl- secretion. Other findings suggest NSP4 forms a pore in 
the ER membrane to elicit Ca2+ release. This model arose from crystallographic analysis of 
the NSP4 oligomerization domain (aa 95- 137) which reveled a core metal Ca2+-binding site 
in homotetramers [132]. Clearly, NSP4 contributes to rotavirus pathogenesis through a 





NSP5, formerly called NS26, is a nonstructural acidic protein encoded by genome 
segment 11. Its sequence has 196-198aa, depending on a strain, and is characterized by high 
serine (24%) and threonine content (4.5%) [145, 146]. NSP5 is produced early in infection 
and was originally characterized to have the mass of 26kDa on SDS-PAGE but further studies 
demonstrated that this form of the protein is a precu sor for subsequent modifications.  
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NSP5 is subjected to two different types of posttransl tional modifications, O-
glycosylation and phosphorylation. Glycosylation of NSP5 is based on the addition of O-
linked N-acetyloglucosamine (O-GlcNAc) monosaccharide residues to serines and threonines 
[146] performed by the cytoplasmic O-GlcNAc transferase [147]. This modification is present 
in many proteins localized to cytoplasm and nucleoplasmic compartments of the cell. 
Although the function of O-glicosylation in NSP5 is not known, its importance might be 
apparent, since many of known GlcNAc-modified proteins are also phosphoproteins [148]. In 
many cases, including also NSP5, the sites of phosphorylation and GlcNAcylation are 
localized to the same or neighbouring residues (serines or threonines). 
SDS-PAGE of immunoprecipitated NSP5 derived from rotavirus infected cells 
revealed presence of not only two main bands with apparent molecular mass of 26 and 28 kDa 
but also of higher isoforms that span from 32 to 34kDa (Fig. 12). From previous studies it is 
known that 26 and 28kDa forms correspond to phosphorylation and glycosylation while the 







Experiments with rotavirus infected cells labeled with [1,6-H3] glucosamine revealed 
that the presence of glycosylation is localized mainly in 26 and 28kDa bands and suggested 
that hyperphosphorylated forms do not contain or contain very little of O-glycosilated 
residues. Treatment of hyperphosphorylated NSP5 with phosphatases caused the 
disappearance of higher molecular weight forms with a complete reduction of the NSP5 
migration to only 26 kDa band. However the 26kDa band still contains phosphorylated sites 
proving that some of them are resistant to phosphatases activity.  
Fig. 12. SDS-PAGE analysis of NSP5. Lane 1: 
immunoblot analysis of extracts of MA104 cells 
infected with rotavirus SA11(4 h post-infection) 
and reacted with anti-NSP5 serum. Lanes 2-4: 
immunoprecipitation of NSP5 from virus 
infected cells labeled in vivo with 
[35S]methionine and treated with CIP and λ-
Ppase as indicated. From [3]. 
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Additionally it is known from the partial acid hydrolysis followed by the two-
dimential thin-layer electrophoresis that in NSP5 phosphorylated residues are limited to 
serines and threonines [3].  
Phosphorylation of NSP5 seems to be a complex process that gives rise to a number of 
isoforms. Although NSP5 immunoprecipitated from infected cells is hyperphosphorylated, 
western blotting analysis of the protein derived from transfected cells shows the presence of 
only basic 26 and 28kDa bands and only traces of the higher forms. This has suggested that 
NSP5 hyperphosphorylation may depend on the presenc of other viral proteins. In deed, 
similar hyperphosphorylation effects to those obtained in virus infected cells were observed in 
cells cotransfected with NSP5 and NSP2. That data indicated that NSP2 alone was sufficient 
for up-regulating NSP5 hyperphosphorylation process, probably on the way of  interaction 










To facilitate the studies on this phenomenon the  sequence of NSP5 was arbitrarily 
divided into five regions (from 1 to 4 and a tail). Several experiments with NSP5 deletion 
mutants have been done and, interestingly, some of them have suggested that NSP5 
hyperphosphorylation is the consequence of a complex autoregulatory mechanism in which 
Fig. 13. Anti-NSP5 western immunoblot of cellular extracts of MA104 cells transfected with 
pT7v-NSP5 or co-transfected with pT7v-NSP5 and pT7v-NSP2, as indicated. λ-Ppase treatment 
of the extract was performed before PAGE. Open and solid arrowheads indicate the NSP5 26 
kDa precursor and phosphorylated forms respectively [Afrikanova, 1998 #103]. 
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the protein is, at the same time, substrate and activator of the process that leads to its 
hyperphosphorylation [149]. 
Some deletion mutants showed to behave as good substrates, while the others played 
as good activators in that process. Deletion mutants lacking either region 1, region 3 or both 
(∆1, ∆3 or ∆1/ ∆3) efficiently induced SDS-PAGE mobility shift in an in vitro translated 
deletion mutants such as ∆1 or ∆2. Similarly, in vivo coexpression experiments have shown 
that the same deletion mutants, ∆3 or ∆1/ ∆3, were able to cause the phosphorylation of the 
mutant ∆2 (fig. 14.). This observation suggested that region 1 and 3 have an inhibitory effect 
on the phosphorylation of NSP5. The fact that purified recombinant histidines tagged deletion 
mutant deriving from transfected cells did not show the phosphorylation activity of a total 
cellular extract containing that mutant, suggested that NSP5 does not posses the kinase 






The interaction with NSP2 was described in vitro with purified proteins [117] and in 
vivo for both infected and cotransfected cells [49] [150] [151]. The co-expression of both 
proteins has a dramatic effect on their localization in the cell, leading to the formation of 
discrete structures that were called VLS (viroplasms-like structures). Analysis by confocal 
microscopy demonstrated a precise co-localization of NSP2 and NSP5 (Fig. 15) [152]. 
 
Fig. 14. Coexpression of SV5- ∆2 with or without activators ∆1/ 
∆3 or ∆3 as indicated.  ∆2 was indicated with anti-SV5 sera [6]. 
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Fig. 15. Immunofluorescence of VLS: panel. Localization of rotavirus NSP2 and NSP5. The two proteins 
were analysed by immunofluorescence microscopy using specific antibodies for NSP2 or NSP5 as 
indicated, in cells transfected with either NSP2(A) or NSP5 (C) or co-transfected with NSP2 and NSP5 




 Experiments focused on viroplasm like structures formation with different NSP5 
deletion mutants showed that localization to the VLS requires N and C terminal parts of 
NSP5. The same parts of the protein were also found to be necessary for its 
hyperphosphorylation ability (Fig. 16) [Fabbretti, 1999 #102].  
 
 
Fig. 16. Schematic representation of the NSP5 mutants constructed. The ability of mutant to produce 
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 The work of several research groups has demonstrated another important 
characteristics of these two proteins. Separately from the involvement of NSP2 in the 
phosphorylation of NSP5 and co-localisation in VLS it was found that NSP2 and NSP5 co-
localise in infected cells in structures called viroplasms. Viroplasms, formed early in 
infection, are specialized, large cytoplasmic, electron-dense, nonmembrane bound structures, 
where the replication and packaging of the viral genome into the capsids takes place. Apart 
from NSP2 and NSP5 they are rich in viral RNA and contain the viral structural proteins VP1, 
VP2, VP3, and VP6 [153] [33] and the nonstructural protein NSP6 [154]. Several studies, 
including neutralization of NSP5 with anti-NSP5 specific intrabodies [155] and recently also 
by RNA interference [156] [97] have demonstrated that both NSP2 and NSP5 are critical for 
the nucleation of viroplasms and for virus replication. The analysis of viroplasm formation in 
infected cells indicated that NSP5 is localized in the outer part while NSP2 has more internal 
localisation (Fig. 17) [104].  
 Since NSP5 localizes to viroplasms, its capability of ss and dsRNA binding has been 
investigated. These studies have shown that NSP5 has unspecific affinity for both ss and 
dsRNA suggesting that the protein could have a role in recognizing secondary and tertiary 
structures of the mRNAs that have to be packaged into the forming core and together with 
NSP2, that has NTPase and ssRNA binding activity, unwind these structures [157]. Recent 
studies [117]  showed that both NSP5  and  RNA share the same binding site on the NSP2 
octamer, and in the consequence, pointing that NSP5 may compete with ssRNA binding site 
on NSP2. This can suggest that one of its functions could be the regulation of  NSP2-RNA 
interactions during genome replication. 
 
 
Fig. 17. Amplified images of viroplasms in rotavirus-infected cells. Double immunofluorescence in non-
transfected infected cells visualized with anti-NSP5 (red) and anti-NSP2 (green) sera. Images were 
obtained by confocal microscopy. Bar, 2 mm. Modified from [150]. 
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 Various studies have shown that NSP5 interacts not o ly with NSP2 but also with the 
viral polymerase VP1 [49] and VP2 [158]. Recent studies using deletion mutants of NSP5 or 
different fragments of NSP5 fused to enhanced green fluorescent protein have proved that the 
48 C-terminal amino acids are the essential for  the interaction with VP1. These studies have 
also shown that NSP5 interaction with VP1 is stronger in the absence of other viral proteins or 
viral RNA, that the one with NSP2 [50], suggesting that NSP5 may act at the crossroad of 
important processes of virus morphogenesis, such as replication, carried out by VP1 in 
conjunction with the scaffold protein VP2 [47, 159, 160] and packaging, for which NSP2 is a 
putative molecular motor[110]. 
 Many different information is known about NSP5, encompassing recent data about its 
ability (together with NSP2) to interact with β-tubulin in microtubules (Cabral-Romero & 
Padilla-Noriega, 2006), but no clear function has been discovered so far. In addition no 
homology between NSP5 and any other protein was found and there is no data about its 







NSP6 is the smallest rotavirus protein. It is encoded in only some strains by segment 
11 that possess an alternative reading frame. In simian strain SA11 it encompasses 92 aa that 
yield 11kDa protein. Until now very few reports have found the role of NSP6, probably also 
due to its low level of expression. It was shown that NSP6 can interact with NSP5 and seems 
that this interaction is due to the 35 C-terminal amino acids of NSP5, overlapping the 
multimerization domain of the protein, suggesting that NSP6 might have a regulatory role in 
the self-association of NSP5 [161] [94]. The absence of NSP6 protein in several strains (group 
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1.6. The virus replication cycle 
 
 
1.6.1. Cell binding and entry 
 
A crucial step in the productive infection of a virus is its successful entry into a host 
cell. It involves a specific attachment of the viral p rticle to a receptor(s) present on the cell 
surface. In case of many viruses, including rotaviruses, a cell entry  is a complex process that 
requires multiple steps and multiple receptors interaction.  
Rotavirus strains can be divided, if it goes to their cell attachment capability, to 
neuroaminidase-resistant or -sensitive strains. Resistant strains do not bind sialic acid residues 
on the cellular membrane and their interaction with the target cell consists contact with the 
other membrane component, whereas in case of the first type of strains interaction of VP4 
with sialic acid takes place and treatment of cells with neuraminidase (NA) greatly diminishes 
virus attachment. Many animal rotavirus strains and, i terestingly, most if not all human 
strains are NA-resistant [162]. 
Although earlier studies implicated VP7 in the rotavirus cell entry [163], subsequent 
studies have increasingly indicated that VP4 is a major player in this process. VP4, the 
characteristic ‘spike’ protein, is involved not only in a cell attachment and penetration but also 
in hamagglutination, neutralization, virulence and protease-enhanced infectivity of the virus 
[164] [165]. The last phenomenon is particularly relevant, considering that rotavirus replicates 
in the mature enterocytes of the small intestine, an environment rich in proteases. As 
previously mentioned, proteolytic cleavage of VP4 causes forming of VP5* and VP8* (that 
remain associated with the virion) [60] that result in transition from disordered to ordered 
state of the ‘spike’. It was demonstrated that VP5* is able to interact with the integrin  α2β1 
(through the sequence DGE) that is considered to be the first receptor for NA-resistant 
rotaviruses and the second in case of NA-sensitive strains, suggesting that α2β1 functions as 
binder or as a second interactor [166, 167]. The subsequent events are less clear but it was 
shown that the interaction of VP7 protein with the integrin αxβ2 (by GRP motif) and αVβ3 
facilitates the virus cell entry and infection [88].  
The internalization mechanism of rotavirus is not fully elucidated but it can be 
mediated by integrins [167] as well as by the cognate protein 70 (Hsc70) that interacts with 
VP5*[168] [169]. 
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The cell entry mechanism of nonenveloped viruses possesses the complication that 
large, hydrophilic particles must traverse a lipid membrane without having the resource of 
fusing two lipid membranes. Up to now there is no clear evidence about the rotavirus 
internalization pathway and it is possible that more than one is utilized. The ultrastructural 
studies have suggested that the virus can penetrate the cell membrane both by endocytosis and 
direct cell membrane penetration [1, 153]. However mo e recent studies showed that rotavirus 
entry can be specified as caveola- and raft-dependent endocytosis, defined by its clathrin 




1.6.2. Virus uncoating, transcription and translation of proteins 
 
 
One of the first events after rotavirus cell entry is the loss by infective TLP of  two 
proteins of the outer layer, VP4 and VP7, that results in exposition of the transcriptionally 
active DLP to the cytoplasm.  
Biochemical studies indicated that the in vivo decapsidation can be mimicked by 
treating TLPs with calcium chelators like EDTA [171]. It was proved that VP7 binds calcium 
and the sensitivity of virions to low calcium concetrations is strain-dependent [171] [89] 
[90]. Several studies have also suggested calcium-driven conformational changes in VP7 [91]. 
Another studies on baculovirus-expressed recombinant VP7 have shown a requirement for 
calcium in the formation of VP7 trimers, which crystallize into hexagonal plates, mimicking 
the arrangement of VP7 on the capsid [92]. Thus, while appropriate levels of calcium help 
maintain the structural integrity of the VP7 layer, low calcium concentrations, similar to those 
in the cytoplasm, trigger the disassociation of VP7 trimers, leading to uncoating of the VP7 
layer [20]. This is an important event in virus replication cycle because it induces the 
transcriptional activity of the virus. Shortly after the  virus uncoating the production of RNA 
transcripts starts and last until 9 to12 hours from the virus infection, after when the synthesis 
begin to decrease [172].  
The transcription is conservative and leads to the formation of mRNAs that are 
identical to the plus strand of the viral dsRNAs. All the transcripts are synthetized de novo 
[39]. The synthesis is mediated by the action of endogenous viral polymerase VP1, that 
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behaves as a transcriptase, and by VP3. The transcription machinery to function properly 
requires also participation of VP2 and VP6 proteins what was described earlier. Since the 
RNA template is double stranded, the necessity of  a helicase activity to unwind dsRNA has 
been proposed, but up to now it is not clear which protein can play this role and VP2 or VP3 
involvement is suggested [173] [64].  
The newly produced mRNAs are capped by the addition of m7GpppGm at the 5’ end, 
but do not contain a poli-A tail at the 3’ end. Although this process is mostly performed by 
VP3 that was characterized as a viral guanylyl and methyl transferase, it is still not fully 
elucidated, because phosphohydrolase activity needed for complete reaction has not been 
attributed to any viral protein so far [32] [31] [44]. 
The primary viral transcripts extrude into the cell’s cytoplasm through the 12  
I-class channels located at the icosahedral five-fold vertices of the DLP particle (Fig. 2EF, 3, 
4) [174].  
The RNA transcripts direct the synthesis of six structural and six non-structural viral 
proteins (i.e., function as mRNAs) and also serve as RNA templates (RNA(+)) for the 
synthesis of the RNA negative strands (RNA(−)), to form the dsRNA genome segments. The 
production of viral proteins starts 2-3 hours after infection with a concomitant inhibition of 
cellular polypeptides  synthesis [76]. 
Translation is performed by the host translation machinery and is facilitated by the 
action of NSP3 protein that recognizes the four-nucleotides consensus  sequence on the 3’ on 
the viral mRNAs. 
 
 
1.6.3. Replication and RNA packaging 
 
The least understood stages in viral morphogenesis are genome replication and 
packaging mechanism. The replication process starts around three hours after viral infection 
and increases in time, reaching a maximal level around 9-12 hours [172]. Once a critical mass 
of viral proteins is accumulated, specialized, cytoplasmic compartments (inclusions bodies) 
known as viroplasms are formed. It was suggested that these structures are the site where viral 
replication, packaging and assembly of the virus take place [105, 175]. This is in agreement 
with the fact that free dsRNA was never found in infected cells. The analysis of the proteins 
found in viroplasms revealed that they contain the proteins found in cores and DLPs (i.e. VP1, 
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VP2, VP3 and VP6) but additionally also two non struc ural  proteins, NSP2 and NSP5. 
Interestingly,  in vitro studies have shown that NSP2 and NSP5, although found in 
viroplasms, do not seem to be necessary for replication, whereas VP1 and VP2 do [176] 
[160]. However additional experiments, including studies on NSP2 temperature sensitive 
mutant, have proved that NSP2 (alone or in associati n with NSP5) is essential for proper 
packaging process [107] [20] [106] [154].  
A significant uncertainness in understanding of the rotavirus biology was the origin of 
the plus-strand RNAs that serve as templates for dsRNA synthesis. An interesting and 
plausible model  for events related to plus-strand RNA synthesis was suggested by Silvestri et 
all. Up to this model, after virion entry and loss of the outer capsid shell, DLPs initiate 
transcription within the cytoplasm, leading to the synthesis of plus-strand RNAs that are 
incorporated into polysomes and translated to produce viral proteins. At least some of the 
DLPs then serve as focal points for the accumulation of newly made proteins into viroplasms 
and are thereby incorporated into the inclusions. Transcripts produced by DLPs in the 
viroplasms are captured by one or more of viral RNA-binding proteins that accrue in these 
inclusions (e.g., NSP2, NSP5, VP1, and VP2). The captured plus-strand RNAs serve as 
sources of templates necessary for genome replication nd assembly of progeny cores and 
DLPs. When the level of transcripts in the viroplasm exceeds the binding capacity of the 
RNA-binding proteins, the transcripts escape and can become incorporated into polysomes. 
Thus, viral gene expression is enhanced, and the additional proteins necessary for increasing 
the sizes and numbers of viroplasms are produced. In this scenario, viroplasm development 
becomes an autoregulatory process controlled by the capacity of the RNA-binding proteins to 
capture transcripts made by the DLPs within the inclusion [97].  
Moreover, studies based on RNA interference have suggested that the viral mRNAs 
involved in protein production were not the same ons as these used for viral replication and 
that the second ones were protected from the action of siRNA, probably because of their 
localization into viroplasms [97].   
One of the most intriguing aspects of rotaviruses and ll segmented dsRNA viruses 
relates to how these viruses co-ordinately replicate nd package the 11 viral mRNAs. 
Although the packaging signals in viral mRNAs have not been described, the hypothesis that 
mRNA packaging precedes dsRNA synthesis implies that i  is the mRNAs which contain cis-
acting packaging signals as opposed to the double-stranded products of replication. The 11 
mRNAs must share common cis-acting signals because they are replicated by the same 
polymerase, and these signals are likely to be formed by secondary structures rather than the 
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primary sequences. In addition, each mRNA must alsocontain a signal that is unique to it 
alone because the 11 mRNAs must be distinguished from one another during packaging. [42].  
The identification of  the RNA sequences necessary fo  replication was possible 
thanks to experiments with open cores [176]. Three regions have been found to play an 
important role. The first is represented by 3’ consensus sequence (3’CS). This is the most 
important cis-acting signal, that consists of very conserved sequence. Although the first 
experiments with open cores had shown that the last 26 nucleotides of viral positive RNA 
strand were important for replication [176], later studies have demonstrated that only last 
seven nucleotides are crucial [177], and last two nucleotides are essential for initiation of 
replication [178]. Additionally, it is necessary tha  3’CS is single stranded to function 
efficiently as replication signal [179]. A second important region is located upstream from the 
3’CS at the 3’ end of viral mRNAs. It was shown forthe genome segment 8 that several 
important sequences were recognized in this region by the viral polymerase [180]. A third 
region, situated on the 5’ terminus, has been shown t  enhance replication. This region lacks 
conserved sequence and its role in replication is not elucidated. It was proposed that 
secondary structure of this region may be responsible for the formation of a panhandle 
structure together with the single strand of 3’CS [181] [45] [177]. Moreover, the fact that 
predicted secondary structures of viral mRNAs contain more stem-loop structures localized 
on 3’ and 5’ ends of mRNAs and that these structures differ for the various mRNAs, can be 
correlated with packaging and assortment phenomenon [42].  
All these processes lead to the production of transcriptionally active, dsRNA-
containing double-layered replication intermediate (RI) particles. These particles are 
responsible for an enhanced second round of transcription, which results in a second wave of 
assembly of double-layered RI particles, which then bud through the membrane of the ER 
(Fig.18). 
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Fig. 18. Replication cycle of rotaviruses. The different steps in the replication cycle of the virus are 
indicated by numbers—1: attachment of the virion to the cell surface; 2: penetration and uncoating of the 
virus particle to yield DLPs; 3: primary transcript ion of the genomic dsRNA; 4: synthesis of viral 
proteins; 5: assembly of core RIs and negative strand RNA synthesis; 6: assembly of double-layered RIs; 
7: secondary transcription from double-layered RIs; 8: secondary, enhanced synthesis of viral proteins; 9: 
secondary, increased assembly of core RIs and negative strand RNA synthesis; 10: secondary, increased 
assembly of double-layered RIs; 11: budding of double-layered RIs through the membrane of the 
endoplasmic reticulum (ER), and acquisition of a membrane envelope; 12: loss of the membrane envelope 
and generation of mature triple-layered virions [182]. 
 
 
1.6.4. Virus release 
 
Rotavirus undergoes a rather unique morphogenesis that till requires further studies to 
become fully understood. The first step of maturation occurs inside viroplasms, where 
immature subviral particles assemble. The cores contain structural proteins VP1, VP3 and 11 
genomic segments surrounded by the inner layer protein VP2. After the core particle is 
assembled it acquires the intermediate layer made of VP6 protein. VP6  localizes in the 
cytoplasm between the viroplasms and reticulum [68]and the assembly of intermediate layer 
is believed to occur concomitantly with the exit of particles from viroplasms into ER [1].  
During this budding, which is mediated by the interaction of the double-layered RIs 
with the ER membrane-associated rotavirus protein NSP4, the particles acquire a transient 
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membrane envelope [183] [68] [1]. The studies with siRNA against NSP4 have shown that 
this protein is necessary for the formation of  theint rmediate layer, because in its absence the 
formation of DLPs and TLPs was affected, suggesting that VP6 interaction with last 20aa of a 
cytoplasmic tail of NSP4 may be crucial for this process. On the contrary, interaction of NSP4 
with VP7 and VP4 do not have a role in the viral budding  in ER [137]. The last step of 
rotaviral morphogenesis occur in the ER. A transient envelope and the outer layer of the virus 
is formed. The transiently enveloped particles where the VP7 localizes in the interior possibly 
relocating across the membrane, contains in addition to NSP4, the virus surface proteins VP4 
and VP7, as well as minor amounts of other non-structu al proteins [184]. The lipid envelope 
is then removed [185] by a largely unknown mechanism, related to two aspects- NSP4 
glycosilation and the difference of Ca2+ concentration between cytoplasm and ER [186] [142]. 
Many interesting information about the virus release come from the use of Caco-2 
cells. The human polarized intestinal epithelial CaCo-2 cells, established from a human colon 
adenocarcinoma, have been shown to spontaneously display many of the morphological and 
biochemical properties of mature enterocytes. In these cells rotavirus was released almost 
exclusively at the apical pole before any cell lysis was detected. It was demonstrated that the 
virus is able to associate with rafts (that act as pl tform for assembly of a virus)  through a 
direct interaction with VP4. Following these studies it was proved that rotavirus does not 
leave the cell in the way of classical exocytosis but is released from the apical surface of 





1.7. Epidemiology, clinical aspects and vaccines 
 
 
Diarrhea remains one of the most common illnesses of children worldwide [188] 
[188]. Although more than twenty different microorganisms (bacteria, parasites, and viruses) 
cause diarrhea [12], one pathogen, rotavirus, is the most frequent causative agent for the most 
severe disease in children younger than 5 years world ide. Rotavirus causes 25–55% of all 
hospital admissions  for diarrhea and more than 0,6 million deaths every year [189] [12]. The 
greatest mortality is in developing countries of south Asia and sub-Saharan Africa. The 
seriousness of the problem is emphasized by the fact th t only in India alone occur more than 
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100 000 deaths every year. About 1 in 200 children born in these regions will die of rotavirus 






Rotavirus is transmitted by the faecal-oral route and  small infectious dose (<100 
virus particles) facilitates spread from person to person or possibly via airborne droplets 
[192]. Once ingested, virus not neutralized by stomach acid attaches to the proximal small 
intestine. During the incubation period of 18–36 h, the virus enters epithelial cells where it 
first elaborates a potent enterotoxin, NSP4, that can cause diarrhea, and then goes on after 18–
36 h to destroy the epithelial surface leading to blunted villi, extensive damage, and shedding 
of massive quantities of virus (>1012 particles per gram) in stools [1] [138]. The outcome is a 
profuse watery diarrhea with loss of fluid and electrolytes that can last 2–7 days and might 
lead to severe or fatal dehydration. Aggressive rehydration with oral or intravenous fluids can 
correct these imbalances and sustain a child until the diarrhea stops. 
The large burden of rotavirus disease has led many international agencies, including 
WHO and the Global Alliance for Vaccines and Immunizations, to select rotavirus as a high 
priority target for accelerated development of global, efficient and safe oral vaccine. 
The first efficient vaccine was a tetravalent rhesus rotavirus vaccine, RotaShield 
(Wyeth-Lederle, Pearl River, NY, USA), developed by Kapikian at the National Institutes of 
Health [193]. The variable efficacy of previous monovalent vaccines based on animal strains 
Fig. 19. Map of the world with estimated mortality from rotavirus diarrhea. Shading 
represents risk of death per child by 5 years of age [8] 
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was improved by development of reassortant strains that had the attenuation properties of the 
animal strains and individual genes encoding the out r capsid proteins of the common human 
strains. Rotashield was tested in a series of clinical trials in the USA, Finland, and Venezuela, 
and has shown to be initially safe and highly effectiv . In August 1998 the vaccine was 
recommended for routine immunization of children in the USA, and was administrated over 
600 000 infants in the first 9 months of the program [194]. Unfortunately, in July 1999, 
intussusception, potentially fatal bowel obstruction was reported to occur in the first 2 weeks 
after administration of the first dose. Because of this event the vaccine was removed from the 
market. This decision till now remains controversial as the exact intussusception risk was 
judged to be about one case of in 10 000 vaccine recipients. The mechanism of this 
association still remains unclear, especially that intussusseption has never been associated 
with natural rotavirus infection. Subsequent analysis indicated that the level of risk was age-
related. The vaccine was offered to children at the tim  of their routine immunizations at 2, 4, 
and 6 months of age, but catch-up immunization was provided any time up to 7 months of 
age. Most of these cases of intussusception happened in children who were older than 90 days 
old at the time of immunization [195].  
The Rotashield vaccine has been acquired by a small biotech company called BioVirx, 
which plans to manufacture the vaccine for use in developing countries. Re-analysis of the 
safety profile of this vaccine suggested that the risk of intussusception could be substantially 
reduced if the first dose of the vaccine was administered only to infants aged younger than 
ninety days. Furthermore, despite the complication of intussusception, the vaccine might be 
more acceptable in developing countries where the risk of a child dying from rotavirus would 
be more than 100-fold greater than the risk of this rare complication [8]. 
Recently two new vaccines have been licensed in Europe and the USA and in several 
other countries. These vaccines are based on slightly different principles to achieve broad 
immunity against the diverse strains of rotavirus in circulation. 
The GlaxoSmithKline vaccine, Rotarix, was developed from a human rotavirus strain 
(89-12) isolated from a patient in Cincinnati by Ward and Bernstein. Strain 89-12, a 
representative of the most common serotype in humans, (P1A[8], G1), was first attenuated by 
passaging 43 times and was then cloned and further passaged in Vero cells and renamed RIX 
4414 [196]. Infants aged younger than 3 months who received the vaccine did not develop 
diarrhea, vomiting, or fever. To minimize the risk the possible of intussusception, 
GlaxoSmithKline pursued an unusual clinical development plan. First the vaccine was tested 
in Finland, then in middle-income countries of Latin America (i.e., Mexico, Venezuela, and 
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Brazil), followed by the trial in Asia (Singapore). The vaccine showed high efficacy against 
any rotavirus diarrhea and was safe. Rates of minor side-effects did not differ between 
recipients of the vaccine versus placebo. Additional results from the trial in Latin America 
showed significant efficacy against non-G1 serotypes, that were predominantly G9 strains. 
Based on these results, GlaxoSmithKline undertook a large trial to confirm that the vaccine 
did not cause intussusception .The trial in which 63 000 infants from 12 countries of Latin 
America and from Finland were enrolled showed that more intussusception events were found 
in recipients of the placebo [197]. The regulatory approach to license this vaccine has also 
been innovative. New drugs are generally licensed first in their country of origin, most often 
in the USA or Europe. This vaccine, however, was fir t licensed in Mexico and the 
Dominican Republic in 2004, and has been licensed in more than 35 countries and the 
European Union. Licensure in Brazil and the European Union which have national regulatory 
authorities meeting WHO standards, will facilitate licensure elsewhere in Latin America. 
WHO and UNICEF require that a vaccine tendered for gl bal use be licensed in the country 
of origin. As a result of the European licensure, the vaccine will now be eligible for 
international procurement by UNICEF for developing countries or by the Pan American 
Health Organizations revolving fund for Latin American countries. In addition, WHO has 
recommended that the effectiveness of any new live oral vaccine be shown in poor 
populations in Africa and Asia before a global recommendation can be made. These studies 
are just starting and results could take 2–3 years [8]. 
The second vaccine, RotaTeq, was developed by Merck. It was prepared from a 
bovine strain of rotavirus, WC3, isolated from a calf in Pennsylvania by Clark and Offit at the 
University of Pennsylvania. The original monovalent bovine strain that was naturally 
attenuated for human beings showed variable effectiveness in several clinical trials done in 
the USA, China, and Africa. To improve the effectiveness of the vaccine against the diversity 
of common serotypes, reassortant strains were prepared. They contain ten genes from the 
parent bovine strain and an individual capsid gene from the most common human serotypes. 
Five single gene reassortants, every one containing a gene for a capsid protein for human 
serotypes G1, G2, G3, G4, and PIA, were combined in a pentavalent vaccine. Preliminary 
clinical trials showed immunogenicity and effectiveness of different formulations, and a final 
formulation containing 12×107 infectious units per dose was selected. This formulation was 
assessed for safety against intussusception in a field trial done in more than 70 000 infants, 
mainly in the USA and Finland but also in several countries of Central and South America, 
Europe, and Asia. Intussusception was monitored intensively for 42 days after receipt of any 
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dose and 11 cases of the disorder were identified, six in vaccinated patients versus five in 
recipients of the placebo. Within 14 days of receipt of any dose of vaccine, one case was 
identified in each of the vaccine and placebo groups. In a detailed follow-up study, the 
vaccine showed an efficacy of 86% against doctor visits, 93% against emergency department 
visits, and 96% against admissions for rotavirus diarrhea. It also protected against the range of 
rotavirus serotypes in circulation. The vaccine was licensed by the US Food and Drug 
Administration in February, 2006 and was recommended by the Centers for Disease Control’s 
Advisory Committee on Immunization Practices for the routine immunization of children in 










1.8.1. Circular dichroism spectroscopy 
 
 
  Circular dichroism (CD) is an optical phenomenon that is based on the asymmetric 
nature of biological macromolecules which are able to rotate the plane of light polarization 
due to the presence of centers of chirality (carbon at ms). CD is a measure of the differential 
absorbance between left and right circularly polarized light. Circularly polarized light and 
linearly or plane-polarized light are readily interconvertible. A plane polarized light beams 
consists of right and left circularly polarized beams of equal intensity and, conversely, a 
circularly polarized light beam consists of two orth gonal plane-polarized beams 90o out of 
phase. A linearly polarized light beam becomes elliptically polarized after passing through an 
optically active medium (Fig.20). Since the conformation of the macromolecules affects its 
optical activity, these properties can be utilized to obtain information about structural 
organization of such molecules in solution. Theoretical calculations and several experimental 
measurements have demonstrated high sensitivity of CD spectra towards protein and nucleic 
acids structure investigation [2].   
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The CD signal of proteins can be measured in two spectral regions. The spectrum in 
the near UV region (320-260 nm) reflects the environments of the aromatic amino acid side 
chains and thus gives information about the tertiary st ucture of the protein. In the far UV 
region (240-180 nm) or amide region, which corresponds to peptide bond absorption, the CD 
spectrum can be used to estimate the content of regular secondary structural components such 
as α-helix and β-strand. All alpha-proteins show a strong double mini um at 222 and 208-
210nm and  a stronger maximum at 191-193nm. All beta-proteins usually have a single, 
negative band (between 210 and 225nm)  and a single positive CD band between 190 and 
200nm with intensities much lower than alpha-helical proteins [198]. For proteins, however, 
the major objective is to deduce average secondary structure from CD data. 
Over the last three decades, various methods have been developed for the analysis of 
protein CD spectra, based upon the spectral characteristics of protein secondary structures 
[199] [200] [201] [202] [203] [204] [205] [206]. Methods use various algorithms and 
calculate the fraction that each component structure contributes to the net experimental 
Fig. 20. Origin of the CD effect. (a) The left (L) and right (R) circularly polarised components of 
plane polarised radiation: (I) the two components have the same amplitude and when combined 
generate plane polarised radiation; (II) the components are of different magnitude and the 
resultant (dashed line) is elliptically polarised. (b) The relationship between absorption and CD 
spectra. Band 1 is not chiral; band 2 has a positive CD spectrum with L absorbed more than R; 
band 3 has a negative CD spectrum [2]. 
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spectrum. The information contained in spectra can be treated as a sum of the characteristic 
individual spectra arising from each type of secondary structure present in a protein sample. 
Typically, empirical analysis methods utilize a refer nce database comprised of spectra of 
proteins whose crystal structures (and therefore their secondary structures) are known.  
 
 
1.8.2. Mass spectrometry 
 
 
Importance of mass spectrometry in biological research 
 
The biological applications of mass spectrometry (MS) currently encompass very 
diverse areas of biology and medicine but is strongly linked to the term “proteomics”. 
Proteomics could be defined as the effort to establi h the identities, quantities, structures, and 
biochemical and cellular functions of all proteins  an organism, organ, or organelle, and how 
these properties vary in space, time, and physiological state (by National Academy of 
Science) [207]. The current importance of MS to biological research has been highlighted by 
the 2002 Nobel Prize in Chemistry, which was awarded to John Fenn and Koichi Tanaka for 
“the development of soft desorption ionization methods for mass spectrometric analysis of 
biological macromolecules”. For a number of years, mass spectrometers were restricted to 
measuring of  volatile compounds and small molecules. Ionization of larger molecules like  
proteins was not possible until the time when the fast atom bombardment ionization method 
was introduced [208]. The ability to ionize larger molecules was further improved with the 
elaboration of Electrospray Ionization (ESI) by Fenn and co-workers in 1988 [209]. The 
electrospray ion source was easily connected to on-line liquid  chromatography (LC), which 
made possible the analysis of complex mixtures. Time-of-flight (TOF) mass analysis had been 
developed and commercialized by 1956, but relatively poor mass resolution was a problem 
until improvements were made in the early 1970s [210]. An ionization technique for 
biological molecules that could be used with TOF analysis was introduced in 1991. This ion 
source, Matrix-Assisted Laser Desorption/Ionization (MALDI), was the result of work in 
Germany by Hillenkamp, Karas, and coworkers [211] and in Japan by Tanaka and coworkers 
[212]. Like ESI, the MALDI ion source was capable of i nizing and vaporizing as large 
molecules as proteins. These methods solved the problem of generating ions from large, non-
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volatile analytes, such proteins or peptides, withou  significant analyte fragmentation. The 




Main applications of MS in biological sciences 
 
 
Recent advancement increased the role of mass spectrom try-based proteomics as an 
indispensable tool for molecular and cellular biology and for the emerging field of systems 
biology. These include the study of protein–protein interactions via affinity-based isolations 
on a small and proteome-wide scale, the mapping of numerous organelles, and the generation 
of quantitative protein profiles from diverse species. The ability of mass spectrometry to 
identify and, increasingly, to precisely quantify thousands of proteins from complex samples 
can be expected to impact broadly on biology and meicine [213]. 
One of the most important applications of MS is an identification of proteins. There 
are two different approaches: first, the masses of peptides obtained from a digested protein are 
measured and serve as a fingerprint to identify the protein. Then these experimental masses 
are compared with the theoretical values calculated by applying known cleavage rules of the 
used protease (e.g. cleavage after K or R for trypsin) to every sequence in the database. If the 
experimental data matches the theoretical data of a protein sufficiently well, this protein is 
supposed to be present in the sample. 
Another important application is quantification of proteins, since diseases often 
produce abnormal expression levels for certain proteins. The expression level of the 
corresponding mRNA molecules does not necessarily correlate with the protein level [214], 
especially for proteins with low numbers of copies (some 10,000 copies per cell), which can 
have an important regulating role in a biological pthway. Therefore, the mRNA expression 
levels found by hybridization experiments convey only limited information and should be 
complemented by the levels of the proteins they encode. Peak intensities in MS spectra cannot 
easily be correlated with the amount of protein present in the sample, since these intensities 
depend on experimental conditions and on chemical properties of the protein. However, if the 
intensities are normalized with an internal standard of known concentration and similar 
chemical properties, these normalized intensities correlate linearly with protein concentration 
[215]. 
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Posttranslational modifications play an important role in biological pathways. Protein 
modifications are determined by examining the measured mass and fragmentation spectra via 
manual or computer-assisted interpretation. Phosphorylation for example is a chemical 
modification of certain amino acids that can switch off and on the activity of a protein. 
Therefore, the amount of phosphorylation for a certain protein can provide an important 
information about the state of a cell. Since this modification always adds the same mass 
(80Da) to a protein, it is easily detectable by MS. Many modifications are detectable this way 
and software that helps identifying modifications of peptides is available [216]. 
The analysis of protein complexes is another area where MS-based proteomics has a 
significant impact. Most proteins exert their function by way of protein-protein interactions 
and enzymes are often held in tightly controlled regions of the cell by such interactions. Thus, 
one of the first questions usually asked about a new protein is to which proteins does it bind? 
To study this question by MS, the protein itself is used as an affinity reagent to isolate its 
binding partners. Compared with two-hybrid and chip-based approaches, this strategy has the 
advantages that the fully processed and modified protein can serve as the bait, that the 
interactions take place in the native environment ad cellular location, and that multi-
component complexes can be isolated and analyzed in a si gle operation [217]. However, 
because many biologically relevant interactions are of low affinity, transient and generally 
dependent on the specific cellular environment in which they occur, MS-based methods in a 
straightforward affinity experiment will detect only a subset of the protein interactions that 
actually occur. Bioinformatics methods, correlation of MS data with those obtained by other 
methods, or iterative MS measurements possibly in conjunction with chemical crosslinking 





Principles of the method and instrumentation 
 
 
Mass spectrometric measurements are carried out in the gas phase on ionized samples. 
By definition, a mass spectrometer consists of three d vices, an ion source, a mass analyser 
that measures the mass-to-charge ratio (m/z) of the ionized analytes, and a detector that 
registers the number of ions at each m/z value.  
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The most common ionization techniques used in biolog cal applications to volatize 
and ionize peptides and proteins or peptides for mass spectrometric analysis are electrospray 
ionization (ESI) and matrix-assisted laser desorptin/ionization (MALDI) [209] [211]. 
ESI ionizes the analytes out of a solution and is therefore readily coupled to liquid-
based (for example, chromatographic and electrophoretic) separation tools. In this technique, 
sample solution enters through a narrow steel needle. Strong electric fields around the tip of 
the needle charge the surface of the emerging solvent and electrostatic repulsion of these 
charges disperses the solvent into a very fine spray of charged droplets, all at the same 
polarity. The process of droplets shrinking is followed by ‘Coulumbic explosion’ and is 
repeated until individually charged 'naked' ions of analyte are formed and released as gas-
phase ions. The completely dissolved ions are formed at the atmospheric pressure and then 
guided into the high-vacuum region of the mass spectrometer through a capillary or by series 
of differentially pumped skimmers of the mass analyzer. For proteins a large number of 
different charge states z occur and the same protein is detected at various m/z values.  Multiple 
charged ions are mathematically transformed into a simple mass spectrum that reveals the 
molecular weights of the fragments [219]. A number of variants of the electrospray technique 
are available; some operate without gas but with a heated capillary. Very sensitive detection 
can be obtained with thinner needles and nL/min flow rates [220]. Since ions are extracted 
continuously, ESI works well with triple quadrupole instruments or ion traps but it can also be 
used with most other mass analyzers [221]. 
While integrated liquid-chromatography ESI-MS systems (LC-MS) are preferred for 
the analysis of complex samples, MALDI-MS is normally used to analyze relatively simple 
peptide mixtures. MALDI sublimates and ionizes the samples via laser pulses. Peptides are 
suspended or dissolved in the matrix that is small, organic, UV-absorbing molecules, 
normally an aromatic organic weak acid (e.g. derivatives of benzoic or cinnamic acid) which 
strongly absorbs energy at the wavelength of the las r. N2-lasers (337 nm) and Nd-YAG (355 
nm) have been successfully applied. The analyte is mixed with the matrix in a solution and the 
mixture is allowed to dry as a crystalline coating on a metal target plate. The matrix plays an 
important role in several ways. It absorbs energy and protects the analyte from excessive 
energy i.e. analyte decomposition and enhances the ion formation of the analyte by 
photoexcitation or photoionization of matrix molecules, followed by proton transfer to the 
analyte molecule. Moreover sample dilution into thematrix prevents association of analyte 
molecules. The resulting crystals are irradiated with laser pulses at the wavelength at which 
the matrix has high spectral absorption. This process desorbs the mixture and photoexcites the 
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matrix. The excited matrix then ionizes the sample thought proton transfer, causing the 
subsequent passage of matrix and analyte ions into the gas phase. The principal ion detected 
using a threshold laser intensity for MALDI is [M + H+], although signals for multiply 
charged ions and oligomeric forms of the analyte may be seen, especially for large proteins. 
At the time that the laser is pulsed and a voltage is applied to the target plate, the ionized 
sample is accelerated by the electrostatic field and expelled into a flight tube. 
Once a sample has been ionized, it must be mass analyzed. The beam of ions is then 
focused and directed into a mass analyzer which separates the ions in respect to their m/z 
value. In the context of proteomics, the key parameters of a mass analyzer are sensitivity, 
resolution and mass accuracy. There are four basic types of mass analyser currently used in 
proteomics research. These are the ion trap, time-of-flight (TOF), quadrupole and Fourier 
transform ion cyclotron (FT-MS) analysers. They are v ry different in design and 
performance, each with its own strength and weakness. These analysers can be stand alone or, 
in some cases, put together in tandem to take advantage of the strengths of each [222]. 
MALDI is usually coupled to ‘time of fligh’  (TOF) analysers that measure the mass 
of intact peptides, whereas ESI has mostly been coupled to ion traps and triple quadrupole 
instruments and used to generate fragmented ion spectra (collision-induced (CID) spectra) of 
selected precursor ions [221].  
 TOF analyzer is conceptually the simplest spectrometer. Applying a fixed voltage at 
the source (ca. 20kV) the ionised gas-phase sample is accelerated to a fixed kinetic energy 
(Ek) and then guided into a high-vacuum field-free flight tube, through which they reach the 
detector. Because the flight tube is a field-free rgion, all the Ek of the ions results from their 
initial acceleration, therefore a group of ions accelerated with the same constant voltage, at a 
fixed point and initial time, and allowed to drift in a field-free region, will traverse this region 
and separate in a time which depends upon their m/z ratios. Measuring that time-of-flight at 
the detector it is possible to determine the m/z value. 
Earlier MALDI-TOF spectra were characterized by poor mass resolution due to the 
distribution of kinetic energy among ions that vary in initial desorption velocity [223] [224] 
and in energy deficits from collisions of desorbed matrix during ion acceleration. In 
continuous ion extraction linear mode, there was no compensation for ions with the same m/z 
value but different initial velocity.  
To overcome this problem two improvements have been implemented in present TOF 
instruments configurations. First, the events of desorption/ionization and acceleration has 
been separated by applying the acceleration field with a slight delay, up to hundreds of 
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nanoseconds, relative to the laser pulse enabling the ions to be focused [225]. In the delayed 
extraction conditions (DE-mode), in fact, a variable voltage grid in front of the source allows 
MALDI-generated ion cloud to expand in a transient field free region (grid has the same 
voltage of source). Then a fast high-voltage pulse (grid has slightly lower voltage than source) 
creates a potential gradient in the ionization region that accelerates slow ions more then fast 
ones. This pulse voltage and time delay corrects the initial velocity differences in such a way 
that identical m/z ions arrive simultaneously at the plane of the detector, enhancing resolution 
of the mass spectrum.  
The second improvement was the introduction of a reflectron device [226] at the axial-
end of the field-free drift region. Even applying DE-mode, after ions are accelerated and 
velocity-focused (ions of the same mass align in time), they can defocus flying down the tube 
causing broadening of signal detector. The reflectron ies to correct this drifting apart and 
tries to focus the ions on the detector. It is an electrical mirror, with a voltage potential applied 
across the sides, which creates a retarding field at a voltage slightly higher than the 
accelerating one. The ions are sequentially slowed down through the reflector until they stop, 
turn around and re-accelerate back in a second drift region to a second detector. Ions species 
with a kinetic energy lower than the accelerating voltage will penetrate less in the reflector 
and will turn back sooner (as ions species with higher kinetic energy will penetrate deeper and 
turn back later) allowing ions of the same /z value and slightly difference in flight times to 
be packed and focused in space and time to the detector.  
To allow the fragmentation of MALDI-generated precursor ions, MALDI sources have 
been recently coupled to quadrupole ion-trap mass spectrometers [227]and two types of TOF 
instruments: the quadrupole TOF hybrid instrument (Fig.21) [228] and the MALDI-TOF-TOF 
(Fig.20) [229]. A collision cell is inserted between the two analyzer. Ions of a particular m/z 
value are selected in the quadrupole mass filter or in the first TOF, fragmented in the collision 
cell and the fragments ions masses are read out by a TOF analyzer (Fig.22). These 
instruments have very high sensitivity, resolution, mass accuracy and high speed data 
acquisition. During MS/MS analysis, MALDI-TOF-TOF instrument offers the possibility to 
finely control fragmentation conditions and simultaneously provides both low-energy and 
high-energy collision induced spectra. The degree of fragmentation and structural information 
obtained are related to adjustment in laser intensiy, collision gas pressure and collision 
energy. A collision energy of 1-2 keV in the CID-cell r sults in the production of low mass 
internal fragments, ions from amino acid side chain fragmentations, ions specific of particular 
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amino acids increasing the confidence in the peptid sequence interpretation and identification 





Fig. 21. The quadrupole TOF instrument combines the front part of a triple quadruple 
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2.1. Nsp5 wt and mutants constructs preparation and production of anti 
NSP5 serum 
 
Plasmid construction was performed using the E. coli DH5α strain (Life Technologies 
Inc.). Nsp5 wt, derived from porcine OSU rotavirus strain (Genbank accession number: 
D00474) was amplified by PCR from cDNA using specific primers on 5’ and 3’ ends (already 
characterized by [49]). The PCR fragment was cloned to pGemTEasy (Promega) vector, 
sequenced and then subcloned to pcDNA3-His, that was described earlier by Eichwald [149]. 
Final cloning to pET23d (+) (Novagen) was done using NcoI and BamHI sites. NSP5S67D 
was subcloned from pCDNA3 construct as mentioned in [6] into pcDNA3-His [149] and 
finally cloned to pET23d (+). Delta C18 mutant was mplified on the matrix of pET23d 
(+)NSP5 wt using subsequent primers: 
forward: 5’GATTCTAGAGTCGACCATGGGTCATCACCATCAC3’ 
 reverse: 5’GTGGGATCCTTACTTTTTCTTATATT3’ 
and then cloned to pET23d(+) where it was sequenced (MWG-Biotech, Ebersberg, Germany). 
Mutant NSP5∆32 was prepared on the basis of already existing construct characterized by 
[49]. NSP5 truncated gene was cloned using NcoI/BamHI sites into pET23d (+) vector. 
 The following constructs were obtained as described in [6].pT7v- ∆3a, pT7v-∆3b, 
pT7v∆3/S63A, pT7v-∆3/S65A, pT7v-∆3/S67A, and pT7v-∆ 3(S63,65A_S67D) were 
obtained by double-step PCR by using internal oligonucleotides to amplified regions 1 and 2 
and cloned KpnI_ClaI in pT7v-(4TclaI5’). pT7v-(4TclaI5’) was obtained by PCR of the 
regions 4 and T, inserting the restriction sites KpnI and ClaI at the 5’ and BamHI at the 3’ The 
fragment was cloned as KpnI/BamHI in pcDNA3. pT7v-SV5 ∆ 2 was obtained by inserting at 
the N-terminus the SV5 tag with oligonucleotides, 5’-
AGCTTGTACCATGGGCAAACCAATCCCAAACCCACTGCTGGGTCTGGATGGTAC- 
3’ and 5’-CATCCAGACCCAGCAGTGGGTTTGGGATTGGTTTGCCCATGGTACA-3’, 
and into HindIII/KpnI. pT7v-NSP5a, pT7v-NSP5/S57A, and pT7v-NSP5(S63,65A/S67D) 
were obtained by PCR of the respective pT7v-∆3 point mutation by using specific primers to 
  Materials and  Methods 
 62  
incorporate KpnI and BstBI restriction sites at the 5’and 3’ ends of the 1+2 region, 
respectively. The fragments were cloned KpnI/ BstBI into pT7v-∆1∆2(KpnI/BstBI). This 
construct was obtained by PCR with specific primer to insert KpnI/BstBI and BamHI 
restriction sites at the 5’and 3’ends of the ∆1∆ 2 region, respectively. 
pQENSP5(S63,65A/S67D), and pQE-NSP5a were obtained by igestion KpnI/EcoRV of 
above described pcDNA3 construct and cloned KpnI/SmaI in pQE-30 (Qiagen, Valencia, 
CA). 
Anti-NSP5 sera were obtained through protein immunization using purified His-
NSPwt produced in E. coli M15 [Rep4] strain as described before [6]. Guinea pigs were 
injected intraperitoneally with 100µg of purified protein for each boost. The boosts were 
repeated three times every 15 days and the animals were bleeded one week later. Antibodies 
were tested by Western Blot analysis on extracts of rotavirus infected and non infected cells 
and dilution 1:7000 was experimentally established as sufficient. 
 
 




MA104 cells were routinely cultured in Dulbecco's modified Eagle's medium 
(DMEM) supplemented with 10% foetal calf serum (FCS), 2mM L-glutamine (Gibco BRL) 
and gentamycin (100 µg/ml). Cells were propagated using trypsin (500 µg/ml), inhibited with 





2.3. Transient transfection of MA104 cells 
 
To prepare cellular extracts cells were transfected essentially as described by 
Africanova, [49]. Briefly, 5x 105 cells growing on a 35 mm diameter Petri dish, were inf cted 
with T7-recombinant vaccinia virus (strain vTF7.3) [230] and 1 h later transfected with 5 µl 
of Transfectam reagent (Promega) mixed with 2 µg of plasmid DNA and incubated for 16 h. 
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At 16 h post-transfection cells were washed twice with cold PBS, kept on ice and 
lysed in 80 µl of cold TNN lysis buffer (100 mM Tris-HCl pH 8.0, 250 mM NaCl, 0.5% 




2.4. Virus infection and propagation 
 
The porcine rotavirus strain OSU, bovine strain RF and simian SA11 were propagated 
and grown in MA104 cells as characterized by Estes, [231]. Briefly, the inoculum was 
activated in presence of 10 µg/ml trypsin until cythopatic effect was visualized. The infective 
medium was frozen and thawed three times, centrifuged at 500 rmp for 10 min to eliminate 
cellular debris and stored at – 80oC.  Virus was titrated using plaque assay as described n 
[232]. 
 The recombinant vaccinia virus VT7/LacOI/NSP2 was propagated and grown in 
BSC-40 cells as described by Ward et al, [233].  
 
 




Samples were loaded and ran in a SDS-PAGE according to Laemmli method [234]. 
After, samples were transfered to a PDVF membrane (Immobilion-P, Millipore) for 2 hours at 
200mA or O/N at 50 mA. The membrane was blocked in PBS-milk 5% for 45 minutes and 
incubated for 1, 5 hour with the primary antibody in PBS-milk 5%. After, three washes in 
PBS-milk 5%, the secondary antibody conjugated to peroxidase was added and incubated for 
1 hour. Finally, the membrane was washed 3 times in PBS-milk 5% for 5 minutes and at last 
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2.6. Sample preparation for MALDI TOF/TOF analysis 
 
 
 MA104 cells were cultivated on 15 cm diameter Petri dishes (Costar) until they 
reached the state of confluence. Cells then were mock-infected (control samples preparation) 
or infected with rotavirus (OSU, RF SA11 or strain) at a multiplicity of infection (MOI) of 5 
PFU/cell. After 12 hours cells were washed 3 times with cold PBS, scraped on ice and lysed 
with cold TNN buffer containing 20mM NaF (phosphatases inhibitor). For every 1 ml of cell 
lysate 30 µl of protein A-sepharose beads (Repligene) were used. B ads were resuspended 
and washed 3 times with lysis buffer (TNN). Prebinding mix was prepared- 1 µl of anti-NSP5 
sera (2.1.) was used for every 4 µl of protein-A beads. Mix was incubated on the rotat r in the 
4oC for 45 min. Afterwards beads were washed twice with cold TNN and lysates of rotavirus 
and mock-infected cells were added. Reactions were incubated on the rotator in 4oC for 2 h. 
After incubation, protein-A beads were washed 3 times and resuspended in 1 ml of cold TNN. 
To increase purity of immunoprecipitation a quick glycerol step gradient was performed. To 
the tubes containing beads resuspended in 1 ml of TNN 500 µl of TNN-glycerol 20% was 
gently overlayed. Samples were centrifuged 30 seconds to pellet the beads and supernatant 
was removed from the top to down. Beads were washed 3 times with TNN. From this point 
samples for MALDI TOF/TOF analysis were prepared with two different methods in purpose 
to increase the possibility for obtaining more reliab e results. Schematic representation of this 
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2.6.1. Protein extraction from SDS-PAGE gel 
 
Protein-A beads with bound NSP5 and immunoprecipitated in the same way control 
samples (mock-infected lysate) were placed in microcentrifuge columns. Attached proteins 
were eluted from protein A-beads with 0.2 M glycin HCl pH 2,8. Immediately after elution 
law pH was neutralized with 1M Tris-HCl pH 8,0. To decrease the volume of samples, 
proteins were acetone precipitated. Pellets were dri d by centrifugation in a SpeedVac, 
resuspended in 1x SDS-PAGE loading buffer and boiled. Samples were loaded on 15% 
polyacrylamide gel in the way that control samples and samples containing 
immunoprecipitated NSP5 were separated by lines of prestained marker (Precision Plus 
Protein Standards, Bio-Rad). One tenth of each sample was loaded in the same order on the 
second half of the gel. After protein separation, the gel was cut into two halves, and on the 
part containing less material, Western blotting was performed. The second half was kept 
or or 
or or 
Fig. 23. Scheme of sample preparation for MALDI TOF/TOF analysis. Cells were infected with 
OSU, RF or SA11 rotavirus strain. NSP5 was immunoprecipitated and subsequently subjected to 
direct trypsinization or immunoprecipitated samples were separated by SDS-PAGE, then NSP5 was 
fractionated, excited from the gel and trypsin-digested. 
   SA11 
   strain 
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during this time in a SDS-PAGE transfer buffer. Result of WB, the film, was superimposed 
on the first half of the gel. NSP5 bands were excised with a clean scalpel, cut in sample pieces 
(~ 1 mm3) and put in a 1.5 ml tube. The lowest band represent d the least modified protein, 
the highest contained the fraction of the protein that underwent more advanced 
posttranslational processing. On the basis of marker bands location control samples were 
precisely isolated. 
 Subsequently samples were prepared using a modification of the method proposed by 
Shevchenko et al. 300 µl of 50 mM ammonium bicarbonate (pH 8,0) was added to each tube 
and sample were vortex for 15 min. The supernatant w s discarded and volume sufficient to 
immerse the gel pieces of 50 mM ammonium bicarbonate (pH 8,0)/50% acetonitrile was 
added. The supernatant was removed and 100 µl of acetonitrile was added to dehydrate the 
gel pieces for 5 min. The supernatant was removed, th  gel pieces were dried in a SpeedVac 
for 5 min. Pieces were covered with 10 mM DTT soluti n and reduced for 1 hr at 56°C. 
Samples were cooled to room temperature and DTT solution was replaced with the same 
volume of 55 mM iodoacetamide solution. Tubs were incubated for 45 min at room 
temperature in the dark with occasional vortexing. Then washing with 300 µl of 50 mM 
ammonium bicarbonate, pH 8,0  for 15 min was performed by vortexing, and 100 µL of 50 
mM ammonium bicarbonate/50% acetonitrile was added. After 15 min. the supernatant was 
discarded and 100 µl of acetonitrile was added to dehydrate the gel pices for 5 min. Liquid 
phase was removed and the gel pieces were dried in a vacuum centrifuge for 5 min. The gel 
pieces were reswollen with a minimum volume of sequencing grade porcine trypsin (0.1 
µg/µl) and after 10 min 100 µl of 50 mM ammonium bicarbonate, pH, 8,0, was added. 
Samples were incubated overnight at 37 °C. The tryptic peptides were extracted, once with 
100 µl water, twice with extraction buffer (50 mM ammonium bicarbonate, 60% CH3CN and 
1 % TFA) and at last with 100 µl of CH3CN and finally collected in 1.5 ml tube. The extracts 
of peptide solutions were dried in a SpeedVac evaporator. 
 
 
2.6.2. Direct trypsinization 
 
After washings with TNN, beads were washed three times with 50mM ammonium 
bicarbonate and then ammonium bicarbonate buffer in volume sufficient to cover the beads 
was added. The buffer contained 0.4µg of trypsin (1ng/µl). Control samples and those 
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containing NSP5 were incubated for 6 hours in 37oC. To stop the reactions acetic acid to final 
concentration of 0.1% was added. Peptides were elutd from the beads by centrifugation and 
frozen in -80oC. 
 
 
2.7. MALDI TOF/TOF analyses 
 
Analyses were performed using 4800 MALDI TOF/TOF™ tandem TOF technology analyzer 
from Applied Biosystems/MDS SCIEX. Peptide masses pr ent also in control reactions were 
considered to be cellular contaminants and were manually eliminated from the spectra. The 
protein was identified with high score by Mascot tool [235] (http://www.matrixscience.com/) 
as the database search engine. 
The measured masses were manually verified using Peptide Mass program 
(www.expasy.com) in case of not modified peptides or using Glycomod tool 
(www.expasy.org) in case of phosphorylated/glycosilated peptides. The peptides that masses 
difference did not exceed 0.2 Da between theoretical calculations and experimental data and 




2.8. Expression of NSP5 and its mutants  
 
 
E. coli BL21 [DE3] cells (Novagene) carrying the plasmid that encoded for a target 
gene under T7 promoter were grown in Terrific Broth medium, containing ampicillin 
(100ug/ml) in 37°C until the culture reached an optical density 0.7-0.8 (absorbance measured 
at 600 nm, GeneQuant Pro, Amersham Pharmacia). Thenbacteria were induced with IPTG 
until the final concentration of 1mM and grown for subsequent 5 hours. After that time 
culture was centrifuge for 30’ /6000rpm/+4 o and pellet was frozen in -80oC. Expression level 
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2.9. Proteins purification and refolding 
 
2.9.1. Inclusion bodies preparation 
 
The E.coli cells pellet was resuspended in buffer 1 (Table 2), complemented with 
protease inhibitor cocktail (Sigma Aldrich). Resuspended bacteria were disrupt by sonication 
on ice, 4x15’’/15 units and centrifuged 10’/+4C o/10.000 rmp. The supernatant was discarded 
and cell paste was resuspended in cold buffer 2. Sonication was repeated as above and 
samples were centrifugeted 10’/10.000 rmp/4Co. A second washing with buffer 2 was 
performed and centrifugation was repeated. The pellet was washed with buffer 3, centrifuged 
and resuspended in buffer 4. The samples were stirrd for 30-60 min at room temperature to 




Table 2. Buffers used in purification and refolding of NSP5wt and its mutants. 
Inclusion bodies purification  
Buffer 1 20mM Tris-HCl, 0,5 M NaCl, 2% Triton X-100, 2mM DTT, pH 8 
Buffer 2 20Mm Tris-HCl, 0,5M NaCl, 5mM imidazole, 6M guanidinium 
hydrochloride and 2mM DTT, pH 8
Buffer 3 
 
20mM Tris-HCl, 0,5 M NaCl, 2% Triton X-100, 2mM DTT, pH 8 
Buffer 4  20mM Tris-HCl, 0,5 M NaCl, 5mM imidazole, 6M guanidinium 
hydrochloride, 2mM DTT, pH 8 
Affinity chromatography  
Buffer A 20Mm Tris-HCl, 0,5M NaCl, 5mM imidazole, 6M guanidinium 
hydrochloride, 2mM DTT, pH 8 
Buffer B 20Mm Tris-HCl, 0,5M NaCl, 20mM imidazole, 6M urea, 2mM DTT, 
pH 8 
Buffer C 20Mm Tris-HCl, 0,5M NaCl, 500mM imidazole, 6M urea, 2mM DTT, pH 8 
Anion exchange chromatography 
 
 
Buffer D Tris-HCl  20mM, 6M urea, 2mM DTT 1M NaCl, pH 8 
Buffer E Tris-HCl  20mM, 6M urea, 2mM DTT 1M NaCl, pH 8 
Refolding buffers  
 
 20Mm Tris-HCl, 0,5M NaCl, 3 M urea, 3mM DTT, 10% glycerol, pH 8 
20Mm Tris-HCl, 0,5M NaCl, 3 M urea, 3mM DTT, 10% glycerol, pH 8 
20Mm Tris-HCl, 0,5M NaCl, 2mM DTT, 10% glycerol, pH 8 
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2.9.2. FPLC purification using AKTÄ system 
 
 
 NSP5wt and its mutants were purified under denaturing conditions. Chromatography 
was performed using FPLC-AKTÄ system (Amersham Pharmacia). First, proteins solubilized 
from inclusion bodies were purified using immobilized metal affinity chromatography. The 
Ni2+-NTA column (1 ml His-Trap, Amersham Pharmacia), was washed with water and 
equilibrated with 10 volumes of buffer A. Prepared inclusion bodies solution was applied on 
the column that was then washed with 10 volumes of buffer B. The proteins were eluted using 
a linear gradient of buffer C in buffer B by increasing concentration of imidazole.  
Fractions were collected and checked on SDS-PAGE gel. Those containing NSP5 
were pooled, dialysed against buffer D at +4oC and subjected to the second purification step, 
ion exchange chromatography. Samples were applied to the anion exchange monoQ HR5/5 
column (Amersham Pharmacia) equilibrated before with 10 volumes of buffer D. The column 
was washed with 10 vol. of buffer D and next proteins were eluted with a linear gradient 0-
100 % of buffer E (growing NaCl concentration). Fractions were collected, peaks were 

















Fig. 24. General scheme for production, purification and refolding of His-tagged NSP5. 
 
 
Expression of the proteins 
in E.coli BL21[DE3] 
Inclusion bodies purification  
and proteins solubilization 
Affinity chromatography in denaturing 
conditions- His-Trap column 
Anion-exchange chromatography in 
denaturing conditions- monoQ column 
Protein refolding by dialysis 
against buffer lacking urea 
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2.9.3. Proteins refolding 
 
 
The samples were transferred to the membrane tubing (Spectrum Laboratories), cut off 
12,000-14,000 Da and diluted to the concentration of 0,1 mg/ml in buffer E. Refolding was 
carried out by very slow (~48 h) dialysis  in +4oC by exchanging the buffer containing urea to 
the one where urea was not present. First, protein was dialysed against buffer containing 3M 
urea. After 12 hours content of urea in dialysis buffer was decreased to 1,5M. During last 12 
hours protein was dialysed against buffer without urea. 10% glycerol was always present in 
the buffer.  Buffer exchange was performed in small vo umes to ensure slow rate of 
denaturant concentration decrease. Buffer was changed often and usually only partially in 
purpose to avoid step gradient and make it more linear instead. Reducing agent (DTT) has 
always been added fresh to prevent forming of disulfide bridges. After refolding samples were 
concentrated using ultracentrifugation tubes (Sartoris). The correct molecular sizes of the 
purified products were confirmed by ESI-MS single quadrupole mass spectrometry (API-




2.10. Size exclusion chromatography 
 
Size exclusion chromatography was performed on FPLC-AKTÄ system (Amersham 
Pharmacia) using Superdex 200 column (Amersham Pharmacia) in buffer containing 20 mM 
Tris-HCl, pH 8.0, NaCl 150mM, DTT 2mM at a flow rate of 0.5 ml/min. Detection was at 
280 nm. The column was precalibrated with seven protein standards of known masses and 
standard curve was made. Eluted fractions were collected, concentrated by speed-vac and 
Western blotting was performed.  
 
 
2.11. Trypsin limited proteolysis 
 
 The mass ratio between trypsin and recombinant protein as well as reaction time was 
established empirically. Trypsin, 1µg, was used for digestion of 130 µg of recombinant 
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protein during time of 1h in room temperature. The us d reaction buffer was Tris-HCl 20mM 
pH 8.0, NaCl 150mM, DTT 1mM. From the total reaction volume of 100 µl, samples of 10 µl 
in different time points were taken. To stop the digestion excess of SDS-PAGE loading buffer 
was added.  All experiments were analysed on SDS-PAGE Coomassie-stained gels. 
Determination of the peptides masses was done thanks to the Termofinnigan LCQ deca 
Electrospray Ionization Mass Spectrometer. Band remained from the limited proteolysis of 
NSP5 wt was isolated from the gel and subjected to complete trypsin digestion and compared 
with parallel analysis of full-length protein.  
 
 
2.12. Circular dichroism measurements 
 
Proteins concentration was determined by UV absorbance measurement at 280 nm 
(Ultrospec3000, Amersham Pharmacia) using the calculated for every protein extinction 
coefficient values. CD measurements were performed on J-810 spectropolarimeter (Jasco 
Inc.) in the range of 250- 190 nm, using a 0.1 cm path length quartz cuvette (Hellma) in case 
of wt and S67D recombinant proteins and 0.02cm for and truncated mutants. Spectra were 
done at the concentration of 3.5, 4.5 and 5.0 µM respectively for S67D, wt and ∆32 mutant 
while ∆C19 protein required higher concentration and its measurements were recorded at 
concentration of 50 µM. All the spectra were averaged from 5 scans of 0.1 nm steps at 10 
nm/min. The measured signals were converted to mean residue ellipticity (MRE, 
deg·cm2/dmol) on the basis of a mean amino acid residue weight using the Dichroweb [236] 
server. All spectra were analyzed in terms of secondary structure using Dichroweb tools. The 
best fitting were represented by CONTIN[204] and CDSSTR programs. 
 
 
2.13. Binding  assay based on ELISA 
 
 
 Refolded NSP5 was tested in ELISA assay for binding activity of its molecular 
partner, NSP2, derived from MA104 cells infection with recombinant vaccinia virus 
VT7/LacOI/NSP2.  ELISA plate (Nunc) was coated O/N on +4oC with 100 µl of NSP5 
diluted to the concentration of 10µg/ml in PBS. In the morning the solution containing ot 
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bound NSP5was discarded and plate was blocked by 1h incubation with PBS-BSA 1%. Then 
plate was washed with PBS-0.1%Tween20. NSP2 and mock-infected extracts (controls) were 
used to make serial dilutions. Plate was incubated in 37oC for 1,5 h and washed three times 
with PBS-0.01% Tween20. After that mouse anti-NSP2 sera was added at the dilution of 
1:1000 and reaction was incubated for next 1h in 37oC. Plate was washed three times with 
PBS-0.01%Tween20 and secondary antibody, peroxidase conjugated goat anti-mouse IgGγ 
(KPL) at the dilution 1:5000, was added (Fig. 25). After 1h plate was washed three times with 
PBS-0.01%Tween20 and ELISA reaction was developed by adding 3.3’,5,5’-tetramethyl-
benzidine liquid substrate and then blocked with 2M HSO4. Result was read in a plate reader 
















2.14. Peptides synthesis for the NSP5 phosphorylation by CK1α 
 
 
 Peptides were synthesized by a solid-phase method by using fluorenylmethoxycarbonl 
(Fmoc) chemistry. Peptide DMA-GG was synthesized by using Fmoc-N,N-
dimethylarginine(Mts)-OH as described [237]. Peptides were purified by RPHPLC on a C-18 
column (Waters RCM, 25 x100 mm) by using a linear gradient of acetonitrile in water (0–
35% over 70 min) containing 0.1% trifluoroacetic acid, and their identity was confirmed by 






     recombinant NSP5  
anti IgG guinea pig HRP-conjugated Abs 
guinea-pig sera anti NSP2 
cellular extract containing NSP2 
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2.15. Expression and purification of His-6-tagged proteins for the in vitro 





 The proteins were prepared as described in [6]. pQE-∆3, pQE-∆3a, and pQE-∆3/S67A 
were expressed in Escherichia coli M15[pREP4]. Culture was induced with isopropyl β-D-
thiogalactoside (1 mM), grown for 4 h, and centrifuged at 3,500 rpm for 10 min. Pellet was 
resuspended in 6 ml of PBS and incubated for 15 min on ice with 0.1 mg_ml lysozyme, 
5mMDTT, 1.5% laurylsarcosine, and mixture inhibitor p otease (Sigma). Lysate was 
sonicated (six times for 10 s each) and centrifuged at 10,000 rpm for 10 min. Supernatant was 
supplemented with 1% Triton X-100 and loaded onto a nickel column (Novagen) previously 
equilibrated in 5 vol of loading buffer (20 mM imidazol in PBS). The beads were washed in 
10 vol of washing buffer (35 mM imidazol in PBS) and eluted in 2 vol of elution buffer (250 
mM imidazol in PBS). The eluted protein was dialyzed against PBS and analyzed by SDS-
PAGE and Coomassie blue staining. pQE-wtNSP5, pQE-NSP5/(S63,65A,S67D), and pQE-
NSP5a were expressed as described above. Pellet was resu pended in 4 ml of 20 mM 
Tris_HCl (pH 8.0) and inhibitor protease mixture, sonicated (four times for 10 s each), and 
centrifuged at 10,000 rpm for 10 min. Inclusion bodies were resuspended in 3 ml of cold 2 M 
urea, 20mMTris-HCl, 0.5MNaCl, and 2% Triton X-100 (pH 8.0), sonicated, and centrifuged 
as above. A second wash in urea was performed, and a last wash was performed in a buffer 
lacking urea. The pellet was resuspended in 5 ml of 20mMTris-HCl, 0.5MNaCl, 5 mM 
imidazol, and 6Mguanidine hydrochloride (pH 8.0), stirred for 45 min at room temperature, 
and centrifuged 15 min at 10,000 rpm. Supernatant was passed on a 0.45- µ m filter and 
loaded onto a preequilibrated nickel column (Novagen). Column was washed five times in 20 
mM Tris-HCl, 0.5 M NaCl, 20 mM imidazol, and 6 M urea (pH 8.0) and eluted in 10 ml of 20 
mM Tris_HCl, 0.5 M NaCl, 6 M urea, and 150 mM imidazol, pH 8.0. The eluted protein was 
refolded by consecutive dialysis in 3, 1.5, and 0M urea in 20mM Tris-HCl (pH 8.0), 250 mM 
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2.16. In vitro CK1α phosphorylation assay 
 
 
 The assay has been described by Marin et al. [238]. In brief, synthetic peptides 
substrates (0.2 mM) were phosphorylated by incubation in a medium (30 µl of final volume) 
containing 50 mM Hepes buffer (pH 7.5), 10 mM MgCl2, 150 mM NaCl, and 50 µM γ-ATP 
(specific radioactivity 4,500– 8,000 cpm/pmol). The reaction was started with addition of 16 
units (107 units/pmol) of recombinant CK1α from zebrafish (Danio rerio) [239]. After 
incubation at 30°C for the times indicated, the mixture was spotted onto phosphocellulose 
paper, which was washed three times in cold 75 mM H3PO4. Filter-associated radioactivity 
was measured by scintillation counting. Kinetic consta ts were determined by regression 
analysis of double-reciprocal plots constructed from initial-rate measurements. Protein 
phosphorylation was carried out in a reaction buffer containing 50 mM Hepes buffer (pH 7.5), 
10mMMgCl2, 150mMNaCl, 50 µM[32P]- γ- ATP (12,000 cpm/pmol), and 1–2 µM of protein 
substrate, in a total volume of 14µl. Then 23 units of recombinant CK1α (65 units/ pmol) was 
added to initiate reactions; incubation was for 30 min at 30°C. Samples were analyzed by 
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3. RESULTS  
 
 
 The results presented in this dissertation have been divided into three parts. The first 
chapter demonstrate the effort of the laboratory that was focused on studying the mechanism 
of NSP5 hyperphosphorylation. The work presented here as been done with a kind help of 
Dr. Catherine Eichwald and in collaboration with Prof. Jorge E. Allende from Instituto de 
Ciencias Biomedicas, Programa de Biologia Celular y Molecular, Facultad de Medicina, 
University of Chile and resulted in a paper issued in PNAS [6]. 
 In the second chapter I have described my work on mapping of post-translational 
modifications of NSP5 where we used MALDI-TOF/TOF spectroscopy as a tool. The 
collected data allowed us to draw certain conclusions how particular regions of NSP5 are 
modified. 
 Finally, in the third part, I have presented structural studies on NSP5, with the use of 
circular dichroism spectroscopy, that let us to draw first conclusions concerning the structure 
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Part 1: Studies on hyperphosphorylation mechanism of NSP5 
 
 
NSP5 was originally characterized to have a molecular mass of 26kDA on SDS-
PAGE. Further studies demonstrated that the 26kDa form is a precursor for subsequent 
processing. SDS-PAGE analysis of rotavirus infected c lls shows that NSP5 appears as two 
major bands of 26 and 28kDa and as series of higher bands whose apparent molecular mass 
spans from 30 to 34kDa.  It was shown that the 26 and 28kDa forms are phosphorylated and 
glicosylated by addition of O-linked N-acetyloglucosamine (O-GlcNAc) monosaccharide 
residues to serines and threonines, while the highest bands are present mostly due to hyper-
phosphorylation. Experiments performed in our labort ry have suggested that NSP5 
hyperphosphorylation is the consequence of a complex autoregulatory mechanism. The 
process involves mobilization of cellular kinases and since it is unlikely that NSP5 posses 
kinase activity by itself, it may have a capability of promoting the activation of cellular 
kinase(s) [149], following interaction with NSP2. 
 We speculated the existence in NSP5 of regions specific for the activation of a cellular 
kinase and for its own phosphorylation. With the aim of understanding the molecular bases of 
this process, we decided to  study a number of different NSP5 deletion mutants on their ability 
to become phosphorylated in vivo. These studies reveal d, that two clearly distinct properties 
of this protein, related to its own phosphorylation could be uncoupled: one such property was 
related to its capacity to be a substrate and the ot r ne was related to its capacity to become 
an activator of the phosphorylation process.  
 To test this hypothesis in vivo, a transfection assay where two mutants of NSP5 were 
chosen as a substrate, was developed. One mutant, ∆2, was used since it is not phosphorylated 
in vivo [152], while it is a good substrate in vitro. The second mutant, ∆4, was used since it is 
not phosphorylated in vivo [152] and is not a substrate in vitro. To distinguish these two 
mutants from other mutants used as activators of cellular kinases in a co-transfection assay, 
the eleven amino acid SV5 tag was added at the N-terminus of the substrate proteins. A co-
transfection assay was performed using mutants that behave as activators, ∆1/∆3 and ∆3, with 
the substrates SV5-∆2 or SV5-∆4. To visualize the effect of the activators with the different 
substrates, the cellular extracts were loaded in a SDS-PAGE gel and a Western blot anti-SV5 
was performed. The results presented in figure 26 show that the SV5-∆2 substrate is able to 
produce a mobility shift in the presence of the kinase activators (figure 26B, lanes 2 and 3). In 
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contrast, the SV5-∆4 substrate was not able to produce this mobility shift (lanes 5 and 6). A 
treatment with λ-Ppase confirmed that the mobility shift present in these samples 
corresponded to hyper-phosphorylation of the SV5-∆2 substrate (figure 26C) [6].  
The conclusion of these experiments is, that the del tion of regions 1, 3, or both 
(mutants ∆1, ∆3, or ∆1/∆3) renders transfected NSP5 able to be hyperphosphorylated, 
suggesting that these two domains act as internal inhibitors in the phosphorylation mechanism 
[49] [152] [149]. The mutant lacking region 2 (∆2) is a substrate in this process and the 




     
     
 
                
      
 
                                       
Fig. 26. Coexpression of SV5-∆2 or SV5-∆4 mutants with activators ∆1/∆3 and ∆3. (A) Schematic 
representation of NSP5 and the deletion mutants constructs. (B) Coexpression assay in MA104 cells of 
SV5-∆2 (lanes 1–3) or SV5-∆4 (lanes 4–6) substrates with or without the indicated activators. (C) λ-Ppase 
treatment of SV5-∆2 cotransfected with activator ∆3. Samples were loaded in a 15% SDS-PAGE, and 
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Ser-67 and the Activation Function 
 
 
 From the results presented above, activation and substrate activities could be clearly 
distinguished. As described above, SV5-∆2 was a good substrate both in the in vivo hyper-
phosphorylation assay as well as in the in vitro translation/phosphorylation kinase assay. On 
the other hand, ∆2 was unable to induce its own phosphorylation. Thus, we decided to study 
role of the region 2 in the activation of the putative cellular kinase. We therefore focused our 
attention into two different Ser-rich motifs within this domain, namely: Ser-Asp-Ser-Ala-Ser 
from residue 63 to residue 67 and Ser-Phe-Ser-Ile-Arg-Ser from residue 73 to residue 78, that 
we termed motifs a and b, respectively (Fig. 27A). We hypothesize that a mechanism of 
hierarchical phosphorylation could be at the basis of the activation step. The hierarchical 
phosphorylation implies that certain residues need to be phosphorylated first in order to make 
available other sites. To investigate whether either of the  two motifs  were involved in the 
activation step, they were independently mutated, in the activator construct ∆3, transforming 
Ser residues into Ala. As shown in Fig. 27, mutation of all three serines of motif a (Ser-63, 
Ser-65, and Ser-67, construct ∆3a) completely abolished activation function, whereas 
mutation of Ser in motif b (construct ∆3b) had no effect. A more detailed analysis of Ser in 
motif a revealed a key role for Ser-67. In fact, the single Ser67Ala mutation eliminated 
activation, suggesting that phosphorylation of thisresidue was required for activation function 
(Fig. 27C). This was further confirmed with a construc  in which Ser-67 was mutated to Asp 
to mimic a phosphorylated residue, with the two other Sers in motif a, Ser-63 and Ser-65, 
mutated to Ala. As shown in Fig. 27C, lane 5, the Sr67Asp mutation (construct 
∆3/S63,65A/S67D) restored activation. Furthermore, the single Ser-67Asp mutation was 
sufficient to render, the otherwise inactive full-length NSP5, able to be hyperphosphorylated 





  Results 
 79  
          
 
Fig. 27. Ser-67 from motif a is essential for activation. (A) Scheme of point mutations in the activator ∆3. 
Motifs a and b are indicated. The S to A and S to 3D modifications are indicated in red and green, 
respectively. (B) Coexpression of SV5- ∆2 substrate with activators ∆3a, ∆3b, or ∆ 3. (C) Coexpression of 
SV5- ∆2 substrate with activators ∆3, ∆3a, ∆3∆S67A, or ∆3(S63,65A,S67D). (D) Scheme of full-length 
NSP5 with point mutations on Sers in motif a (Left), and coexpression of SV5-∆2 with the NSP5 point 
mutants (Right). Cellular extracts were loaded on a 15% SDS-PAGE, and substrate was visualized by 






 Taken together these results demonstrated that in a first step, phosphorylation of Ser-
67 is necessary for NSP5 to become an activator: once phosphorylation of Ser-67 has taken 
place, both domains 1 and 3 do not hinder hyperphosphorylation any longer. It appears that 
these domains prevent phosphorylation of Ser-67, probably by impairing its accessibility. This 
interpretation was supported by the fact that wtNSP5, and more importantly the activation 
negative NSP5a, (with Ser in motif a mutated to Ala), were efficiently hyperphosphorylated 
when coexpressed with an activator (such as ∆1/∆3), but not when expressed alone (Fig. 
28A). Furthermore, transfected NSP5/S67D, but not NSP5/S67A or NSP5a, became 
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Fig. 28. Activator-dependent wt NSP5 phosphorylation. (A) Coexpression in MA104 cells of wtNSP5 or 
NSP5a with the activator ∆1/ ∆3. Immunoblot developed with anti-NSP5 serum. The arrow indicates the 
position of ∆1/ ∆3. Bracket indicates NSP5 phosphorylated forms. (B) Expression of full-length wtNSP5 
and NSP5 point mutants. Lane 5 corresponds to NSP5 from rotavirusinfected MA104 cells. Samples were 





Ser-67 Phosphorylation and CK1 
 
 
 The canonical consensus sequence for phosphorylatin by CK1α is D/EXXS*/T*, 
where X is any amino acid, D is aspartic acid, E glutamic acid and S*/T* are the target serine 
or threonine that is phosphorylated [240]. The sequence similarity between the consensus 
phosphorylation sites of protein kinase 1, also know  as CK1 and motif a, suggested that CK1 
could be involved in the phosphorylation of Ser-67. This possibility was investigated in an in 
vitro kinase assay by using recombinant CK1α (from zebrafish) and two synthetic substrate 
peptides of 14 residues encompassing motif a, from residues E58 to L71: peptide NSP5wt had 
the NSP5 wt sequence whereas peptide NSP5(S67A) contained a Ser to Ala mutation in the 
position corresponding to Ser-67. As shown in Fig. 29A, NSP5wt was a substrate of CK1α, 
whereas peptide NSP5(S67A) was not phosphorylated at all. When compared to a CK1 
consensus specific substrate peptide (RRKHMIGDDDDAYSITA) [239], phosphorylation of 
peptide NSP5wt by CK1α showed a similar Km (specific peptide Km=283µM; NSP5wt 
Km=218µM) but a lower catalytic constant of 1.7 min
-1 for the NSP5wt peptide vs. 50 min-1 
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for the specific substrate. This result indicated CK1 as a candidate enzyme involved in the 
phosphorylation of Ser-67 to render NSP5 susceptible to hyperphosphorylation. Similar 
experiments with recombinant CK2 showed that this kinase does not phosphorylate Ser-67 
(data not shown). However, when the involvement of CK1 in NSP5 hyperphosphorylation 
was further investigated in the in vitro assay by using as substrate the bacteria-expressed 
proteins, a surprising result was obtained. CK1α was able to phosphorylate only the activation 
positive substrates ∆3 or NSP5/(S63/65A/S67D) generating mobility shifted species with 
higher apparent molecular weights. The whole process depended on the phosphorylation of 
Ser-67 because the Ser-67Ala point mutation (construct ∆3/S67A) as well as mutation into 
Ala of all three Ser residues of motif a (constructs ∆3a and NSP5a) completely abolished 
phosphorylation activity (Fig. 29 B). This result strongly suggested that CK1 or a CK1-like 






Fig. 29. NSP5 phosphorylation by recombinant CK1 from zebrafish. (A) Time course of CK1α 
phosphorylation of motif a peptides derived from NSP5. The amino acidic sequence of both peptides is 
indicated. NSP5wt(●)a; NSP5(S67A) (○). (B) SDS-PAGE autoradiography of in vitro phosphorylation 
assay of mutants ∆3, ∆3/S67A, and ∆3a (Left) or wtNSP5, NSP5/(S63,65A/S67D) and NSP5a (Right), with 
recombinant CK1α and [32P]-γATP. The 38-kDa band corresponds to autophosphorylated CK1α. 
Reactions were carried out at the indicated concentrations of substrate proteins. Negative control 
reactions containing either CK1α alone (lanes 1 and 9) or substrate ∆3 alone (lane 8) are shown [6]. 
 
 
From the obtained data we would like to propose a model of NSP5 
hyperphosphorylation (Fig. 30). In this model the phosphorylation of Ser-67 by CK1α is 
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followed by, or happen concomitantly with protein dimerization. Phosphorylated Ser-67 
component activates the other monomer of the dimeric complex rendering it (or both) 
susceptible to hyperphosphorylation, by the same CK1 or a CK1-like enzyme. It is known, 
that the tail is involved in dimerisation [161] [149], and since the presence of C-terminal part 
of NSP5 was shown to be necessary for both, substrate and activator function (experiments 
performed by dr. Catherine Eichwald), we suggest tha e interaction between an activator 







Fig. 30. Model for rotavirus NSP5 hyperphosphorylation. Interaction of NSP2 with monomeric (a) or 
dimeric (b) NSP5 promotes phosphorylation of Ser-67 by CK1 (in either one or both subunits), which in 
the case of the monomer may induce dimerization (c). A phosphorylated Ser-67 in the dimer induces 
conformational changes (d) to render the other partner molecule (and probably both) susceptible to 
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Part 2: Post-translational modification studies: mapping phosphorylation 




It was previously reported that NSP5 is modified by two types of post-translational 
modifications: O-glycosylation [146] and phosphorylation [3] [49] [241]. Glycosylation of 
NSP5 consists in the addition of O-linked N-acetyloglucosamine (O-GlcNAc) 
monosaccharide residues to serines and threonines, performed by cytoplasmic O-GlcNAc 
transferase [147]. Although not fully understood, the importance of O-GlcNAcylation is 
apparent, since many of known GlcNAc-modified proteins are also phosphoproteins [148]. In 
many cases the sites of phosphorylation and GlcNAcylation are localized to the same or 
neighboring residues (serines or threonines). Additionally, O-GlcNAc modification is 
transient (due to the activity of neutral β-N-acetylglucosaminidase [147]) so direct interplay 
between glycosylation and phosphorylation can take place, regulating the protein activity. 
Studies performed in our laboratory showed that NSP5 hyper-phosporylation is a complex 
process that is triggered by phosphorylation of serine 67 by casein kinase 1α (CK1α) [6] 
[242].  
The correlation between these two types of post-translational modifications, their 
range and meaning for the activity and function of NSP5 have not yet been fully elucidated. 
With the objective to map posttranslational modificat ons of NSP5, we performed 
studies on the protein using MALDI TOF/TOF spectroscopy. Different eukaryotic expression 
systems that could be used in our laboratory for the production of NSP5, like recombinant 
vaccinia virus or Sindbis virus replicon expression system did not ensure appropriate 
expression levels as well as did not offer the same profile of modifications that occur in this 
protein during rotavirus infection. Since these modifications could play an important role on 
NSP5 activity during the viral life cycle and, in particular, during the replication process, we 
preferred to use rotavirus infection as a source of NSP5.  
To ensure the accuracy of analysis different experim nts were performed with about 
50 millions infected cells every time. In some experim nts cells were infected with the 
porcine strain OSU, and in others with the bovine RF strain. The sequences of NSP5 encoded 
by these strains differ slightly, so peptides resulting from the trypsin digestion of the same 
regions of the protein have different masses. Additionally, samples were prepared for MALDI 
analysis by two different methods (described in detail in the “Material and methods” chapter). 
In both cases NSP5 was immunoprecipitated with an anti-NSP5 polyclonal antibodies and 
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protein-A beads but further processing was different. I  the first method, protein was 
trypsinized while still bound to the beads. This method allowed analysis of the entire range of 
NSP5 modifications present in the infected cell. Inthe second method, the 
immunoprecipitated protein was resolved by PAGE and then different bands corresponding to 
isoforms with different load of post-translational modifications were excised, digested and 
analyzed (Fig. 31). Peptides coming from the lower bands of the gel should contain less 
phosphate than the ones deriving from the upper bands.  
The diversity of the sequence of the analyzed proteins as well as the sample 
preparation methods were used with the purpose to diminish occurrence of false results and to 
contribute to their robustness. There was a chance that peptides coming from contaminants or 
differently modified peptides from different regions of NSP5 could have very similar masses 




The spectra were recorded on a 4800 MALDI TOF/TOF™ tandem TOF technology 
analyzer (Applied Biosystems/MDS SCIEX). The masses of the peaks were then analyzed by 
MASCOT tool (http://www.matrixscience.com/), which is based on a probabilistic model of 
the number of matching masses [235]. Unfortunately, because of low intensity of NSP5 
peptides derived peaks, contaminations coming from cellular proteins covered NSP55 signal 
and the peptides masses were not associated with NSP5 with high scores. After spectra 
cleaning by erasing peaks present also in the control samples (i.e.: immunoprecipitations of 
mock infected cells), the program clearly assigned p ptides as belonging to rotavirus NSP5 
(Fig. 32). 
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Fig. 31. Western blotting of immunoprecipitated NSP5 derived from 
rotavirus infection of MA104 cells. Dashed squares represent way of 
protein fractionating and excited fragments of the gel that were next 
trypsinized. The peptides were analyzed by MALDI TOF/TOF 
spectrometry.  
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The example of a spectrum, in this case resulting from the analysis of samples 
prepared by the direct trypsinization method, is shown in Fig. 33. The masses associated with 
dashed arrows perfectly fit the theoretical masses of the peptide that would derive from a 
tryptic digestion encompassing the fragment of NSP5 sequence spanning from amino acid 56 
until 77, either non modified (Fig. 33B) or with one site phosphorylated (Fig. 33C). That 
peptide contain serine 67 that was earlier recognized to be part of a non canonical 
phosphorylation site for casein kinase 1α as shown in part 1 of this thesis and in reference [6], 













Fig. 32. Mascot Search Results- original output of the program. 
 
Search title       : NSP5 
Database           : MSDB 20060831 (3239079 sequences;  
1079594700 residues) 
Taxonomy        : Other viruses (305319 sequences) 
Top Score         : 154* for S30217, NS26 protein - human 
rotavirus A 
*Protein score is -10*Log(P), where P is the probability that the 
observed match is a random event.   Protein scores greater than 
67 are significant (p<0.05). 
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Selected masses were subjected to further manual processing with help of the 
PeptideMass program (www.expasy.org) that allows executing theoretical trypsin proteolysis 
of chosen protein with the purpose to find among them nonmodified NSP5 peptides. 
Subsequently masses were also analyzed by the GlycoMod program (available also on 
www.expasy.org site) that allows to identify phosphorylation and glycosylation 
modifications.  Since NSP5 was demonstrated to bearphosphate residues and O-linked N-
acetyloglucosamine monosaccharide residues (at serine  and threonines), initially only these 
modifications were especially taken into consideration. The difference between theoretical 
and experimental values was established to not exceed 0.2 Da. Moreover, recently in our 
laboratory one new experiment with involvement of another rotavirus strain, simian SA11, 
was performed. Unfortunately the analysis revealed th  absence of many peptides, that were 
found in previous studies. This fact convinced us to extend the range of considered 
posttranslational modification to the possibility of occurrence of two others- methylation and 

















































































































































































































































































































































SPEDIGPSDSASNDPLTSFSIR  SPEDIGPSDSASNDPLTSFSIR+(Phos) 1  
Fig. 33. Fragment of the experimental spectrum resulting from the analysis of samples derived from direct 
trypsin digestion of immunoprecipitated NSP5 sample (A).  The upper panels show peptides that represent the 
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acetylation. The inclusion of these two modifications to the analysis let us to reveal the 
presence of additional peptides of the protein thatpreviously were not found in experiments, 
nevertheless the potency of this findings must be verified by biochemical experiments 
performed on infected cells. 
Protein methylation is a post-translational modification by which a methyl group from 
S-adenosylmethionine is added to a protein by enzymes from the protein arginine 
methyltransferases family (PRMTs). PRMTs arelocated in the cytoplasm, in the nucleus or in 
both of them [243]. In eukaryotes, proteins can be methylated on the side chain nitrogens of 
arginine, lysine, and histidine residues or on the carboxyl groups of proteins. Methylation on 
side chain nitrogens is considered largely irreversible while methylation of the carboxyl 
groups is potentially reversible [244]. Arginine methylation is implicated in many cellular 
processes including transcription, RNA processing and transport, translation, signal 
transduction, DNA repair, apoptosis etc. It increases bulkiness of the affected residue and its 
hydrophobicity blocks hydrogen bonding but, in contras  to phosphorylation or acetylation, 
does not alter its charge. The maintenance of charge is particularly important because 
positively charged arginines often participate in bding other proteins or nucleic acids. In 
addition to its involvement in the pathology of disea es, protein methylation has also been 
shown to be important for virus replication and infectivity in a variety of viruses. For example 
Herpes simplex virus (HSV) replication is regulated, in part, by methylation of the RNA 
binding domain in the HSV ICP27 protein [245].  
Acetylation is the post-translational modification f histone and non-histone proteins 
that is part of an important cellular signaling process, controlling a wide variety of functions 
in both the nucleus and the cytoplasm. It is a reversible process, in which histone 
acetyltransferases (HATs) transfer the acetyl moiety from acetyl coenzyme A to the amino 
groups of internal, highly conserved lysine residues [246]. Recent investigations designate 
this signaling pathway as one of the primary targets of viral proteins after infection. Indeed, 
specific viral proteins have acquired the capacity to interact with cellular acetyltransferases 
(HATs) and deacetylases (HDACs) and consequently to disrupt normal acetylation signaling 
pathways, thereby affecting viral and cellular gene xpression. 
The calculations encompassing these two additional modifications were done with 
higher stringency. The peptides supposed to carry methylation and/or acetylation were also 
considered as possibly true, however were distinguished in tables in italic. Results of all 
performed experiments, divided by strain, are colleted in tables 3, 4 and 5. 
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MSO- methionine oxidized 
Cys_PAM-cystein with acrylamide adduct (only in- gel digestion method) 
[dir]- direct trypsinization method 
[26/28/ 30 / <32] – in- gel trypsinization method and  band fraction where the peptide was found 
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186-197 1 1418.73 
 
























Tab. 3. Collection of peptide masses observed upon OSU strain infections together with fitting 
posttranslational modifications. Possible modification that were considered are phopshorylation and 
glycosilation, masses containing methylation and acetylation  were conditionally included and are 
written in  italic. 
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MSO- methionine oxidized 
Cys_PAM-cystein with acrylamide adduct (only in- gel digestion method) 
[dir]- direct trypsinization method 
[26/28/ 30 / <32] – in- gel trypsinization method and band fraction where the peptide was found 
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Tab. 4. Collection of peptide masses observed upon RF strain nfections together with fitting modifications. 
Possible modification that were considered are phopshorylation and glycosilation, masses containing 
methylation and acetylation  were conditionally included and are written in italic. 
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MSO- methionines oxidized 
[dir]- direct trypsinization method 
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Tab. 5. Collection of peptide masses observed upon SA11 strain infections together with fitting 
modifications. Possible modification that were considered are phopshorylation and glycosilation, masse 
containing methylation and acetylation  were conditonally included and are written in italic. 
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Although observations coming from all the experiments allowed drawing several 
conclusions, one important thing must be mentioned. The data analyzed in the these studies 
derived from naturally infected cells, so represent the dynamic state of NSP5 modification 
level, that changes during the course of infection. Saying shortly- the same peptide may 
contain e.g. one, two or three sugar moieties as well as can be phosphorylated, depending on 
the time-point of infection. The analyses of masses let to identify fragments that belong to 
almost all parts of NSP5 sequence, either modified or without modifications. From these 
observations we deduced the possible range of modification of this important rotaviral 
protein. The schematic view on NSP5 sequence and its modifications depicted in figure 34, 
was drawn based on the analysis of peptides masses, that were observed in at least two 
different experiments performed by two different methods. In that scheme we showed 
possible modifications, that do not have to be present in the protein at the same time, however 
the tendency of particular regions to be particularly modified is demonstrated. All depicted 
modifications met the highest (red) stringency criteria, nevertheless the peptides containing 
methylation or acetylation were believed less certain and were shown in blue, as we do not 
have the confidence, that these modifications, in contrary to phosphorylation and 
glycosilation, occur in NSP5. The other data, that did not feet all the stringency conditions, 
because for instance occurred among the analyzed results with a lower frequency, can also be 
discussed and are shown in tables 3 and 4. Data from table 5, where results from a single 
experiment with SA11 strain were placed, are less reliable and must be confirmed with 
subsequent studies.  
In  summary, from all the information obtained, few remarks can be made. The 
peptides assigned to the region 1 were well represent d.  Among all the peptides, we found 
these, that feet perfectly the amino acids 1-19 of region 1 not modified, carrying one, two, 
five and six N-acetyloglucosamines and with one or two phosphorylation sites. Additionally 
there is a high possibility, that the N-terminal part  is also methylated. Other masses reflected 
perfectly the masses of peptides encompassing amino ac ds 20-32, bearing exactly four sugars 
but  also  four sugars and one and two phosphates. The general view on the region 1  suggest 
high level of glycosilation of this part of NSP5. 
In the region 2, two potential phosphorylation sites were assigned. The peptide fitting 
to the region 56-77 was found without any modifications, but also with one serine or 
threonine phosphorylated. There is a big probability, that phosphorylation occurred at serine 
67. An interesting observation is that the phosphorylated peptide derived only from the upper 
bands of the gel and was absent (or not found) in the lower bands of fractionated NSP5. 
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Serine 67 is a key residues from  which initiates all the phosphorylation mechanism of NSP5 
and the absence of the phosphorylation in lower bands may signify, that the 
hyperphosphorylation of NSP5 is a very quick cascade process.  
Moreover, the first part of region 3, spanning from the position 80 to 115 was not 
represented in most of the experiments, suggesting that this peptide was not read by the 
machine because of its low level of ionization that depends on the sequence. Another, less 
possible reason for that fact, is that this peptide is so highly modified that its mass was out of 
an efficient range of the spectrum reading. Adding methylation as a possible modification to 
the selection criteria, increased hits assigned to this NSP5 region, and indicated the possibly 
of occurrence of two sugar moieties and one methylated site there.  
In contrast, sequence between aa 115 and 134, assigned also to region 3, was 
abundantly recognized in all the experiments, non modified and modified. This region of 
NSP5 sequence is different for both strains (OSU and RF). In the bovine RF strain, eight 
potential modification sites are present, and in its case three added sugar moieties and two 
phosphorylation sites were characterized. OSU strain contains only four serines and one 
threonine in the same peptide and we managed to map in these region one glycosylation and 
one phosphorylation site. We found this part of the protein also modified in more extended 
way, for example we found peptide with six N-acetyloglucosamines and one phosphate and 
also with six phosphates but this result can not be treated as secure, because was not found in 
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Fig. 34 Scheme showing the schematic representation f NSP5. The regions of the protein correspond to 
the bar above the scheme. Localisation of serines and threonines are depicted, the sites of trypsin 
cleavages are indicated by numbers. The modifications shown here were selected with the high stringency 
criteria, and these very probable are shown in red (phosphorylation and glycosilation), the ones that still 




The beginning of region 4 revealed addition of one N-acetyloglucosamine in all the 
three strains. Moreover methylation of this part of the protein was deliberated as possible, 
because was found in all the experiments. Furthermore, in region 4, consistently to previous 
data obtained in our laboratory, suggesting that this part of NSP5 is phosphorylated, two 
phosphorylation sites were determined and perhaps some methylation and acetylation sites as 
well.  Finally, all the peptides that form the end of the region 4 and the tail were completely 
reconstituted in both strains. This region of NSP5 was found as not modified and this is 
concordant with the fact that it lacks serines and threonines. 
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The method of in gel digestion (fig. 35) should allow to separate differently modified 
isoforms of NSP5 and help to understand how the protein is changed. Up to the previous 
studies [3], NSP5 derived from highest bands of SDS-PAGE gel should be 
hyperphosphorylated and rather not glycosilated. Although, the phosphorylation contributes to 
polypeptide charge and changes peptide’s migration in the gel, the separation depends not 
only on the amount of phosphate added but also on the sequence where the phosphate moiety 
was attached. We found many phosphorylated peptides in the upper bands (including the one 
encompassing serine 67) and some in the lower. The fact that NSP5 isoforms visible in the 
lowest bands contain certain level of phosphorylation was known earlier and is concordant 
with our studies. However the presence of sugars in the upper bands is surprising, because is 
contradictory to the previous data obtained in our laboratory by Afrikanova and et al. We 
suspect, that this result may be explained with the fact, that in gel digestion method did not let 
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Fig. 35. Western blotting of immunoprecipitated NSP5 derived from rotavirus infection of MA104 cells. 
Dashed squares represent way of protein fractionating. The scheme shows which peptide were found in 












OSU:37-50     (HexNAc)1 
         115-133 (HexNAc)1(Phos)2 
RF:  115-138 (HexNAc)5(Phos)2 
        135-142 (HexNAc)1 
OSU:20-36     (HexNAc)2(Phos)1 
RF:   1-19       (HexNAc)1 
        20-36      (HexNAc)5(Phos)1  
        115-134  (HexNAc)3(Phos)2 
        134-138  (HexNAc)1 
 
OSU:37-50     (Phos)1 
         56-77     (Phos)1 
         115-134 (HexNAc)1(Phos)1 
RF:   1-19       (HexNAc)6(Phos)1 
         33-55     (HexNAc)1 
         51-55     (HexNAc)1 
         56-77     (Phos)1 
         115-133 (HexNAc)1(Phos)1 
         115-134 (HexNAc)6(Phos)1 
         115-136 (HexNAc)3 
         134-138 (HexNAc)1 
         145-172 (Phos)2 
 
    
OSU:56-77    (Phos)1 
RF:   1-19      (HexNAc)1 
         56-77     no modifications 
         115-134 (Phos)6 
         134-138 (HexNAc)1 
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Part 3: Structural studies on NSP5 
 
 
The aim of this part of the thesis was to express, purify, and analyze NSP5 protein. 
With our studies we wanted to add new data to very limited information about NSP5 
structural organization and protein conformation. To achieve this, in addition to the full length 
protein, two different truncation mutants and one point mutation mutant were constructed, 
expressed and purified. Proteins secondary structure was analyzed by circular dichroism 





Expression of NSP5wt in E.coli 
 
 
In order to facilitate the recombinant protein purification the cDNA encoding Nsp5 
was cloned into a vector containing a tag of six histid nes which is used in a metal-chelating 
affinity chromatography purification. First, for Nsp5 expression the pQE system (Qiagen) was 
chosen.  High level of expression of his-tagged proteins in E.coli using pQE vectors is based 
on a powerful phage T5 promoter transcription-transl tion system. The promoter is 
recognized by E.coli RNA polymerase. There are two lac operator sequences which increase 
lac repressor binding and ensure efficient repression of the T5 promoter. The extremely high 
transcription level can be only efficiently regulated and repressed by the presence of high 
levels of lac repressor protein. E.coli host strain M15 [pRep4] utilized in that expression 
system uses a lac repressor gene in trans to the gene that is supposed t  be expressed. The 
strain contains the low-copy plasmid pREP4 which posses kanamycin resistance and 
constitutively expresses the lac repressor, encoded by lac I gene. Expression of recombinant 
protein encoded by pQE vectors is rapidly induced by the addition of isopropyl-β-D-
thiogalactoside (IPTG) which binds to the lac repressor protein and inactivates it. Once the lac 
repressor is inactivated the host cell’s RNA polymeras  can transcribe the sequence 
downstream from the promoter and production of the recombinant protein starts.  
In spite of the relatively small size of the 6xHis-tag, it has been reported to affect the 
activity of some purified recombinant proteins. Considering that the C-terminus of NSP5 is 
necessary for the protein dimerization [161] [149], we decided that the tag should rather be 
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attached to the N-terminus of the recombinant protein, in particular because the protein was 
designated for structural studies.  
The vector pQE30 codes for a polyhistidine tag, which s localized before a 
multicloning site. Therefore bacteria, transformed with the plasmid carrying a foreign gene, 
produce a recombinant protein that has a tag situated t its N-terminus. The pQE30-NSP5wt 
construct was prepared (Fig. 36A) [6] and viral protein was efficiently expressed in M15 
























Unfortunately practically all the recombinant NSP5 was localized in the non soluble fraction 
of the cells, accumulating in aggregates called inclusion bodies. In these aggregates only a 
small fraction of the protein is folded correctly, and the rest is in a denatured and usually 
nonfunctional form [247] [248].  
The maximized  yield of soluble protein can be achieved by optimizing several factors 
such as the expression temperature, E. coli strain used, pH of the growth medium, a folding 
1 2 
Fig. 36. Expression of His6NSP5-pQE30 in E.coli M15 [pRep4].  (A) A schematic representation of NSP5 
in pQ30 plasmid. (B) SDS-PAGE analysis of protein production. Line 1 represents protein of 
M15[Rep4] carrying NSP5 gene, uninduced control; line 2- the same bacteria induced with 1mM IPTG; 
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partner the protein is fused with, rate and expression level and co-expression with chaperones 
and foldases [249] [250]. To increase soluble fraction of NSP5 we tested different conditions 
of bacteria cultivation that included growing in a lower temperature (25oC) and slowing down 
the rate of production by inducing a recombinant protein production with a very low 
concentration of IPTG.  Also, another strain of E. coli, BL21 [DE3], was tested. To express 
NSP5 in this strain the pET plasmids system (Novagene) was used. 
The pET system is driven by the promoter of the bacteriophage T7 . It was pointed out 
that T7 RNA polymerase is very specific for T7 promoters and it does not recognize DNA 
from other sources, since these promoter sequences are very rare. Also, termination signals 
for T7 RNA polymerase are rare too, therefore long transcripts can be made without 
premature truncation.  The T7 RNA polymerase is about five times faster than E.coli RNA 
polymerase, so genes controlled by T7 promoters can be overexpressed.  In order for this 
system to work, the T7 RNA polymerase must be supplied to the cells.  A special strain called 
BL21 [DE3] has been made for this purpose. The BL21 [DE3] cells are lysogenic for a 
fragment of the phage DE3.  This fragment contains the lacI gene, the lac UV5 promoter, the 
start of lacZ (beta galactosidase) and the T7 RNA polymerase gen.  The lac UV5 promoter, 
inducible by IPTG, is responsible for driving the expression of T7 RNA polymerase. This 
fragment is inserted into the E.coli chromosome. In addition to the T7 RNA polymerase, th re 
is a vector that carries the cloned gene behind a T7 promoter, and termination signals are 
downstream of the gene to stop the transcription (pET vector).  In theory, the gene can only be 
made if IPTG is added to activate the lacUV5 promoter and turn on synthesis of T7 RNA 
polymerase.  This in turn transcribes the gene in the pET vector.  In practice though, the E. 
coli RNA polymerase does make a small amount of T7 RNA polymerase without induction.  
It may bind upstream of the lac UV5 promoter and read through it.  For that reason it is said 
to be a ‘leaky’ system.  This usually causes a small amount of the cloned gene to be expressed 
without IPTG induction.   
In this study the pET23d (+) plasmid was used. As in the case of previous system, the 
construct was designated in the way, that polyhistidine tag was localized on the N-terminus of 
NSP5 (Fig. 38A). In this system control of inducible expression in case of NSP5 fails and the 
protein was produced with or without the presence of IPTG.  Although it was very efficiently 
overexpressed, practically all the produced protein, as in case of the pQE/M15 [Rep4] system, 
formed aggregates. 
Very low expression (nanograms per liter of bacterial culture) of soluble NSP5 was 
only obtained with the M15 [Rep4] strain. The purity degree of NSP5 after metal affinity 
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One of possible solutions was to change the expression ystem. We tested two 
different eukaryotic expression systems, recombinant v ccinia virus expression system and 
Sinbis virus replicon-based DNA expression system. The results of experiments were not 
satisfactory, since these systems did not ensure appropriate expression level of NSP5. 
It was then decided to produce the protein in E. coli and to recover it from inclusion bodies. 
Protein derived from inclusion bodies can be refolded in vitro to give a functional protein. 
Sometimes the formation of inclusion bodies can be ev n advantageous, since the expressed 
level of desired protein is very high and protein can be purified simply by washing and 
pelleting the aggregated bodies. Because of the convenient cloning sites, short linker between 
polyhisidine tag and the viral gene and a good expression level the pET/BL21 system was 










Fig. 37.  His6NSP5 expressed in M15 [Rep4] and purified by 
metal affinity chromatography in nondenaturing conditions 
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NSP5 wt purification and refolding. 
 
 
In the first attempts two methods for the purificaton and refolding of 6His-tagged 
NSP5 protein were used. Both of them were based on solubilizing inclusion bodies and in-
column refolding of the bound protein that was performed by buffer exchange, using a linear 
gradient from a buffer containing 8 M urea to a non-de aturing buffer (0 M urea). Finally, 
bound, renaturated proteins are eluted with a gradient of imidazole. In case of some protein 
those protocols work and functional proteins can be obtained. [251] [252] [253]. 
Unfortunately in the case of NSP5 problems of heavy precipitation during refolding occurred, 
and in addition, the purity of the product was too l w. However protein obtained in this way 
served to guinea pigs immunizations and anti-NSP5 serum generation. 
 In this situation we decided to go through all thepurification steps in denaturing 
conditions and to refold the protein at the end by the dialysis method. The protocol for 
inclusion bodies purification, detailed purification steps and renaturation procedures are 
















Fig. 38. Expression of His6NSP5-wt in E. coli BL21 [DE3]. (A) A scheme of  His6NSP-wt construct in 
pET23d(+) vector. (B) Expression of His6NSP5-wt in BL21[DE3]. Lines left to right: marker; BL21 
[DE3] not transformed; marker; BL21 [DE3] transform ed with pET23d (+) -His6NSP5-wt. 
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described in “Material and methods” chapter. Shortly, the cocktail of denatured proteins was 
passed through affinity chromatography column (His-Trap, Amersham Pharmacia). 
Immobilized metal affinity chromatography (IMAC) systems have three basic components: an 
electron donor group, a solid support and a metal ion. The metal ion (usually Ni2+, Co2+, Cu2+ or 
Zn2+) is restrained in a coordination complex where it still retains significant affinity towards 
macromolecules [254]. To purify NSP5 we used His-Trap affinity column of Amersham 
Pharmacia that utilizes Ni2+ metal ion. Protein was eluted using imidazole gradient in the 
presence of urea (Fig. 39A), fractions of protein were checked on SDS-PAGE gel and those 










The ion exchangers are insoluble solid matrices containi g fixed ionogenic groups 
which bind reversibly to sample molecules (proteins, etc.). Desorption is then brought about 
by increasing the salt concentration or by altering the pH of the mobile phase. The two major 
classes of ion exchangers are cation exchangers and anion exchangers, having negatively and 
positively charged functional groups, respectively. In case of  His6-NSP5, since the isoelectric 
point, (pI), is about 6.4, an anion exchange chromat gr phy was applied. The protein was 
eluted with increasing NaCl gradient (Fig. 40A), a peak of pure recombinant  His6-NSP5wt 
was collected and sample was checked on SDS-PAGE. 
Fig. 39. Affinity chromatography purification of  H is6-NSP5 wt. (A) elution profile and  
(B) SDS-PAGE gel demonstrating fractions containing recombinant protein (marked  with square). 
A B 
  Results 
 108  
The refolding step is complex and depends greatly on the renaturing conditions, such 
as, pH, rate of dialysis, protein concentration andredox conditions. The protein was refolded 
by dialysis, according to the protocol described in the chapter [2.8]. Because glycerol 
stabilizes proteins and often facilitates renaturation allowing the return to native secondary 
structure as well as preventing aggregation, it was added to the refolding buffer.  
NSP5 has four cysteins but as it is a cytoplasmic protein, disulfide bonds should not be 
formed. For this reason a reducing agent (DTT) was present during refolding process. 
Cysteins in NSP5, when present in an oxidizing enviro ment, were found to be very reactive. 
It is noticeable that disulfide bridges can be formed during polyacrylamide gel running even 
though the sample buffer contained a reducing agent like β-mercaptoethanol or DTT, what 
result in dimer formation (Fig. 40B and C- arrow). Including a reducing agent into a SDS-








      
 
 
The yield and homogeneity of purified refolded  His6-NSP5wt protein was high. The 
final product was checked by SDS-PAGE, Western blotting (Fig. 40B and C) and its correct 
molecular mass (small differences may occur due to a calibration of the system)  was 
confirmed by ESI-MS single quadrupole mass spectrometry (Fig. 41). 
 
 
Fig. 40. Second step of  His6-NSP5wt purification and final product after renaturation. (A)  Protein was 
eluted from anion exchange monoQ HR5/5 column with an increasing gradient of NaCl. The peak 
containing recombinant NSP5 was collected (dashed square). (B) Final product of purification: SDS-
PAGE (12 %) gel, reducing conditions, stained with Coomassie blue and Western blotting anti-NSP5 
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Sine NSP5 is not an enzyme it was hard to say if the renaturated protein was well 
folded and active. In order to check its biological activity, a binding assay to NSP2, a well 
established partner of NSP5, was designed. The platw s coated with recombinant NSP5 and 
cellular extract containing NSP2 was then added. Significant binding signal, decrease of 
signal in wells with serial dilutions of NSP2 extract as well as a big difference between 





Fig. 41. ESI-MS single quadrupole mass spectrometry result of purified His6NSP5-wt; mass 
calculated- 22693.0 Da, mass obtained-  22689.0 Da 
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This result showed that the refolded protein retaind its ability to interact with NSP2, 





Trypsin limited proteolysis assay.  
 
Although the full-length NSP5 was produced and a satisfactory protein purity was 
achieved, significant precipitation was observed anhence such preparation was not suitable 
for more advances structural studies. 
Limited proteolysis involves the incomplete digestion of a protein by a protease, 
which can be examined as a function of time or ratio of protease to protein concentration. The 
partial digestion of a protein defines those fragments resistant to proteolysis and, therefore, 
are expected to have a more compact structure. In contrast, flexible and exposed to solvent 
regions, are prone to be digested. Information from these experiments can aid the design of 
constructs for structural biology studies.  
Purified His6-NSP5wt was subjected to limited proteolysis by trypsin as described 
under “Materials and Methods”. With the time course of the reaction a peptide with an 
apparent  molecular mass in PAGE lower than 20 kDa remained, indicating it was more 
resistant to trypsin proteolysis than the full length protein (Fig. 43A).  That band as well as the 
full-length protein band were isolated from the gel, subjected to complete trypsin digestion 
and peptide’s masses were estimated by mass spectrom try. After analysis it was clear that the 
Fig. 42. Schematic representation of NSP5-NSP2 ELISA binding assay result.  
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trypsin-resistant part of NSP5 initiated at position 32, exactly at the beginning of region 2 and 










Fig 43. (A)Time course of trypsinolysis of His6-NSP5wt, arrow shows a trypsin-resistant band; (B) 
Representation of a mass spectrometry analysis of the full-length and trypsin-resistant fragment. 
Sequence in blue represents regions that were not found in neither full-length nor trypsin resistant part of 







Expression, purification and refolding of NSP5 mutants. 
 
 
To study structure of NSP5 three different mutants were prepared (the schemes of the 
constructs are shown in Fig. 45A). The N-terminus truncated mutant, His6-NSP5∆N32, in 
which the region one was deleted, was constructed on the basis of observations derived from 
trypsin limited proteolysis experiment. The protein with truncated N-terminal part was much 
more resistant to trypsin than the full length protein, suggesting that it might behave better in 
the solution, showing lower levels of precipitation a d being more suitable for structural 
studies. In addition, taking into consideration thesecondary structure predictions, a mutant 
deleted on the last 19aa was also constructed (His6-NSP5 ∆C19). Secondary structure 
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consensus method available on Expasy web server. All the programs concordantly predict the 
presence of around 20 aa long α-helix in the C-terminal region of NSP5 (Fig. 44). Although  it 
was demonstrated, that this region is necessary for the protein dimerization [161] [149], the 
recombinant protein without the C-terminal tail may still fold into a soluble version of  NSP5, 
indicating many interesting structural features. 
A third mutant (S67D) was also constructed. This mutant was relevant because of its 
previous characterization in the context of NSP5 hyperphosphorylation mechanism (see page 
77). We wanted to check if that feature affects the secondary structure content and reflects in 
change of the structural organization in comparison to the wild type protein.  
   








jalign        : -----E----------EEE-------EE----------------HHHHHHHH---------------------EEE---EEEE-----EEE-----------------EEE------EE------EEEE--------------------EE---EEEE----------HHHHHHHHHHHHHHHHHHHHHHH---- : jalign 
jfreq        : --------------EEEE--------EEE--------E-----HHHHHHHHH--------------------EEEEE--HHE------------------------EEEEEEE--EEEEE----EEEEE----------------EE-------EEE----------HHHHHHHHHHHHHHHHHHHHHHHH--- : jfreq 
jhmm      : -----EE---------EEE--------EE----------E----HHHH--------------------------E-----------EEEEE--------------EEEEEE----EE-----EEEEE--------------------EE-----EEEEE--------------HHHHHHHHHHHHHHHHHHH--- : jhmm 
jnet          : --EEEEE--------EEEE------------------EEE---HHHHHHHHH---------------------EEEE---EE------EE---------------EEEEEE---EEEEE----EEEEE-------------------EEE---EEE-----------HHHHHHHHHHHHHHHHHHHHHHH--- : jnet 
jpssm       : --EEE---------------------------------------HHHH--------------------------EE-------------------------------EEE------EE-----EEEEE--------------------EE--------------------------HHHHHHHHHHHHHHHHHH--- : jpssm 
 
jpred         : -----E----------EEE--------E----------------HHHHHHHH---------------------EEE----EE------EE---------------EEEEEE----EEE-----EEEEE-------------------EEE---EEE-----------HHHHHHHHHHHHHHHHHHHHHHH--- : jpred 
 




Code for alignment: 
 
Shades of red      - high level of conservation of chemical properties of the amino acids 
jalign              - Jnet alignment prediction 
jfreq                 - Jnet PSIBLAST frequency profile prediction 
jhmm             - Jnet hmm profile prediction 
jnet              - Jnet prediction 
jpssm             - Jnet PSIBLAST pssm profile prediction 
jpred               - Consensus prediction over all methods 
Jnet Rel           - Jnet prediction of prediction accuracy, ranges from 0 to 9, bigger is better. 
H      - alpha helix 








Fig. 44.  NSP5 secondary structure predictions by JPRED. 
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DNA constructs were generated (Fig. 45A) and the proteins were expressed, purified 
and refolded using exactly the same protocol as in case of wild type protein. Expression level 
in BL21 [DE3] strain was high (Fig. 45B) and the produced proteins also formed inclusion 
bodies. The purified proteins were refolded as mentioned before and final products were 
analyzed by SDS-PAGE and Western blotting (Fig. 46)As in the case of wild type protein, 
during the run of the samples in the gel (despite of the presence of reducing agent in the 
loading buffer), disulfide bridges are formed and the dimmer formation can be seen. Addition 
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Fig. 45.  Schemes of NSP5 constructs and proteins overexpression in E.coli BL21 DE3 strain. 
(A) Schematic representation of NSP5 mutants constructs cloned into pET23d (+) vector. (B) 
SDS-PAGE analysis of proteins production; lines 1, 5 and 7- marker; line 6- control, BL21DE3 
non transformed; other lines - BL21DE3 transformed with pET23d(+)-His6-NSP5S67D (line 2), 
His6-NSP5∆N32 (line 3) and His6-NSP5∆C19 (line 4). The proteins were analyzed in 12% SDS-
PAGE gel stained with Coomassie blue dye. 
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 The principle of size exclusion chromatography (gel filtration chromatography) is 
based on molecular volumes. The small molecules which diffuse into the gel beads (the 
porous three dimensional matrix that acts as a steric ba rier) are delayed in their passage down 
the column compared to the large molecules which cannot diffuse into the gel and move 
continuously down the column with the eluent. Therefor  the large molecules leave the 
column first followed by the smaller molecules in the order of their size. The gel filtration 
chromatography can be used to estimate approximate ol cular weight of purified proteins in 
native condition, in contrary to SDS-PAGE. It can also give important information about 
protein like precipitation or aggregation, dimer fomation, etc., that are crucial for advanced 
structural studies like crystallography. 
  Size exclusion chromatography of NSP5wt and mutants was performed using 
Superdex 200 column (Amersham Pharmacia), calibrated with a set of standards prior to the 
experiment (Fig. 47B). Unfortunately all the proteins were eluted in the void volume, 
confirming our presumption about high aggregation leve . The only protein that behaved 
differently, due to its heterogeneous migration, and retained partially its size was the NSP5 
∆N32 mutant. Although the main portion of the protein was eluted in the void volume as 
1         2                 3 
4             5     6 
Fig. 46.  Analysis of purified NSP5 mutants. Proteins were analyzed by, respectively, SDS-
PAGE Coomassie blue staining and anti-NSP5 Western blotting. Lines 1 and 5- His6-NSP5 
S67D; 2 and 4, His6-NSP5 ∆19; 3 and 5- His6-NSP5 ∆N32; In all the lines, both of Coomassie 
and WB, the artificially formed dimers are noticeable, except line 2, where DTT was present in 
loading and running buffer.  
97.4 
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aggregated or precipitated protein, there was also some fraction that reflected the size of a 
dimeric NSP5 mutant. The collected fractions were subjected to Western blot analysis. The 
peak that left the column with the void volume (Fig. 47A; fractions 13 and 14) was 
recognized as NSP5, but in the ‘hill’ around 14 ml of the elution volume NSP5 was also 
found (Fig. 47A, C), suggesting that some part of the refolded protein did not aggregate and  
managed to form a dimer, maintaining its proper structure. The fact that the peak is not sharp 
might be explained by certain level of  protein degradation, that could occur during refolding. 
In fact, the WB show that the bands of fractions 27, 28 and 29 are not perfectly homogenous. 
The possible explanation for that phenomenon is, that e dimer formation may require a 
shorter NSP5 construct, and some level of protein dgradation (truncation from N- or C-
terminus) enabled its formation, suggesting that for structural studies purpose even a shorter 
NSP5 mutant is required.   




















                                                                                                                                                                      






Fractions:     13         14         27           28       29 
    Vo 
void volume 
Fig. 47. Size exclusion chromatography of His6-NSP5 ∆N32. (A) elution profile, two peaks visible, one 
within Vo and one around 14ml of elution volume.   (B) calibration standards of Superdex S200 column; 
their molecular weights in kDa (first column) and elution volume (third column) are listed. (C) Western 
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The purified NSP5wt and mutants were analyzed by circular dichroism (CD) 
spectroscopy. CD spectroscopy is an important method, c mplementary to crystallography in 
studies of protein structure, stability and folding. The sensitivity of far-UV allows estimating 
the content of secondary structure elements present in the protein and also assess if the protein 
is folded, which is especially an important issue in the case of refolded proteins.  
For all analyzed proteins the percentage of secondary structure was estimated through 
deconvolution of the CD spectra in the range 190-24 nm using several methods available on 
the Dichroweb site. The best fittings between the experimental and calculated spectra were 
obtained using ContinLL and CDSSTR tools. The references set in these methods consist of 





The spectrum of wild type NSP5 reflects good fitting when analyzed with ContinLL 
tool. Calculated contents of secondary structure elem nts for all tested proteins are collected 
in table 5. The spectrum reflects characteristics of an α-helical component profile (Fig. 48).  
The estimated percentage of α-helix (9.8%) is concordant with secondary structure p edictions 
data. Quite high content of β-strands was also found. However accuracy for assessm nt of 
protein secondary structure by CD is more accurate for α-helical elements. Noticeable high 
participation of unordered elements that reaches almost 50%, could indicate a non- globular 
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We constructed, produced and purified S67D mutant, because it revealed to be more 
eager to become hyperphosporylated than the wild type protein. It was possible that 
introducing in that position a negatively charged residue, aspartic acid, changes protein 
conformation and affect content of secondary structure elements. However, the data obtained 
do not confirm this hypothesis, as the spectrum for the mutated protein does not significantly 










To make these result even more clear, spectra of both proteins were superimposed 
(Fig. 50). The differences in an intensity (not in spectral shape) might be affected by protein 
Fig. 48. Far-UV NSP5wt spectra.  Experimental data (green) and reconstructed by 
ContinLL (blue). Differences in fitting marked in pink. 
Fig. 49. NSP5 S67D spectra of experimental data reconstructed by ContinLL data. 
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concentration change due to precipitation prior to the experiment. These observations are in 
agreement with secondary structure content calculations that are practically identical. The 
small differences could derive rather from not identical experimental and reconstructed data 
coverage. This mean that the wild type protein an mutant have the same content of secondary 















The spectrum profile of ∆N32 mutant was also very similar to the one of wild type 
protein (Fig. 48, 50). This could be interpreted with the absence of organized structural 
elements in N-terminal part of NSP5, consistent with the limited proteolysis data. The shape 
of the spectrum is more α-helical than in the case of wild type protein since it has a more 
noticeable shoulder peak at about 222 nm, a typical attern of α-helical conformation  
 The higher percentage of estimated α-helix content can take its origin from the fact, 
that helices localized in another part of the protein contribute more to the truncated protein as 
well as from a better fitting of reconstructed and experimental data. It is highly probable that 
the N-terminal part of NSP5 is mostly disordered anit appears not to be necessary for proper 
NSP5 folding. 
  190             200                              220                             240             260 
Fig.  50. Superimposition of far-UV CD spectra of NSP5wt and S67D mutant. 
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In contrast, removing of the last 19aa from the C-terminal part of NSP5 drastically 
changed the spectrum profile (Fig. 51). In His6-NSP5 ∆C19 spectrum it is noticeable, a 
minimum at around 200nm characteristic for disordere  proteins. Estimations computed by 
Contin LL tool (3.5% of α-helical component) had poor fitting and high NRMSD value. This 
parameter is an important measure of the correspondence between the experimental and 
calculated spectra and can be used to judge the quality of the results [256]. To confirm these 
findings spectra were also analyzed with another tools, including Yang.jwr software (0% of α-
helix), that confirmed complete lack of α-helical structure elements that are present in the full 
length protein and NSP5 ∆N32 mutant. However other elements (β-sheets and turns) are 
maintained in calculations on the similar level than in other proteins, what can prove that C-
terminal deletion mutant is folded. These observations, together with secondary structure 
predictions, lead us to speculate that practically l  α-helical conformation motifs are present 






Fig. 50.  NSP5 ∆N32 spectra of experimental data and fitting reconstruction calculated by 
CDSSTR tool. 
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In the table 6 the summary of  all CD experiments is shown. The most significant 
observation is, that remove of C-terminus from the wild type protein (NSP5∆C19 mutant) is 
reflected by a huge drop of total α-helices percentage, indicating, that most of α-helical 
elements are situated in the carboxy-terminal part of NSP5. This is concordant with the 
secondary structure predictions (Fig. 44) and confirmed by previous observations, that this 
region of the protein is involved in NSP5 dimerizaton. This result may suggest, that the 







  190         200                       220              240                      260    
 
Fig. 51. NSP5 ∆C19 spectra. Experimental data in machine θ units (mdeg) and converted to MRE 
units data, reconstruction adjusted by CDSSTR tool. 
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Protein NRMDS α-helices (%)  
 
β-strands (%)  Turns (%) Unordered(%) 










29.9 17.4 44 
 
NSP5∆N32 0.042 18 22 16 43 
















Tab. 6. The contents of the secondary structures elements etimated by ContinLL and CDSSTR 
tools on the basis of  far-UV circular dichroism experiments performed on NSP5 wt and its mutants. 
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Rotavirus NSP5 is phosphorylated and O-glycosylated s rine- and threonine-rich 
nonstructural protein, that localizes in viroplasms of virus-infected cells. It undergoes a 
complex posttranslational hyperphosphorylation, generating species with reduced PAGE 
mobility.  The phosphorylation of NSP5 is a complex process that requires in the initial steps 
the interaction of at least three different partners, the substrate NSP5 in a dimeric form, NSP2, 
as a possible inducer of conformational change in NSP5 to make Ser 67 accessible for 
phosphorylation, and the cellular kinase, CK1α, responsible for such activity. The presence of 
glycosilation and phosphorylation in NSP5 was already known, but there was no evidence 
about their range and contribution to the protein’s function. In this work we attempted to map 
these modifications using MALDI-TOF/TOF spectroscopy as a tool. The collected data 
allowed us to add new information on how particular regions of NSP5 are modified.  
Structural organization of NSP5 was unknown and in th s work we found new data, that can 
contribute to this subject. In this discussion section we wanted to address the questions and 
conclusions, that appeared during these studies, and find the common points between all the 
three parts of the thesis. 
 
One of distinguishing features of NSP5 in infected cells is its complex migration 
pattern observed in SDS-PAGE, as a consequence of its hyperphosphorylation. In some of the 
previous studies NSP5 was presented to have a kinase activity, and the pattern of its 
phosphorylation in virus infected cells has been proposed to be, in part, due to 
autophosphorylation. However, no clear evidences of NSP5 enzymatic activity have been 
reported, so the data that support that theory are ve y poor and not consistent with the 
characteristics described for eukaryotic kinases [49] [257] [258] [161]. 
NSP5, when expressed alone, is mostly non-phosphorylated, whilst interaction with 
NSP2 was shown to induce a phosphorylation cascade [49]. The studies performed in our 
laboratory suggested, that NSP5 hyperphosphorylation is a multi-step process that requires 
activation of the NSP5 substrate. We speculated the existence in NSP5 of regions specific for 
the activation of a cellular kinase or the substrate. The use of NSP5 deletion mutants proved 
to be a useful strategy to understand the molecular bases of this process. We decided to study 
a number of different deletion mutants on their ability to become phosphorylated in vivo. 
These studies revealed that two clearly distinct prope ties of the protein, related to its own 
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phosphorylation could be uncoupled: one such property was related to its capacity to be a 
substrate and the other one was related to its capacity to become an activator of the 
phosphorylation process [6]. 
The conclusion from a series of experiments previously carried out in our laboratory is that 
regions 1, 3, or both, prevent transfected NSP5 from getting hyperphosphorylated when 
expressed alone, suggesting that these two domains act as internal inhibitors in the 
phosphorylation mechanism [49] [152] [149] [6]. In fact, deletion of either region 1 or 3 (or 
both) render NSP5 able to be phosphorylated. In addition, a mutant such as ∆2, which does 
not get phosphorylated at all, becomes an excellent substrate when co-expressed with ∆1 or ∆ 
1/ ∆ 3, thus indicating that region 2 is involved in inititating the cascade.   One could 
speculate that in virus-infected cells, interaction with NSP2 may neutralize the inhibition of  
the  two inhibitory regions. 
Thus, we intended to study the role of the region 2 in the activation of 
phosphorylation. We decided to investigate, if phosphorylation of serines present in this 
region could be involved in such process. We selectd in this region two serine motifs. The 
first motif, called  motif a (Ser-Asp-Ser-Ala-Ser ), consists of three serines at positions 63, 65 
and 67, and the second one named motif b (Ser-Phe-Ser-Ile-Arg-Ser), contained serines 73, 75 
and 78. To study these motifs, the serines were point mutated to alanine in mutant ∆3, that 
was previously demonstrated to play an activator role in the hyperphosphorylation 
mechanism. We showed, that the point mutations in serines of motif a, blocked two different 
functions of NSP5- its hyper-phosphorylation and the cellular kinase activation. A precise 
analysis of the three serines present in this motif, revealed clearly that serine 67 was 
responsible for the lack of activation function. This was confirmed with the mutation from 
serine to aspartic acid (this amino acid can mimic phosphorylated serine, due to the length and 
the negative charge of the R group [259]. The results strongly suggested, that a phosphate in 
serine 67 was required to restore kinase activation and ability to be hyperphosphorylated. 
More importantly, when this mutation (S63, 65A and S67D) was introduced in the full-length 
NSP5, the protein gained the ability to become hyperphosphorylated, a property that was not 
possible for the NSP5 wt alone, but that is characte istic for NSP5 in virus-infected cells (that 
is, in the presence of NSP2). On the other hand, co-expression of NSP2 with NSP5a 
(S63A,S65A,S67A) did not produce its hyperphosphorylation, while NSP5 S67D 
(S63,65A,S67D) was hyper-phosphorylated even in the absence of NSP2. These results 
(experiments performed by Dr Catherine Eichwald) toge her with the fact that deletion 
mutants ∆1, ∆3 and ∆1/∆3 are hyperphosphorylated in vivo in absence of other viral proteins 
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[49] [152], suggested that NSP5 hyperphosphorylation is due to conformational changes in 
NSP5, produced by the interaction with NSP2, a situation that can be mimicked by deletion of 
regions 1, 3 or both, that play an inhibitory effect. In this hypothesis, serine 67 becomes 
available for phosphorylation by a cellular kinase(s), and this event makes the protein a 
permissive substrate for phsophorylation of serines and threonines of other regions, especially 
in region 4.  
The next question we pointed was, if we could determine the kinase that is responsible 
for serine 67 phosphorylation. Among phosphorylation sites of known kinases we did not find 
exactly the sequence encompassing the motif with serine 67 that fit the consensus. However, 
the sequence similarity between consensus phosphorylati n sites of CK1 (D/EXXS*/T*, 
where X is any amino acid, D is aspartic acid, E glutamic acid and S*/T* are the target serine 
or threonines) and motif a (SDSAS), suggested the possibility that motif a was a non-classical 
phosphorylation site for CK1, suggesting that this kinase could be involved in 
phosphorylation of serine 67. Experiments performed in vitro using of a recombinant CK1α 
from zebrafish confirmed this hypothesis. In the experiments two synthesized peptides, 
encompassing motif a from wt protein and with serine 67 mutated to alanine, confirmed that 
this sequence was a substrate for CK1α. Subsequent experiments with  recombinant proteins 
produced in E. coli used as substrates, supported this finding.  
However, not only phosphorylation of serine 67 by CK1α has a crucial role in the 
hyperphosphorylation process of NSP5. The lack of the tail (T) in deletion mutants with well 
established activation function, like ∆1 and ∆1/∆3, hindered their capacity to 
hyperphosphorylate the substrate SV5-∆2. As described earlier [161], the last C-terminal 10 
amino acids of NSP5 appear to be involved in the int raction with another NSP5 molecule, 
that results in the dimerization of the protein.  
On this basis we proposed a model for NSP5 hyperphosphorylation. In this model 
(Fig. 28), NSP5 molecule interacts with NSP2 and this interaction renders NSP5 sensitive to 
phosphorylation by CK1 on the serine 67. This phosprylation step is essential, because 
phosphorylated serine 67 switches a cascade of events l ading to hyperphosphorylated 
protein. This event is followed by, or parallel with dimerization of activator and substrate 
through the C-terminal tailpiece. The Ser-67 phosphrylated component activates the other 
monomer of the dimeric complex rendering it (or both) susceptible to hyperphosphorylation. 
In the above mentioned in vitro studies with recombinant CK1α from zebrafish, we have 
suggested that the cellular kinase CK1α can be responsible for the whole 
hyperphosphorylation [6]. However recent studies by means of specific RNA interference 
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technique performed in our laboratory by Dr Michela C mpagna showed, that CK1α  is the 
enzyme that only initiates the cascade of NSP5 phosphorylation, indicating, that kinases other 
than CK1α are involved in vivo in the downstream process. Depletion of CK1α results in lack 
of NSP5 hyperphosphorylation, that however did not affected neither its interaction with the 
virus VP1 and NSP2, proteins normally found in viroplasms, nor the production of viral 
proteins. In contrast, the morphology of viroplasms was clearly altered in cells, in which 
CK1α was depleted and a moderate decrease in the production of double-stranded RNA and 
infectious virus was observed [242].  
 
In the second part of the thesis I have presented our studies on posttranslational 
modifications of NSP5. It was previously known that NSP5 is post-translationaly modified by 
introduction of two types of modifications: O-glycosylation [146] and phosphorylation [3] 
[49] [241]. Glycosylation of NSP5 consists in the addition of O-linked N-acetyloglucosamine 
(O-GlcNAc) monosaccharide residues to serines and threonines. Although it is not fully 
clarified, the O-glycosilation can be important, since many of known GlcNAc-modified 
proteins are also phosphoproteins [148]. In many cases the sites of phosphorylation and 
GlcNAcylation are localized to the same or neighboring residues (serines or threonines). 
Moreover, O-GlcNAc modification is transient, so direct interaction between glycosylation 
and phosphorylation can take place, regulating the protein’s function and activity. Although 
the phosphorylation of NSP5 is responsible for the different isoforms visualized in PAGE (λ-
phosphatase treatment reduces all of them to a single mi rating band), it is not known whether 
the different isoforms have also changes in the levl of O-glycosylation.  
With the objective to map posttranslational modificat ons of NSP5, we performed 
studies on the protein using MALDI TOF/TOF spectroscopy. As a source of NSP5 for the 
analysis we used rotavirus infected cells, because our aim was to study the original 
modifications  occurring on NSP5 during the viral life  cycle, especially during the replication 
process, that could play an important role on NSP5 activity. Unfortunately, the amount of 
protein we were able to obtain using this method was low. To ensure the accuracy of the 
experiments, the samples were prepared for MALDI analysis by two different methods and 
three different strains of rotavirus were used for infections. The sequences of NSP5 encoded 
by these strains differ slightly, so some peptides resulting from the trypsin digestion of the 
same regions of the proteins have different masses, th refore when comparing results we 
could observe similarities in modifications of certain regions of the protein and we could 
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diminish the possibility of false data generation. The samples analyses let us to find many 
interesting observations. 
 One of the findings was that among the collected data, the peptide encompassing 
serine 67, non-phosphorylated or with one phosphate add d, was present. As described earlier 
serine 67 is phosphorylated by CK1α and this event starts the phosphorylation process of 
NSP5. Interestingly, we did not find the phosphorylated peptide in the lower 26kDa band, but 
only in the upper bands of the PAGE analysis (or among peptides prepared by direct 
trypsinization of the immunoprecipitate). One possibility is that since the phosphorylation of 
serine 67 triggers the cascade, subsequent phosphorylations should occur very fast. Therefore, 
after serine 67 phoshorylation by CK1, the protein would be immediately 
hyperphosphorylated and shifted to higher bands of SDS-PAGE gel.  Previous experiments 
with λ-phosphatase treatment revealed that the 26kDa band still contains phosphate,  
demonstrating resistance of some sites to phosphatases [3]. Even so, the obtained data suggest 
that phosphate observed in 26kDa band does not belong to serine 67.   
 The whole analysis let us to conclude, that region 1 of NSP5 is very heavily 
glycosilated. The role of this glycosilation is not clear, but it was demonstrated in literature 
that GlcNAc attachment can play a protective role [260], preventing the N-terminal part from 
degradation by cellular proteases. Analysis of NSP5 sequence, performed by the YinOYang 
1.2 server (http://www.cbs.dtu.dk/services/YinOYang/), that predicts O-GlcNAc acceptor 
sites,  revealed the similarities between computed results (Fig. 52) and obtained experimental 
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Fig. 52. Oryginal output of YinOYang 1.2 Prediction  Tool, that computed O-GlcNAc acceptor 
sites in NSP5 sequence (the protein’s regions are d emonstrated as a bar above the graph). Up 
to the prediction the N-terminus of NSP5 is heavily -glycosilated, that is consistent with 
experimental data. 
 
Furthermore, the first part of region 3, spanning from the position 80 to 115 was not 
represented in most of the experiments. The possible explanation for this fact can be, that this 
peptide may not be ionized well enough, so the machine was not able to read its signal. There  
are  two  main  effects  influencing  the  signal  intensity  of  a  peptide:  first,  the amount  of  
peptides  incorporated  into  the MALDI  crystal  depends  on  the  peptide  itself  and  on  the 
sample  preparation.  Second,  the  capability  to  become  ionized  differs  from  peptide  to  
peptide, depending on their sequence [261]. Another, possible reason for the  absence of this 
peptide in most analyses can be the fact, that it is so highly modified that its mass was out of 
an efficient range of the spectrum reading. In contrast, sequence between aa 115 and 134, 
assigned also to region 3, was abundantly recognized in all the experiments both, non-
modified and modified. This region of NSP5 sequence is different in the three analyzed 
strains (OSU, RF and SA11). In the bovine RF strain, e ght potential modification sites are 
present, and in its case, three added sugar moieties and two phosphorylation sites were 
characterized. OSU strain contains only four serines and one threonine in the same peptide 
and we managed to map in these region one glycosylation nd one phosphorylation site. 
Interestingly, glycosilation range of this region is are also similar to the result generated by 
the YinOYang 1.2 Prediction Server. 
 The beginning of region 4 revealed the addition of one N-acetyloglucosamine in all 
the three strains. Moreover, up to the previous data obtained in our laboratory [149], this 
 REGIONS:    1          2                             3       4                T 
  Discussion  
  129 
region was assigned to have main phosphoacceptor sites. Results obtained by MALDI 
TOF/TOF confirmed that this part of NSP5 is phosphorylated, because at least two 
phosphorylation sites were determined to be present th re. 
Finally, all the peptides that form the end of the region 4 and the tail were completely 
reconstituted and found as not modified, as this region of NSP5 lacks serines and threonines. 
The idea of enclosing methylation and acetylation t selected posttranslational 
modifications increased the abundance of obtained data, nevertheless this eventuality must be 
still confirmed by biochemical studies on infected cells.  
 
There was no evidence about the structure of NSP5, and since this kind of information 
often can add invaluable insight in understanding the function of a protein, we decided to 
study also this subject. For this purpose we produce  recombinant NSP5wt and some mutants 
and used them to study their structural features. Fir t, we tried to produce NSP5wt using an 
eukaryotic expression systems. We tested the use of vaccinia expression system and Sindbis 
virus replicon expression system, but these systems did not ensure appropriate expression 
levels of NSP5, required for structural studies. The yield of protein produced was extremely 
low and we then moved to the use of a bacterial expression system instead. NSP5 was 
produced in E.coli with a high yield, although we were unable to find conditions to produce 
the protein in soluble form. Standard changes of prcedures, such as different strains used for 
protein production and lower temperature of bacteria cultivation, did not help to increase 
NSP5 solubility and prevent inclusion bodies formation. NSP5 production in bacteria was 
followed by development of an efficient two-steps purification protocol and refolding 
procedure. Refolding was performed by very slow remove of denaturing agent by dialysis, in 
constant presence of DTT, to prevent disulfide bonds formation because NSP5, as a 
cytoplasmic protein, does not have them. 
The biological activity of renaturated NSP5 was tested by the interaction with its 
molecular partner- NSP2. Designed ELISA-based binding assay demonstrated, that at least 
some pool of renatured protein is folded and has the ability to bind NSP2. Although the full-
length NSP5 was produced with a satisfactory protein purity, significant precipitation was 
observed. This problem was also found in recently published literature [117], and hence this 
fact strikes off the protein for more detailed structural studies like crystallization. It was then 
decided to look for more suitable constructs. 
To achieve this aim we used limited proteolysis assay, as a tool to design constructs 
better suited for structural biology studies. Limited proteolysis involves the incomplete 
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digestion of a protein by a protease. The partial digestion of a protein defines the fragments 
resistant to proteolysis and, therefore, expected to have a more compact structure. In contrast, 
flexible and exposed to solvent regions are prone t be digested.  
The results coming from these experiments were quite surprising. As a protease we 
used trypsin, and despite the fact that NSP5 sequence contains a large number of cleavable 
sites we found that a big part of the protein was resistant to proteolysis. Examination by mass 
spectrometry of the bands remaining revealed that te part prone to digestion was the N-
terminus. The link between this result and our previous observation, that in Eukaryotic cells 
the N-terminus of NSP5 is heavily glycosilated seems to be apparent. In bacteria the protein is 
not posttranslationaly modified, so carries no sugar. The sensibility of this region to digestion 
may signify that it does not have an organized structure, or is not buried inside the protein and 
so being exposed to the solvent is sensitive to the protease. This would be consistent with the 
hypothesis of the possible protective function of N-terminus glycosilation.  
 The part of the protein starting exactly at the beginning of region 2 (from aa 33) 
remained, in contrary, resistant to trypsinolysis. On the basis of this experiment we generated 
a new construct with the first 32 N-terminal residues deleted (His6NSP5-∆N32) that we 
subsequently produced, purified and refolded.  
The suggestions from previous studies as well as predictions of secondary structures 
were strong enough to induce us to produce another mutant. Most of secondary structure 
prediction methods indicated that the last 25-30aa of NSP5 could be involved in the formation 
of an α-helical structure. Since it was demonstrated earlir that the C-terminus is involved in 
dimerization [161], we speculated that this α-helix could be the reason of protein dimerization 
by interaction between two α-helices. We also hypothesized, that outside of the cell 
environment and without the molecular partners, NSP2 and VP1, this C-terminal α-helices 
could oligomerize, causing problems, like protein’s agregation.  We decided to delete last 
19aa in purpose to investigate if this kind of construct was a better candidate for obtaining 
some new information about NSP5 structure. 
The production of His6NSP5-S67D was inspired by the fact, that it has an ability to 
become hyperphoshorylated even in the absence of NSP2. An introduction of aspartic acid in 
the position of serine 67 mimics phosphorylated serine. Since, we hypothesized, that 
interaction with NSP2 change the conformation of NSP5 and renders it to become susceptible 
to phosphorylation, we wanted to check, if the different behavior of S67D mutant alter the 
secondary structure content, in comparison to the wt protein.   
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All the purified proteins were analyzed by size exclusion chromatography, to estimate 
their aggregation level. Although, we did not notice the precipitation of the  newly produced 
truncation mutants, they were tested by gel filtraton chromatography. Unfortunately, all 
proteins were eluted in the void volume, confirming that some level of aggregation was taking 
place. The only protein that was not eluted in a homogenous peak with the void volume, but 
generated also a second peak reflecting the size of a dimer was His6NSP5-∆N32. The 
collected peak was analyzed by Western blotting  confirming that consists NSP5. Most likely 
a fraction of the refolded protein managed to maintain its proper structure without becoming 
aggregated. It is also possible that during refolding slight degradation occurred suggesting that 
even a shorter construct was required for structural studies, concordantly with recent studies 
performed by cryoelectron microscopy structures of NSP2-NSP5 complexes, where a 
construct encompassing aa from 66 to 188 were succesfully used [117].  
To investigate the secondary structure of NSP5 the proteins were analyzed by circular 
dichroism spectroscopy. Despite of some attempts, we did not manage to obtain promising 
NSP5 crystals and studies are still in the course. Having in our hands the full length protein, 
one point mutation and two truncation mutants, we were able to draw interesting conclusions 
about the structural organization of NSP5. Analysis of the results showed, that renaturated 
proteins were folded with a percentage of random coil (reaching almost 50%), which 
indicated a relevant content of unordered regions. Although introduction of a negatively 
charged residue at position 67 (aspartic acid) in S67D mutant changed NSP5 ability to get 
hyperphosphorylated without interaction with NSP2, it did not effect the spectrum shape, 
suggesting lack of secondary structure alteration. The analysis revealed significant amount of 
β-strands, but it is known that accuracy for assessmnt of protein secondary structure by CD 
is more accurate for α-helices. The very similar spectra of ∆N32 mutant and wt protein 
suggests that the N-terminal part does not fold into either α nor β structures. The most 
meaningful observation was that removal of the C-terminus from the wild type protein 
(NSP5∆C19 mutant) caused a drop of total α-helices percentage, pointing that most of the α-
helical elements are situated in the carboxy-terminal part of NSP5, concordantly with 
predictions. We suppose, that the NSP5 dimerization may occur by formation of coiled-coil 
structure between two α-helices.  
High amount of unordered elements and presence of distinctive C-terminal α-helix, 
obtained by far-UV CD experiments, was in accordance with a  model (Fig. 53.) obtained by 
Porter, a new accurate server [262] for protein secondary and tertiary structure prediction.  
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The high percentage of disorder determined by CD experiments induced us to consider 
the possibility, that NSP5 is an intrinsically unfolded protein. Intrinsically 
unstructured/disordered or natively unfolded proteins have a broad occurrence in living 
organisms. They are characterized by the lack of stable secondary and tertiary structure under 
physiological conditions in the absence of a binding partner/ligand. Intrinsically disordered 
proteins fulfill essential functions, which are often linked with their disordered structural 
state. This kind of proteins tend to have a low sequence complexity, although it is not a 
general rule [263]. It has been shown recently thate more low-complexity regions an 
eukaryotic protein has, the less it is likely to be solubly expressed in bacteria. This can be true 
also in case of NSP5 and might be related to the fact th t low-complexity regions, which are 
more frequent in eukaryotic proteins than in bacterial proteins, are more sensitive to 
proteolytic degradation [264]. Disordered regions often prevent crystallization of proteins, or 
the generation of interpretable NMR data. Therefore, structural biologists use disorder 
predictions to delineate compact domains to solve their 3D structure, or to dissect target 
sequences into a set of independently folded domains in order to facilitate tertiary structure 
and threading predictions [265] [266].  
Taking into consideration these information we run a series of predictions of 
disordered regions in NSP5 (with a kind help of Dr.Sonia Longhi). The analysis was made 
using hints found in [265], all the addresses of used ervers can also be found in the cited 
Fig. 53. Secondary and tertiary NSP5 structure prediction carried out by PORTER server. Visible  
C-terminal  α-helix. Model pictured  by VMD program. 
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paper. The graphed result of this analysis we demonstrated in figure 54. The level of disorder 
predicted  by all the tools is very high, e.g. RONN indicates the regions lacking 3D structure 
in native conditions, and in case of NSP5, it is all the sequence length without its C-terminus 
and short region spanning from aa 110 and aa 125, that is predicted to form 3 short β-sheets. 
In yellow shading (aa 1-19, 47-54, 174-196) are shown the regions, that could fold in the 
presence of a molecular partner, so NSP2 or VP1. This regions are too short to be able to fold 







Summarizing, it is highly possible, that NSP5 is a naturally unstructured/disordered 
protein. Its significant portion can be flexible or disordered, and some regions of the protein 
can change the conformation under the interaction with its partners. NSP5 interacts with 
NSP2 and VP1 and it also binds nonspecifically to RNA, so its disordered nature may be 
necessary to impart the dynamics necessary to coordinate its functions in genome 
replication/packaging and assembly. Previous structu al analysis of NSP2-RNA complexes 
indicated that RNA and NSP5 bind to very similar positively charged regions near the twofold 
axes of the NSP2 octamer [117].  It is known that te 48aa of C-terminus are essential for 
interaction with VP1 [50], the N- and C-terminal parts of NSP5 are required for the 
interaction with NSP2, 30 amino acids of region 3 could also be important [150]. These 
Fig. 54.  Results of disorder regions for NSP5 (OSU strain) performed by different methods.  
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regions may flexibly change its conformation, when they interfere with the ligands.  The 
glycosilation of the N-terminus can play the protective role against cellular proteases when 
this part of the protein is not under interaction. The meaning of phosphorylation still remain 
unclear, however it can play some particular role in maintaining the dynamic equilibrium of 
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